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Evaluation of liver resident Kupffer Cells (KC) has shown that in mouse these cells derive from 
a population of foetal liver monocytes that seed the tissues during embryogenesis and 
maintain themselves in steady state conditions independently of circulating monocytes, via 
local proliferation. The factors which regulate this KC autonomy have not yet been 
determined, but likely comprise both biochemical and physical factors which form their 
‘niche’. Furthermore, their regulation, and specifically whether they retain total autonomy 
from monocyte-derived macrophages following liver injury has not been extensively studied. 
In this thesis I aimed to address the role of availability of the macrophage growth factor CSF1 
in maintenance of KC and their autonomy from monocytes in homeostasis, and the roles and 
long-term fate of KC and monocyte-derived macrophages following acute and chronic liver 
injury.  
An optimal method for isolation and identification of F4/80hiCD11blo KC for flow cytometric 
analysis was first established. To explore the role of CSF1 in maintenance of KC, Csf1r-mApple 
mice were generated which revealed that KC expressed the highest levels of the csf1r-
mApple transgene compared with other leukocytes in the liver. In vivo administration of 
fluorescently-labelled CSF1-FcAF647 revealed that KC captured 10x more circulating CSF1 per 
cell than other myeloid cells in the liver and lung, suggesting efficient capture of CSF1 may 
be one mechanism that allows KC to regulate differentiation of monocytes in the liver. 
Delivery of CSF1-Fc to chimeric mice led to an increase in proliferation and accumulation of 
resident KC and a transient increase in the number of bone marrow-derived F4/80hiCD11blo 
cells in the liver, which were lost by 2 weeks following withdrawal of CSF1-Fc. These bone-
marrow derived macrophages did not express the putative KC marker Tim4, indicating that 
they did not fully adopt a KC phenotype. 
Acute CCl4-driven liver injury resulted in a transient loss of approximately 50% of the resident 
KC population which recovered in number by 6 days post injury, through proliferation of the 
remaining KC. This was despite the fact that injury led to the massive recruitment of 
monocyte-derived macrophages some of which matured into an F4/80hiCD11blo population, 
but which also lacked Tim4 expression. These cells were spatially distinct from KC and were 
found clustered around blood vessels, presumed to be the region of necrotic damage. 
Comparison of gene expression was consistent with their involvement in tissue repair. 
Following CCl4-driven chronic liver injury, KC were depleted in number, but unlike in acute 
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injury, the population did not return to normal numbers even 8 weeks following cessation of 
treatment. This time, the recruited macrophages these were not found in clusters but 
alongside resident KC in the parenchyma. However, in both acute and chronic injury, 
monocyte-derived macrophages could no longer be seen 8 weeks after injury, and did not 
mature into long-lived, self-renewing KC.  
In conclusion I found that CSF1 is one of the major limiting factors that dictates the size of 
the KC niche, but additional factors are required to fully support monocyte engraftment to 
the KC population. Following CCl4-driven acute liver injury, monocyte-derived macrophages 
do not contribute long-term to the KC population despite exhibiting a F4/80hiCD11blo 
phenotype during the latter stages of liver repair. KC are depleted long-term following CCl4-
driven chronic liver injury, but monocyte-derived macrophages remain unable to replenish 




Macrophages are cells of the immune system present in every organ in the body. They 
maintain tissue health by clearing dead and dying cells, and also switch on other immune 
cells when there is injury or infection.  
Liver disease represents a serious global health and economic burden and macrophages are 
involved in disease progression and repair and regeneration. In the healthy liver there is one 
population of macrophages but during liver disease these cells are out-numbered by an 
additional population of macrophages which are recruited from the bone marrow.  
These two populations of macrophages have differing roles and to target them for 
therapeutics we must first understand the differences between them. Additionally, 
macrophages which arrive in the liver during disease may replace the resident population 
that was present in the healthy liver. This may have long-term adverse consequences for liver 
function.  
I aimed to understand how macrophages are maintained in healthy and damaged liver using 
animal models and markers to distinguish between the resident and recruited macrophages. 
I found that the resident macrophages present in the healthy liver are very separate from 
the recruited macrophages, and were not replaced by them following acute or chronic liver 
injury. I found that multiple factors contribute to the maintenance of the healthy liver, 
including a growth factor, and possibly being in direct contact with other cell types in the 
liver. The recruited macrophages honed to the area of injured liver and may play a role in 
tissue repair. Increased understanding of the relationship between these two types of 
macrophage may help with developing new therapies to treat liver injury and disease. 
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Chapter 1:  Introduction 
 
1.1 General overview 
Immunology is a broad term that encompasses the study of immune responses to injury, 
infection and disease, to self-antigens resulting in allergy, auto-immunity or cancer, but also 
the homeostatic role of innate immune cells in maintaining tolerance to food, pollen and 
microbiota antigens, in clearance of dead and dying cells, and tissue remodelling. At the heart 
of these homeostatic immune functions are macrophages, which are present in vast numbers 
in all tissues of the body. Cells with macrophage-like morphology and function appear across 
both vertebrate and invertebrate species including worms, molluscs and sponges (Buchmann 
2014), indicating that they have highly conserved and indispensable functions. Elie 
Metchnikoff noted macrophages first in 1882 when he described their phagocytic functions 
within tissues. Macrophages are an extremely diverse group of cells which maintain tissue 
health, initiate inflammatory immune responses, but conversely also dampen inflammation 
and contribute to tissue repair. They can be short-lived and recruited from bone marrow 
precursors in times of inflammation or stress, or they can be very long lived, surviving in the 
tissue from before birth and into adulthood, proliferating in situ. Thus the term ‘macrophage’ 
encompasses a great number of distinct cell populations, of which the roles and 
developmental relationships between them are still to be fully understood; the major 
paradigm that in adults macrophages are continually replenished by their precursors 
monocytes from a pool of haematopoietic stem cells, which has largely governed our 
understanding of macrophage biology for the last century and a half, is currently being 
rewritten. In this introduction I will first summarise the roles of monocytes and macrophages, 
and will then examine in detail what was known about their origins and developmental 
relationships at the point at which I commenced this project. I will then focus on the resident 
macrophages of the liver, Kupffer Cells (KC), as the maintenance and origin of KC forms the 
focus of this thesis.  
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1.2 Tissue macrophages and the mononuclear phagocyte system 
1.2.1 Traditional view of the mononuclear phagocyte system 
After their initial discovery, the cellular origin of macrophages was heavily debated in the 
earlier half of the 20th century, driven by a desire within the scientific community to classify 
macrophages into their correct ‘system’. Aschoff observed in 1924 that endothelial cells were 
also capable of phagocytosis and grouped the two cell types into what he called the 
‘reticuloendothelial system’ (Aschoff 1924). This term was used by immunologists and 
clinicians until van Furth and Cohn proposed that macrophages be grouped into the 
‘mononuclear phagocyte system’ (MPS) along with their pre-cursors monocytes (van Furth 
et al. 1972). This new classification was made on the basis that tissue macrophages were 
observed to be replenished by blood monocytes after lethal irradiation, and that monocytes 
were also capable of phagocytosis (van Furth et al. 1972). Thus it became dogma that all 
macrophages present in the steady state and during infection and inflammation are derived 
from bone marrow haematopoietic stem cell (HSC) precursors via a circulatory monocytic 
intermediary. Although some aspects of this original proposal have been demonstrated to 
hold true, the linear description that bone marrow precursors give rise to monocytes which 
give rise to macrophages is overly simplistic, and will be discussed in further detail later in 
this introduction.  
 
1.2.2 Monocytes subsets and function 
Adult monocytes are circulating cells which mature in the bone marrow (BM) from HSCs via 
a series of progenitors: first the Common Myeloid Progenitors (CMP), which give rise to 
Monocyte and Dendritic Cell Precursors (MDP) and then the Common Monocyte Progenitor 
(CMoP) (Hettinger et al. 2013). In mice, monocytes can be split into two subtypes, delineated 
on the basis of Ly6C expression: Ly6Chi, or classical monocytes, and Ly6Clo, or non-classical 
monocytes. These subsets parallel CD14+CD16- and CD14-CD16+ monocytes in humans 
respectively (Ziegler-Heitbrock et al. 2010). The murine subsets can be further defined by 
their expression of chemokine receptors; Ly6Chi monocytes express CCR2, but express only 
low levels of CX3CR1, whilst Ly6Clo monocytes are CCR2- but express high levels of CX3CR1. 
Ly6Chi monocytes require CCR2 to emigrate from the bone marrow into the blood, and they 
accumulate in the bone marrow of Ccr2-/- mice (Serbina and Pamer, 2006). Studies that used 
adoptive transfer of both monocyte subsets from CX3CR1+/GFP mice suggested that the role 
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of classical monocytes was to emigrate from the circulation to tissues during inflammation, 
whilst non-classical monocytes were recruited to tissues under homeostatic conditions 
(Geissmann et al. 2003). However, more recent studies indicate that the two subsets 
represent a developmental sequence, with short-lived Ly6Chi monocytes, which have a half-
life of around 20 hours (Yona et al. 2013), giving rise to the more long-lived (4-10 days) Ly6Clo 
monocytes (Varol et al. 2007; Yona et al. 2013). An additional heterogenous ‘transitional’ or 
Ly6Cint subset (or CD14loCD16+ in humans) has also been defined (Ziegler-Heitbrock et al. 
2010; Mildner et al. 2017), further supporting their developmental relationship. Whilst Ly6Chi 
monocytes very clearly do give rise to macrophages in both homeostasis and inflammation 
(Guilliams et al. 2018), the role of monocytes is now thought to stretch beyond simply that 
of a precursor to macrophages, as they also have important functions in their 
undifferentiated state. For example, Ly6Clo monocytes have been observed to patrol the 
lumen of blood vessels, and have even been termed the ‘resident macrophage’ of the 
circulatory system (Hanna et al. 2011; Carlin et al. 2013; Auffray et al. 2007), as in 
homeostatic conditions they remove cell debris, phagocytose apoptotic cells, and present 
antigen which may also lead to tolerogenic responses (Thomas et al. 2015).  
 
1.2.3 Roles of tissue macrophages 
Macrophages are large, highly differentiated myeloid cells found in every tissue in the body. 
They have protrusions which allow them to ‘feel’ into the tissue, giving them a stellate, or 
star-like appearance. The name macrophage translates literally from Greek as ‘big eater’, an 
accolade to their highly efficient phagocytic ability. However, their roles are many and 
diverse, contributing to maintenance of healthy tissue, responding to infection or injury and 
subsequent tissue repair. Additionally, inappropriate activation of macrophages can lead to 
autoimmunity and cancer.  
In the steady state, macrophages perform a host of functions including tissue surveillance, 
phagocytosis of dead and dying cells, tissue remodelling, and providing cytokines and 
chemokines. The precise nature of the role of macrophages is specific to the tissue in which 
they reside, and although core shared functions of macrophages across tissues are 
programmed by macrophage lineage transcription factors such as PU.1 (Lavin et al. 2014), 
they also exhibit transcriptional identities that arise in response to local  microenvironmental 
signals (Lavin et al. 2014; Epelman et al. 2014b), resulting in highly specialised functions. For 
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example, alveolar macrophages (AM) clear excess surfactant in the alveolar space, and AM 
depletion either directly or as a result deficiency in their main growth factor GM-CSF leads to 
pulmonary alveolar proteinosis (Dranoff et al. 1994; Forbes et al. 2007; Trapnell et al. 2009). 
In the brain, microglia (the resident macrophage population) are required for efficient 
synaptic pruning, and CX3CR1-knock out mice which have a severe reduction in microglia 
demonstrate delayed pruning and immature synapses (Paolicelli et al. 2011). Splenic red pulp 
macrophages are efficient at recycling iron from senescent red blood cells which filter 
through the spleen (Kohyama et al. 2009), whilst peritoneal macrophages can respond to 
local retinoic acid signals to control IgA production by B1 cells (Okabe and Medzhitov 2014).  
Macrophages are also professional antigen presenting cells, expressing MHCII on their 
surface (Hume 2008), and their presentation of self-antigen along with innocuous particles 
breathed in the air or ingested in food, appears to actively suppress T cell-specific responses, 
resulting in peripheral tolerance (Heymann et al. 2015; Munn et al. 1996). The pan 
macrophage marker F4/80 appears to be required for this tolerogenic response as mice 
deficient in functional F4/80 fail to develop CD8+ T regulatory cells capable of suppressing an 
antigen-specific delayed-type hypersensitivity reaction (Lin et al. 2005). 
In addition to their steady state roles, macrophages are a critical part of the innate immune 
response to infection and injury. They are activated very early in the immune response 
through their recognition of damage associated molecular patterns (DAMPs) and pattern-
associated molecular patterns (PAMPs) via pattern recognition receptors (PRRs). DAMPs are 
released by dying cells and include molecules such as heat shock protein 60 (hsp60) – which 
is detected by the toll-like receptors TLR2 and TLR4 resulting in TNF-a secretion and nitric 
oxide production (Ohashi et al. 2000) – or ATP which acts as a ‘find-me’ signal, promoting 
their phagocytosis of apoptotic cells by macrophages (Elliott et al. 2009). PAMPs are 
conserved moieties derived from pathogens, for example LPS, which is sensed by TLR4 
leading to a proinflammatory response via an IL-6 pathway (Greenhill et al. 2011). Once 
activated, macrophages can also recruit additional immune cells via chemokine secretion. 
Neutrophils are recruited first, for example to the spleen at the onset of Candida infection 
due to CXCL1 and CXCL2 production by splenic red pulp macrophages (Kanayama et al. 2015). 
Monocytes are then recruited to tissues and rapidly differentiate into macrophages where 
they also contribute to the inflammatory immune response but then switch to a pro-
restorative phenotype, contributing to wound healing (Minutti et al. 2017). Thus resident 
macrophages and monocyte-derived macrophages very often co-exist during the 
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inflammation and repair phases of injury or infection, although in many injury and infection 
models their exact differing roles are still to be clearly defined. For example, although use of 
LysMCre-DTR mice to delete macrophages clearly demonstrated delayed wound closure in a 
skin inflammation model compared to control mice (Lucas et al. 2010), this model could not 
distinguish between resident and recruited macrophages since LysM is universally expressed 
by macrophages and monocytes as well as neutrophils (Orthgiess et al. 2016). However, tools 
to better distinguish between resident and recruited macrophages, and monocytes are 
currently available and are detailed below.  
 
1.2.4 Tools to assess the relationship between monocytes and macrophages 
There are a range of tools available to investigate the relationship between monocytes and 
macrophages, allowing researchers to deplete specific macrophage or monocyte 
populations, and trace their differentiation, proliferation and survival. Total body, lethal 
irradiation of mice leads to severe depletion of bone marrow cells, and of many radio-
sensitive immune cell populations in tissues, including resident macrophages in most organs. 
Reconstitution with bone marrow from a congenic mouse strain produces a chimera in which 
HSCs are of donor bone marrow origin, allowing their fates in tissues to be tracked using flow 
cytometry or imaging methods. Although irradiation chimeras have been used for decades 
in macrophage research, the improvement in multi-colour flow cytometry over the last 10 
years or so has allowed for much more detailed and sophisticated analysis of the monocyte 
and macrophage compartments in more recent studies. Currently, the most commonly used 
system in mouse takes advantage of CD45.1 and CD45.2, which are naturally occurring 
isoforms of CD45, for which there are very good commercially available antibodies, to 
distinguish between host and donor cells. A variation of this protocol is to shield the organs 
of interest with a lead brick to prevent damage to, or loss of the resident cells in the tissue. 
These ‘partially irradiated’ or ‘protected’ chimeras therefore allow tracking of monocytes (or 
other precursor cells of interest) into tissues without disrupting the incumbent resident 
macrophage population. Similarly, parabiosis, which is the joining of two mice via their 
circulatory systems can be used to track recruitment of circulating cells from one parabiotic 
partner to the tissues of the other partner, again allowing researchers to determine the level 
of recruitment of monocytes to macrophage populations. Knock out mice have been 
available for decades, and can be effectively used to deplete a precursor population to look 
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at the effect on the mature populations they normally differentiate into. However, a global 
knockout deletes the gene in all cells which express it, which may have major functional 
consequences in cell types other than those of direct interest. Fluorescent reporter mice are 
widely available for many genes of interest, but all cells expressing the gene of interest will 
be labelled, and they only label current gene expression. Thus the Cre-lox system is very often 
used in which a specific gene promoter drives Cre expression, resulting in excision of a stop 
codon upstream of the gene for a fluorescent reporter. Constitutive Cre mice, in which there 
is constant Cre expression, can be used to label current and historic gene expression, but 
does not allow distinction between the two. Inducible Cre systems, usually requiring 
tamoxifen administration to activate Cre expression, can be used to label cells within a 
specific time window to trace their fate, and the fate of their progeny. Yona and colleagues 
used CX3CR1gfp/+, constitutive CX3CR1Cre/+:R26-yfp and inducible CX3CR1CreER/+:R26-yfp mice 
side by side. The reporter (CX3CR1GFP) demonstrated that most tissue macrophages don't 
express CX3CR1, but come from a precursor which expressed CX3CR1 at some point in its 
development (shown by the constitutive Cre), but largely persist independently of CX3CR1+ 
monocytes (shown by the inducible Cre) (Yona et al. 2013). 
An overview of the tools currently available to researchers in the macrophage field 
are detailed in table 1.1  
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Table 1.1 Tools to investigate the relationships between monocytes and macrophages in mouse 




Can be reconstituted with bone 
marrow from wild type mice, 
reporter/Cre mice; 
Can make competitive bone 
marrow chimeras 
Irradiation damages 
populations of interest; 
Can only study from 8 weeks 
onwards; 
Irradiation may mobilise; 
Animals given antibiotics; 
Potential inflammatory 
response to irradiation 
(Klein et al. 2007; 
Bain et al. 2014; 
Molawi et al. 
2014; Merad et al. 





Protects the population of interest 
from irradiation; 
Reduces inflammatory response to 
irradiation; 
Can be reconstituted with bone 
marrow from wild type mice, 
reporter/Cre mice; 
Can make competitive bone 
marrow chimeras 
Can only study from 8 weeks 
onwards; 
Animals given antibiotics; 
Systemic effects of 
irradiation of extremities 
unknown 
 
(Jenkins et al. 
2011) 
Parabiosis Exchange of circulating cells, 
antigens and immune factors 
without triggering an immune 
reaction; 
Can stitch partners of different 
strains/gender/age 
Ethically questionable; 
Animals given antibiotics; 
Risk of death through 
wound infection 
(Hashimoto et al. 
2013; Bain et al. 
2014; Guilliams et 
al. 2013; Molawi 
et al. 2014; Merad 
et al. 2002) 
Knock out  Does not require tamoxifen 
administration; 
Highly efficient way to silence a 
gene 
May universally knock out 
gene from all populations - 
cannot study knock out on 
only specific populations; 
Gene redundancy means 
population of interest may 
still persist  
(Bain et al. 2014) 
Fluorescent 
reporter 
Widely available for lots of genes; 
Multiple fluorescent colours 
available; 
No requirement for tamoxifen 
May label multiple 
populations in addition to 
population of interest; 
Only reports current gene 
expression (this could also 
be a pro) 
(Yona et al. 2013) 
Constitutive Cre No requirement for tamoxifen 
administration – cheaper/easier; 
Can study fate from embryogenesis 
Can have low recombination 
efficiency; 
Overlap in gene expression 
means multiple populations 
may be labelled; 
No control over when 
populations become 
labelled; 
Possible Cre toxicity 
(Hashimoto et al. 
2013; Yona et al. 
2013; Gomez 
Perdiguero et al. 




Labels cells within specific time-
frame; 
Can study different populations 
depending on timing of tamoxifen; 
Can study cell fate from 
embryogenesis 
Can have low recombination 
efficiency; 
Overlap in gene expression 
means multiple populations 
may be labelled even with 
single tamoxifen dose; 
(Yona et al. 2013; 
Bain et al. 2014; 
Gomez Perdiguero 
et al. 2014; 
Hoeffel et al. 
2015; Schulz et al. 
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Must administer tamoxifen 
– could have side effects; 
Possible Cre toxicity 




1.3  Macrophage self-renewal and embryonic origin 
1.3.1  Embryonic myelopoiesis 
The traditional view of the MPS that all tissue macrophages require replenishment by adult 
circulating monocytes has recently been challenged. However, before I explore what is now 
known about the relationship between monocytes and macrophages, I will first look at how 
myelopoiesis occurs in the embryo, as this is when the very first macrophage populations are 
formed. Tissue macrophage populations are established in the embryo before the onset of 
mature haematopoietic stems cells. In mouse, the first blood cells are produced within blood 
islands that begin to form in the extraembryonic yolk sac from gestational day E7-E7.5 (Haarl 
and Adolph, 1970), and it is here that primitive erythropoiesis is established (Silver and Palis 
1997). The additional presence of macrophages in the yolk sac was first recorded over a 
century ago, and early studies in the 70s and 80s consolidated this work, identifying F4/80+ 
cells of macrophage morphology in the yolk sac from day 10 of gestation (Cline and Moore 
1972; Takahashi et al. 1989). These studies provided evidence that the very first 
macrophages were developmentally distinct from those described by the MPS.  
Until recently, and when I started my PhD, two waves of haematopoiesis had been described 
during development, with the first, ‘primitive’ wave of progenitors capable of giving rise to 
primitive macrophages in the yolk sac, followed by the onset of ‘definitive’ haematopoiesis 
with the generation of HSCs in the aorta-gonad-mesonephros (AGM) (see Ginhoux & Jung 
2014 for a review). However, there have been some discrepancies with regard to how the 
terms primitive and definitive are used (Frame et al. 2013). In part, this may be due to the 
fact that multiple waves of haematopoiesis have been described in the yolk sac (Palis et al. 
1999; Palis et al. 2001; Bertrand et al. 2005; Hoeffel et al. 2015), and multipotent precursors, 
capable of giving rise to erythrocytes as well as macrophages (and granulocytes) have been 
considered ‘definitive’ in the erythrocyte field, but ‘primitive’ in the macrophage field (Frame 
et al. 2013). Additionally, studies over the years have assigned different names to what are 
most probably the same cells and the subject of macrophage ontogeny is still being actively 
researched which is constantly refining the way we identify and define macrophage 
precursors and their progeny. However, I will summarise what is currently known about 
myelopoiesis during development below.   
There is consensus that the first primitive wave of myelopoiesis occurs in the yolk sac from 
as early as E7.5 in mouse, with the emergence of a precursor with a largely macrophage-
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restricted potential, which have been termed Mac-CFCs (Palis et al. 1999), or ‘early’ 
erythromyeloid progenitor cells (EMPs) (Hoeffel et al. 2015). These cells mature into 
primitive macrophages in situ in the yolk sac, bypassing any pro-monocyte or monocyte 
intermediary (Hoeffel et al. 2015), which aligns them with the ‘foetal macrophages’ described 
earlier by Takahashi and colleagues, who found no evidence for monocytic peroxidase (PO) 
activity in this lineage (Takahashi et al. 1989; Naito et al. 1990). These early precursors are 
defined by their reliance on the transcription factor PU.1, and a CD45-c-Myb-c-kit+ phenotype. 
The designation of these progenitor cells by Hoeffel et al. as ‘EMPs’ is arguable, since they 
do not possess granulocyte potency (McGrath et al. 2015), and as such they will be referred 
to as yolk sac macrophage precursors, as proposed previously (Bertrand et al. 2005). 
A second wave of development in the yolk sac occurs at around E8.5 with the emergence of 
a multipotent progenitor defined as ‘late’ EMPs (Hoeffel et al. 2015a), which are probably 
the cells designated as HPP-CFCs, observed at E8.25 in earlier studies by Palis et al. (2001), 
or Ys-EMPs by Bertrand et al. (2005). These cells have been defined as PU.1-CD45-c-Myb+c-
kit+. These c-Myb+ EMPs can give rise to macrophages directly in the yolk sac, but also enter 
the embryo proper from around E8.5 when the circulatory system becomes established 
(McGrath et al. 2003), and enter the foetal liver between E9.5 and E10.5 (Hoeffel et al. 2015; 
Gomez Perdiguero et al. 2015). Here they seed the liver with foetal monocytes via a c-
Myb+CSF1R+ myeloid progenitor (Hoeffel et al. 2015; Gomez Perdiguero et al. 2015). It is only 
recently that primitive macrophages and their precursors, and c-Myb+ EMPs have been 
considered developmentally distinct, as historically they had been referred to collectively as 
‘primitive’. However, the wave of c-Myb+ ‘late’ EMPs is now often referred to as ‘transient 
definitive’ (Hoeffel and Ginhoux 2018), given their ability to disseminate into the embryo 
proper and seed the foetal liver with foetal monocytes.  
Much later, at around developmental day 10.5, the first immature haematopoietic stem cells 
(HSCs) arise in the embryo proper within the AGM, originally identified by their ability to 
repopulate lethally irradiated mice in sex-mismatched transplants with cultured AGM tissue 
(Medvinsky and Dzierzak 1996). Immature HSCs then migrate to the foetal liver where they 
mature fully (Kieusseian et al. 2012). HSCs can give rise to an additional population of foetal 
monocytes in the liver by around E14.5 via a Flt3+ progenitor (Gomez Perdiguero et al. 2015), 
and this was thought to be the major pathway by which tissue macrophages arose (reviewed 
in Ginhoux & Jung 2014), but this has since been largely disproven, as discussed below.  
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1.3.2 Embryonic origin of tissue macrophages 
The discovery that there are distinct waves of macrophage progenitors arising during 
embryogenesis raises the question of which of the early macrophage progenitors give rise to 
the macrophage populations which are present in the tissues at birth, and whether this 
differs between tissue macrophage populations.  
Expression of transcription factors is tightly regulated during embryogenesis, and recent 
research has focussed on exploiting temporal gene expression patterns to differentially label 
primitive and definitive waves of macrophage precursors to determine their fate. In 
particular, tamoxifen-inducible Cre-lox labelling systems have been utilised, in which an 
injection of 4-hydroxytamoxifen (4-OHT) is used to label a specific population and their 
progeny. Recombination time is limited to under 24 hours, allowing labelling within a short 
developmental window (Samokhvalov et al. 2007). Using this approach, several research 
groups have labelled cells expressing Runx1 at E7.25-E7.5, a time point at which Runx1 is 
restricted to the yolk sac (Ginhoux et al. 2010). Labelling of Runx1+ yolk sac macrophages 
resulted in YFP labelling in microglia at E10.5 (Ginhoux et al. 2010; Hoeffel et al. 2015) 
indicating that primitive macrophages seeded the microglia population, whilst there was no 
labelling of alveolar or dermal macrophages (Ginhoux et al. 2010), but a small contribution 
of primitive macrophages to Langerhans cells (LC) was seen (Hoeffel et al. 2012). Later 
labelling at E8.5 resulted in little labelling in primitive macrophages, or in microglia, but 
approximately 30% labelling in macrophage populations in the liver, skin, kidney and lung 
which was maintained into adulthood (Hoeffel et al. 2015).  
Similarly, CSF1RMerCreMerRosa26YFP mice have been used to label CSF1R+ primitive 
macrophages in the yolk sac at E8.5. In one prominent study, YFP expression was found in 
macrophages populations in the skin, liver, spleen, pancreas, lung and kidney 4 weeks after 
birth, suggesting that these populations were derived from yolk sac macrophages (Schulz et 
al. 2012). However, the efficiency of YFP labelling was not shown. A later study demonstrated 
that labelling at E8.5 did indeed lead to YFP expression in all tissue macrophages at E13.5, 
but that the extent of labelling diminished and was almost negligible by birth, with the clear 
exception of microglia which were still 60% YFP+ 6 weeks post birth (Hoeffel et al. 2015). This 
was confirmed in another study which found maximal YFP labelling of 30% in the adult brain, 
a small contribution of YFP+ cells to macrophage populations in the heart and liver, but 
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minimal labelling in the skin, kidney, spleen, peritoneum and lung 10 weeks after birth 
(Epelman et al. 2014a), whilst initial labelling in the gut rapidly declined following birth (Bain 
et al. 2014). Together, these studies suggest that although primitive macrophages seed 
macrophage populations in all tissues, they are largely displaced by a later lineage of cells, 
with the exception of microglia. Another study, again labelling CSF1R+ cells in 
CSF1RMerCreMerRosa26YFP mice with a 4-OHT pulse at E8.5 found YFP+ cells in the foetal liver at 
E10.5 which were also AA4.1+c-Kit+CD45lo (Gomez Perdiguero et al. 2015) suggesting they are 
likely to be the ‘late’ EMPs which were described to migrate from the yolk sac to the foetal 
liver to give rise to foetal monocytes (Hoeffel et al. 2015). YFP+F4/80bright cells were 
subsequently found in the liver, skin and lung (Gomez Perdiguero et al. 2015). Critically, at 
E10.5 there were no YFP+ cells within the AGM region indicating that the F4/80bright cells had 
not come from early definitive HSCs within the embryo proper (Gomez Perdiguero et al. 
2015). Although these data would appear to conflict the findings by Hoeffel and colleagues 
(2015) that CSF1R-YFP+ cells are displaced by a later lineage of cells, again, the labelling 
efficiency in this study was not shown, and may simply represent a small remaining 
contribution of primitive macrophages to some tissue macrophage populations.  
Taking the converse approach, Flt3CreRosa26YFP mice, in which there is constitutive YFP 
expression in all foetal and adult HSC-derived cells and their progeny, were used to 
determine whether the early primitive macrophage lineage was displaced by definitive HSC-
derived macrophages. In some tissues, Flt3-YFP+ cells largely did not contribute to tissue 
macrophage populations apart from small contributions to liver (14%), brain (2%) and LC 
(30%) which plateaued at around 8 days post birth which did not further increase over one 
year. However, 60% of dermal macrophages were YFP+ at birth (Gomez Perdiguero et al. 
2015) and 35% of gut macrophages were YFP+ at 8 weeks of age (Bain et al. 2014). Labelling 
was initially low in AM and brain macrophages, but gradually increased over one year 
indicating that HSC-derived cells gradually replenished the population in these tissues with 
age (Gomez Perdiguero et al. 2015). Induction of labelling of Tie2, which is expressed in the 
yolk sac, foetal liver, AGM and by HSCs, as well as endothelial cells, at E7.5, E8.5, E9.5 and 
E10.5 demonstrated that the earlier the tamoxifen pulse, the greater the labelling in 
microglia, confirming that this population arises from the earliest primitive yolk-sac derived 
macrophages, and by comparing levels of labelling across the time points the authors also 
deduced that labelling of KC, AM, LCs and F4/80hi cells in the spleen occurred independently 
of the HSC lineage (Gomez Perdiguero et al. 2015).  
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Further study using the Runx1-labelling system found that labelling at E7.5 labelled primitive 
macrophages, E8.5 labelled EMPs and E9.5 labelled HSCs. This revealed that apart from 
microglia, the most efficient labelling of tissue macrophages arose with labelling at E8.5, 
indicating EMPs as the main precursor (Hoeffel et al. 2015). These EMPs express c-Myb, 
which is a master regulator of haematopoiesis (Ferrero et al. 2018). In disagreement with this 
study, F4/80hi macrophages could still be detected in c-Myb-/- mice which lack c-kit+ EMPs 
(Schulz et al. 2012). However, the fact that in this model the F4/80hi macrophages of primitive 
origin were not replaced does not preclude the fact that EMP-derived cells could displace 
them in normal development. In agreement with this, foetal monocytes were shown to be 
the main precursor for AM, which colonize the lung and develop into mature AM during the 
first week post birth, at the time that there is a ‘boost’ in production of their growth factor 
GM-CSF (CSF2) (Guilliams et al. 2013). Primitive foetal macrophages (likely of yolk sac origin) 
are also found in the lung during embryogenesis, but Guilliams et al did not find these to give 
rise to the mature AM population, using a series of foetal macrophage and foetal monocyte 
transfer experiments to look at their long term potential to become AM (Guilliams et al. 
2013). They argue that these primitive foetal macrophages are probably the F4/80hi cells 
observed in c-Myb-/- embryos studied by Schulz et al. (Schulz et al. 2012), but that since the 
c-Myb-/- animals die before full term, Schulz and colleagues could not prove the conclusion 
that these primitive macrophages give rise to the mature AMs seen in adult mice.  
The exact signals which mediate recruitment of embryonic macrophages to the organs are 
not fully elucidated. The establishment of the circulation appears to be absolutely critical to 
allow access to the tissues. Indeed, there were no skin-infiltrating macrophages (Hoeffel et 
al., 2012) or microglia (Ginhoux et al., 2010) present in Ncx1-/- embryos, which lack a 
heartbeat and therefore have no blood circulation. The formation of the blood brain barrier 
occurs around the same time as foetal monocytes emerge from the foetal liver, which may 
prevent their recruitment, perhaps explaining why microglia remain of primitive origin, 
unlike other tissues (Hoeffel et al., 2015). Whilst the circulatory system provides a means for 
macrophage precursors to disseminate around the developing foetus, it is likely that 
additional chemotactic signals are required for precursors to extravasate into tissues. CSF1 
and its interaction with its receptor are highly implicated in recruitment of monocytes to 
tissues  in adult mice (Tagliani et al., 2011; Jenkins et al., 2013). However, whilst microglia 
are absent from CSF1R deficient mice, they are present in normal numbers in CSF1 deficient 
mice (Hoeffel et al., 2015). Likewise, absence of the CSF1R did not affect the subsequent 
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recruitment of foetal monocytes to the developing dermis, although it did affect their 
differentiation into LC (Hoeffel et al., 2012). Thus other signals must be responsible for 
macrophage recruitment during embryogenesis, and signalling axes such as CX3CR1-CX3CL1 
is one such potential candidate (Hoeffel et al., 2010).  
Together, these studies demonstrate that primitive yolk sac-derived macrophages arising as 
early as E7.5 colonise all tissues and form the initial macrophage population resident in 
developing tissues. With the exception of microglia, which maintain this heritage, these early 
primitive macrophages are displaced by a later lineage of cells during embryogenesis, but 
these are not of definitive HSC origin. Instead, most tissue macrophage populations at birth 
originate from c-Myb+ EMPs in the liver which differentiate into tissue macrophages via a 
foetal monocyte intermediate. 
 
1.3.3 Maintenance of tissue macrophage populations in adult mice 
Many studies have attempted to determine whether the resident macrophages seeded 
during embryogenesis survive long term in adult mice under steady state conditions, and to 
what degree recruitment and differentiation of monocytes contributes to maintenance of 
resident macrophage populations. These studies have demonstrated that dependent on 
tissue, resident macrophages can be maintained either through local proliferation, longevity 
or through replenishment by circulating adult monocyte-derived macrophages recruited to 
the tissue in steady state conditions, or following injury or inflammation. These modes of 
maintenance are not mutually exclusive, as populations of macrophages of multiple 
ontogenies co-exist within most tissues, and even populations that exhibit the same basic 
phenotype can represent a mix of embryonically-derived and monocyte-derived cells. 
Furthermore, the extent to which a population is maintained independently of monocytes, 
or depends on monocyte replenishment can change with time.  
Early studies that appeared to support the notion that all macrophages required continual 
replenishment by monocytes generally involved total body irradiation to fate map 
transferred donor bone marrow, which lead to replacement of the incumbent macrophage 
populations. Chromosomal labelling of bone marrow and use of lethal irradiation chimeras 
was used to demonstrate that macrophages from various tissues were of donor and 
therefore haematopoietic origin (Virolainen 1968; Goodman 1964; Hess et al. 2004). Later 
studies using whole body irradiation chimeras reconstituted with congenic WT- or 
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competitive WT and CCR2-/- -donor bone marrow confirmed that Ly6Chi monocytes from the 
circulation are certainly capable of replenishing macrophage populations in the lung 
(Guilliams et al. 2013), liver (Klein et al. 2007), heart (Molawi et al. 2014) and gut (Bain et al. 
2014). However, two studies looking across multiple organs were published just before I 
started my PhD, which challenged the notion that tissue macrophages are dependent on 
monocytes. Using s100a4CreR26tomato and Flt3Cre mice to track monocytes, Hashimoto and 
colleagues concluded that resident macrophages in the lung, spleen, peritoneal cavity, bone 
marrow and brain did not rely greatly on adult monocytes or their progenitors, and their own 
parabiosis experiments further supported this conclusion (Hashimoto et al. 2013). At the 
same time, Yona and colleagues used an inducible Cx3cr1CreERR26YFP system that labels 
monocytes (albeit with very low efficiency), which indicated minimal contribution of 
monocytes to macrophage populations in the liver, spleen, lung, peritoneal and to LC in the 
skin (Yona et al. 2013). Further studies focussing on individual tissues have revealed in 
greater detail which macrophage populations rely on monocyte replenishment and which 
rely on proliferation, and which are maintained through a combination of the two in the 
steady state.  
The Runx1 and CSF1R inducible Cre methods used to fate map primitive embryonic 
macrophages, described above, provide some of the strongest evidence that microglia 
maintain their embryonic lineage in adult mice and are not replenished by monocytes. In 
further confirmation of this, there was no emergence of non-host cells in the microglial 
compartment of each parabiotic mouse pair over a 5 month period (Ajami et al. 2007). Even 
following microgliosis caused by facial nerve ataxotomy or in a chronic mouse model of ALS, 
parabiosis revealed no evidence of monocyte recruitment and differentiation into microglia 
(Ajami et al. 2007). In experimental autoimmune encephalitis (EAE), the murine model of 
multiple sclerosis, monocytes were recruited to the brain and gave rise to macrophages 
which were phenotypically indistinct from resident microglia. These cells were transient and 
did not survive long-term in the brain following resolution of disease (Ajami et al. 2011). 
Together these studies demonstrate that microglia maintain tight autonomy from the HSC 
lineage, even during acute and chronic brain injury. In stark contrast, although CSF1R-labeling 
at E8.5 led to YFP labelling in the gut in the neonate, this rapidly declined into adulthood and 
whole body chimeras and parabionts confirmed that Ly6Chi monocytes largely replenished 
the population. Microbiota may be signalling their replenishment as continual antibiotic 
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antibiotics for only the first 4 weeks after treatment. (Bain et al. 2014). Although colonic 
macrophages were found to proliferate in the first 3 weeks after birth, this ability declined 
as their dependence on BM-derived monocytes increased. As such, Ccr2-/- mice had normal 
colonic macrophage numbers at birth which declined with age (Bain et al. 2014). The absence 
of colonic macrophages in adult Ccr2-/- mice also suggests that dependence of colonic 
macrophages on monocytes is non-redundant and these cells cannot rely on self-renewal in 
the absence of monocytes. Microglia and colonic macrophages represent the far extremes 
of the spectrum of reliance on self-renewal versus monocyte replenishment. All other tissues 
appear to fall somewhere in between (fig 1.1). 
Detailed studies of the heart have revealed multiple populations of cardiac macrophages that 
exist concurrently. In one study, four populations, defined by their MHCII and CD11c 
expression profiles displayed varying degrees of monocyte replenishment in parabiotic mice 
over a 2 week period (Epelman et al. 2014a). When the macrophage populations were 








Figure 1.1 Spectrum of tissue macrophage maintenance through self-renewal versus monocyte 
recruitment. Images adapted from (Epelman et al. 2014b). 
 
 
contribute to all macrophage populations, whilst during cardiac distress caused by AngII 
infusion, a combination of monocyte recruitment and in situ proliferation caused the 
macrophage compartments to expand. Notably, once the tissue macrophages had been 
repopulated by monocytes following artificial depletion or cardiac distress, self-maintenance 
then resumed with monocytes maturing into self-renewing resident macrophages (Epelman 
et al. 2014a). Epelman et al (2014a) demonstrated that the MHCII+CD11c+ population of 
cardiac macrophages was the most dependent on circulating monocytes, and consistent with 
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this, had the highest proportion of Flt3Cre+ cells indicative of having come from an HSC 
precursor, prompting suggestion by others that this is in fact a population of dendritic cells 
(DC) (Molawi et al. 2014). Molawi and colleagues instead defined four cardiac macrophage 
populations on the basis of MHCII and CX3CR1 and found using CX3CR1Cre-R26-yfp mice that 
all cardiac macrophages passed through a CX3CR1+ stage during embryogenesis, but labelling 
declined with age, indicating the loss of embryonic-derived cells. (Molawi et al. 2014). 
Molawi et al also used parabiosis between a WT mouse and a Ccr2-/- host to show that 16% 
of all cardiac macrophages were of non-host origin over a 10 week period, whilst adoptive 
transfer of YFP-labelled bone marrow into rag2-/-yc-/-Kitw/wv mice which accept grafts without 
irradiation showed a small but significant contribution of 7% YFP+ cells within the total 
cardiac pool (Molawi et al. 2014). Both studies therefore largely agree that in the steady state 
cardiac macrophages are gradually replaced by monocytes over time. In the lung parabiosis 
studies demonstrated that AM were largely self-maintaining, with less than 5% of the 
population deriving from the parabiotic donor monocyte-derived cells (Guilliams et al. 2013). 
Chimeras made within 24 hours after birth demonstrated that adult LCs were of host origin 
up to 7 months after irradiation, and that these cells were largely of foetal liver-derived 
monocyte origin (adoptive transfer of foetal monocytes at E13.5-E14.5) with a small 
contribution from yolk sac macrophages (Runx1 labelling at E7.5) (Hoeffel et al. 2012). 
Thus some macrophage populations rely heavily on monocytes whilst others do not. What 
was known about the origin of KC in the steady state is discussed in detail later in section 
1.4.2.  
 
1.3.4 Tissue macrophages proliferate in situ 
So how are fully differentiated, mature tissue macrophage populations maintained if they   
are not solely reliant on recruitment of monocytes? A pool of highly multipotent long term 
haematopoietic stem cells (LT-HSC) reside within the bone marrow. These are largely 
quiescent, which may be to ‘protect’ stem cells from replication-induced DNA mutations. LT-
HSC give rise to rapidly dividing daughter cells (Foudi et al. 2009), and a branching model is 
generally accepted in which there is progressive loss of proliferative potential and potency 
as cells differentiate, coinciding with initiation of lineage-specific transcription. Monocytes 
are generated in the bone marrow from highly proliferative precursors, but they do not 
proliferate in the circulation because they do not express the necessary transcription factors, 
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and are not exposed the extrinsic factors which then signal their proliferation upon arrival in 
tissues (Swirski et al. 2014). Instead, their number is controlled by release from the bone 
marrow (Swirski et al. 2014). Given that tissue macrophages are mature, terminally 
differentiated effector cells, it might seem logical that they should not retain capacity to 
proliferate. Indeed, this is one of the original tenets of the MPS model that accompanies the 
concept that macrophages are exclusively maintained and replenished by monocytes. 
However, despite van Furth’s conclusion that KC were of monocytic origin, his own papers 
reported that approximately 1% of the KC population and of the resident peritoneal 
macrophages were in mitosis during homeostasis, determined by incorporation of 
radioactively labelled thymidine over one hour (van Furth and Cohn 1968; Crofton et al. 
1978). With more sophisticated methods to assess proliferation at the single cell level, 
including BrdU incorporation, expression of the cell cycle marker Ki67 and cellular dyes and 
genetic labelling which can trace proliferation history, multiple research groups have shown 
that resident macrophages in just about every tissue are able to proliferate (Epelman et al. 
2014a; Molawi et al. 2014; Hashimoto et al. 2013; Guilliams et al. 2013; Czernielewsk et al. 
1985; Chorro et al. 2009; Jenkins et al. 2011, 2013).  
During inflammation, resident macrophages are often severely reduced in number, in what 
has been termed the ‘macrophage disappearance reaction’ (Nelson and Boyden 1963; Haskill 
and Becker 1985). Monocytes are recruited to tissues in response to inflammation, but in 
many cases the remaining resident macrophages have been shown to proliferate during the 
recovery phase of injury to restore their numbers. In the case of zymosan-induced peritonitis, 
a small number of resident macrophages survive and analysis of the phosphorylation status 
of histone H3 showed that these macrophages proliferate to restore normal numbers of 
resident macrophages (Davies et al. 2011). Colony Stimulating Factor 1 (CSF1) was found to 
be the major factor controlling proliferation in this scenario and blockade with an anti-CSF1 
antibody completely shut off proliferation of resident macrophages (Davies et al. 2013). In 
the context of a helminth-induced type-2 immune response, proliferation driven 
predominantly by IL-4 provides a mechanism for the expansion of peritoneal macrophages, 
overriding CSF1 signalling, allowing expansion of the macrophage population without 
monocyte recruitment (Jenkins et al. 2011, 2013). Likewise, KC in the liver proliferate 
following acetaminophen injury to the liver (Zigmond et al. 2014), AM proliferate following  
influenza infection (Hashimoto et al. 2013) and cardiac macrophages proliferate following 
cardiac stress (Epelman et al. 2014a). LC in the skin were shown to proliferate in a mouse 
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model of atopic dermatitis (eczema) (Chorro et al. 2009), and these findings were mirrored 
in two human skin samples from patients with eczema (Chorro et al. 2009). One clear 
exception is in the gut, where there was no clear proliferative burst in the macrophage 
population following inflammation with acute DSS colitis (Bain et al. 2014).  
One question raised by the discovery that mature tissue macrophages can proliferate is 
whether all cells within a population possess equal proliferation potential, or whether there 
is a hierarchy, akin to that of HSC. Multicolour fate mapping using inducible confetti mice, in 
which cells can express either GFP, YFP, RFP or CFP suggests within the LC population, 
proliferation may occur within distinct units, as foci of proliferating cells surrounded by 
daughter cells expressing the same fluorescent marker emerged following induction of Cre 
activity (Ghigo et al. 2013). In contrast, two rounds of depletion of AM using CD169-DTR mice, 
one of which was followed by pulse labelling of proliferating cells with BrdU and the other 
without labelling revealed that both BrdU+ AM and BrdU- AM equally expressed Ki67 (a 
marker cells in active cell cycle). The authors interpreted this as all AM having equal ability 
to proliferate, or in other words that proliferation of AM was stochastic (Hashimoto et al. 
2013). The Jenkins lab used the H2B-GFP labelling system used to identify LT-HSC (Foudi et 
al. 2009) to look for a local tissue progenitor to peritoneal macrophages (Bain et al. 2016). 
Although we were unable to identify a clear progenitor, proliferation appeared to be non-
stochastic, suggestive that there is some heterogeneity of proliferation in the steady state 
(Bain et al. 2016). In chapter 5 I attempted to use this same system to look for a local tissue 
progenitor for KC.  
 
1.3.5 The concept of the macrophage niche 
The fact that reliance on monocyte recruitment versus in situ proliferation for the 
maintenance of macrophages is so tissue-specific raises the question of the importance of 
local environmental factors in defining their size, ontogeny and function. This has resulted in 
the idea that there is a macrophage ‘niche’ (Jenkins and Hume 2014), which may comprise 
both physical and biochemical factors which may dictate physical location of tissue 
macrophages (Guilliams and Scott 2017). The idea of the macrophage niche will be explored 
in further detail in chapters 5, 6 and 7. 
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1.3.6 Comparison of origin in species other than mouse 
The majority of studies into macrophage origin have been conducted in mouse due to ease 
of breeding, availability of reporter strains and a well mapped genome. However, there are 
many similarities in how macrophage populations are established and maintained across 
species. For example, the presence of two anatomically distinct sites for haematopoiesis – 
one in the yolk sac and one in the embryo – appears conserved among species, as shown in 
early studies on Xenopus and chicks (Kau and Turpen 1983; Lassila et al. 1978). Furthermore, 
a recent study showed that in zebra fish, the earliest primitive macrophages, and not EMPs 
give rise to microglia (Ferrero et al. 2018). However, unlike in mouse, these primitive 
macrophage-derived microglia are transient, and are replaced by HSC-derived macrophages, 
indicating that the maintenance of the embryonic macrophage lineage varies between 
species.  
Despite this, emerging evidence suggests that mice are a relevant model for comparison with 
human macrophage maintenance. The origins of tissue macrophages are, for obvious 
reasons, more difficult to study in humans, but patients undergoing tissue or stem cell 
transplant provide a rare opportunity. Evidence from these types of case studies suggests 
that dependency of resident macrophages on monocyte replenishment in humans mirrors 
the tissue-dependent nature seen in mouse. For example, a case study in which a woman 
who had received a sex-mismatched cord blood stem cell transplant showed that although 
>99.5% chimerism was maintained for over 2 years in the bone marrow and in the periphery, 
fewer than 0.1% of microglia in the brain were of donor origin, indicating that microglia 
persist independently of monocyte recruitment even in the context of chemotherapy which 
might have disrupted the blood brain barrier (Takahashi et al. 2016). In HLA-mismatched lung 
transplant patients, the origin of AM in bronchiolar alveolar lavage (BAL) fluid was assessed 
and greater than 87% of AM remained of donor origin up to 3 ½ years following transplant, 
indicating that, as in mouse, AM in humans are not rapidly replenished by circulating 
monocytes (Nayak et al. 2016). In comparison, around 70% of human dermal macrophages 




1.4 The liver and liver Kupffer Cells 
Unlike many other tissue macrophage populations, the origin and maintenance of liver KC in 
adult mice had been less well studied when I embarked on my PhD, and this became the 
major focus of my studies. KC are vital for maintenance of both liver tissue health, and for 
protecting the body from autoimmunity via maintenance of peripheral tolerance. Thus a 
better understanding how they are maintained, particularly in the context of liver injury or 
dysfunction, may provide crucial insight into how to manipulate these cells to improve or 
enhance their function.  
 
1.4.1 Location and role of liver Kupffer Cells  
The liver is a highly vascularized tissue, structured into repeating hepatic lobules. Each lobule 
comprises the portal triad, composed of a portal vein, hepatic artery and bile duct. Blood 
flows from the portal vein and hepatic artery to the central vein via the sinusoids. KC sit 
within the sinusoids, spanning their diameter and maintaining close contact with the liver 
sinusoidal endothelial cells (LSECs) (Burkel and Low 1966; Wisse et al. 1983) (fig. 1.2). In fact, 
when von Kupffer first identified KC they were mistakenly thought to be endothelial cells 
until they were subsequently identified as macrophages by Browiecz (reviewed by Dixon et 
al. 2013). Histologically, KC can be identified by this sinusoidal location, with archetypal 
processes which stretch from the body of the cell through the vessels giving their distinctive 
star-shape (Lopez et al. 2011; Sasmono et al. 2003; McCuskey et al. 1990; Movita et al. 2012) 
described by von Kupffer. In mouse, KC express high levels of the pan macrophage marker 
F4/80, which has been used for their identification widely in both imaging and flow 
cytometry; F4/80 immunofluorescence staining alone reveals KC within the liver parenchyma 
with their typical star-like shape. They are present in both the centrilobular and periportal 
regions of the liver, but are absent in the area surrounding the central vein. They are most 
abundant in the periportal region, which could reflect the fact that this is where endotoxin 
arrives in the liver through the portal vein, and these KC are larger and have a greater 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 1.2 Structure of the liver. Blood drains through the sinusoids from the portal triad to the central 
vein. Kupffer Cells (KC) sit within the sinusoids which are lined with liv r sinu idal endothelial cells 
(LSECs). KC are absent in the area surrounding the central vein and are most abundant near the portal 
triad. 
 
Like other tissue resident macrophages, KC express multiple scavenger receptors on their 
surface (Hughes et al. 1995), allowing them to efficiently sense and respond to factors in their 
local environment. They can initiate immune responses, for example by upregulating 
expression of the class A scavenger receptor MARCO in response to bacterial infection 
(Gordon et al. 1999), leading to endocytosis and production of reactive oxygen species (ROS) 
(Movita et al. 2012). In other contexts they can dampen immune responses and can produce 
the anti-inflammatory cytokine IL-10 following signalling through TLR4, TLR7/8 and TLR9 
(Movita et al. 2012). They can also protect tissues from injury and express high levels of 
haemoxygenase 1 (HO-1) which catalyses the degradation of haemoglobin, which was shown 
to reduce susceptibility of mice to ischaemia reperfusion injury (IRI), through the dampening 
of inflammation and protection from oxidative stress (Devey et al. 2009; Bauer and Bauer 
2002).  
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KC are crucial for maintaining tissue health, in particular by scavenging and phagocytosing 
erythrocytes damaged by oxidative stress from the circulation (Terpstra and van Berkel 2000) 
as well as other apoptotic cells (Dini et al. 2002). They are professional antigen presenting 
cells (APC), and present scavenged material via MHCII on their surface. However, unlike 
mature dendritic cells, T-cell priming by KC leads to the induction of Foxp3+, IL-10-producing 
regulatory T cells, which is at least in part through their expression of the suppressive 
costimulatory marker PDL-1 (Heymann et al. 2015). They are continually exposed to LPS in 
the circulation from the intestines, but repeated signalling through TLR4 leads to them to 
display ‘endotoxin tolerance’ causing a refractory period to subsequent LPS stimulus, 
preventing potentially harmful overactivation and inappropriate immune response to 
commensals (Hafenrichter et al. 1994; Liu et al. 2008). The liver as an organ has been 
described as a second ‘firewall’, protecting the body from overt responses to endotoxin and 
other bacterial products during systemic infection or gut mucosal damage, and KC were 
shown to be an important part of clearing live commensal bacteria from the blood stream 
(Balmer et al. 2014). Thus, KC are key in maintaining peripheral tolerance and in dampening 
immune responses to commensal bacteria. However, bacterial clearance by the liver was 
impaired in the context of liver dysfunction (Balmer et al. 2014), indicating that KC may lose 
some of this tolerogenic function under ongoing or chronic inflammatory conditions. One 
possible explanation for this loss of function during liver dysfunction is that KC may be 
replaced by monocyte-derived macrophages under inflammatory conditions which cannot 
recapitulate normal KC functions, and this idea is explored in chapter 6. 
 
1.4.2 Maintenance of Kupffer Cells in mouse 
As discussed in section 1.3.4, lineage fate mapping studies have revealed that at birth, murine 
KC are derived largely from a foetal monocyte precursor generated from yolk sac-derived 
EMP progenitors. Many of these studies additionally looked for retention of CSF1R- driven 
fluorescent label in macrophage populations in multiple tissues in adult mice. These generally 
indicated that at least some of the fluorescent label was retained in KC post birth (Schulz et 
al. 2012; Epelman et al. 2014a). However, the frequency of label-expressing KC was shown 
to decline with time in some studies, between birth and 6 or 12 weeks of age (Hoeffel et al. 
2015; Bain et al. 2014) which would argue that either monocytes were replenishing the 
population or that non-labelled KC were out-competing labelled KC. Flt3Cre-YFP labelling 
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demonstrated that there appeared to be a small contribution (~15%) of HSC-derived cells to 
the KC population in the first few weeks after birth (Schulz et al. 2012; Perdiguero et al. 2014). 
In agreement with this, there was incorporation of monocyte-derived KC during the 
immediate postnatal phase, accounting for around 40% of the KC population at 8-12 weeks 
of age in this study. This coincided with an expansion in the total KC population size during 
which there is also an increase in liver mass (Scott et al. 2016). However, using the Flt3Cre-YFP 
labelling approach, there appeared to be no further incorporation of YFP up to one year in 
mice, indicating autonomy from cells of HSC lineage in the steady state likely occurs at some 
point between birth and adulthood (Gomez Perdiguero et al. 2015). In agreement with this, 
equivalent numbers of KC were found in WT and Ccr2-/- mice at 8 weeks of age and very few 
non-host KC were present in WT and Ccr2-/- parabiotic partners following 10 weeks of 
parabiosis (Bain et al. 2014). Together these studies indicate that in adult mice KC are 
maintained by self-renewal and are not replenished by monocytes.  
The differentiation, proliferation and survival of KC is highly dependent on the growth factor 
CSF1 and its signalling through the CSF1 receptor (CSF1R). Accordingly, both op/op mice, 
which have a natural mutation in the csf1 gene (Wiktor-Jedrzejczak et al. 1982; Yoshida et al. 
1990), and mice lacking CSF1R activity display a deficit in KC number (Dai et al. 2004; 
MacDonald et al. 2010). CSF1 availability has been proposed previously as a key factor in 
defining the macrophage niche (Jenkins and Hume 2014), and signalling through the CSF1R 
has been shown to be required for conversion of monocytes to tissue macrophages 
(Hashimoto et al. 2013). Thus CSF1 consumption likely plays a key role in regulating the 
autonomy and origin of KC. Expression of the CSF1R by tissue macrophages including KC, 
along with uptake of CSF1 through the CSF1R will be explored further in chapter 4, whilst the 
role for CSF1 in maintaining the KC niche is discussed in detail in chapter 5. CSF1 and the 
CSF1R are introduced in more detail in both chapters 4 and 5, and therefore are not discussed 
further here. 
 
1.5 Kupffer Cells and monocyte-derived macrophages in liver injury 
1.5.1 Human liver injury and disease and animal models 
Liver injury can be acute or chronic in nature, causing high morbidity and often mortality. 
Acute liver failure is a rare condition, affecting fewer than 6 in a million people in the 
developed world, defined by loss of metabolic liver function, systemic inflammation and 
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possibly multiorgan failure including encephalopathy (Bernal and Wendon 2013). In the US 
and the UK, paracetamol or acetaminophen (APAP) overdose is the most common cause of 
acute liver failure, accounting for around 50% of all cases, whilst hepatitis infection is the 
biggest global cause (Bernal and Wendon 2013). By definition, acute liver injury is the 
occurrence of apoptosis and necrosis of hepatocytes in previously healthy liver (Forbes and 
Newsome 2016). This triggers an inflammatory immune response, including the recruitment 
of neutrophils and monocytes, followed by liver regeneration with the activation of 
myofibroblasts, and hepatocyte proliferation resulting in wound healing and finally the 
resumption of steady state metabolic function (Markose et al. 2018; Forbes and Newsome 
2016). 
Nearly 850 million people are estimated to have chronic lifver disease worldwide, resulting 
in 2 million deaths each year (Marcellin and Kutala 2018). Chronic liver disease can be caused 
by alcohol, viral infection or non-alcoholic fatty liver disease, but is generally characterised 
by progressive fibrosis (Schuppan and Afdhal 2008) resulting from impaired tissue repair 
under ongoing inflammation (Wick et al. 2010). Uncontrolled, progressive fibrosis eventually 
results in liver cirrhosis characterised by loss of endothelial fenestration, portal hypertension 
and loss of metabolic function, and possibly the development of hepatocellular carcinoma 
(HCC) (Schuppan and Afdhal 2008). Cirrhosis carries a particularly high bacterial infection risk, 
as the liver in its immunocompromised is unable to effectively deal with bacteria translocated 
from the gut. Bacterial infection is responsible for up to 50% of all deaths in cirrhosis patients, 
and infection with E. coli is particularly common (Bunchorntavakul et al., 2016). Finally 
patients reach end stage liver disease, for which the only current treatment is liver 
transplant, and without which encephalopathy, multiple organ failure and death will result. 
In rodents there are several liver damage and disease models. APAP overdose is commonly 
used as an acute liver injury as it closely mimics the injury seen in humans using the same 
toxic substance. Chronic injury can be modelled through bile duct ligation which results in 
secondary biliary fibrosis, but has a high mortality rate, through viral hepatitis or 
Schistosomiasis infection or spontaneous mouse models, such as Ob/Ob mice which have a 
mutation in the gene coding lectin, and become obese, insulin resistant and develop fatty 
livers. Non-alcoholic fatty liver disease (NAFLD) can also be modelled through diet, such as 
the methionine- and choline- deficient diet (MCD) or high fat diet (HFD) (Liu et al. 2013). One 
of the most widely used models for livery injury is the halogenated alkane Carbon 
tetrachloride (CCl4), which causes sterile, toxic liver damage. The mechanisms through which 
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it causes toxicity are many and there is not space to detail them here, but a comprehensive 
review has been published describing its many actions (Weber et al. 2003). Briefly, 
cytochrome activity in the liver metabolises CCl4, producing the free radical CCl3•. In the 
presence of oxygen CCl3• becomes the highly reactive radical CCl3OO• causing major damage 
to cells (Weber et al. 2003). A single dose of CCl4 results in acute necrotic damage in the 
centrilobular region, mimicking that seen with APAP overdose (Weber et al. 2003), which is 
quickly resolved through a cascade of immune responses, including the recruitment of 
eosinophils which secrete IL-4, driving the hepatocyte proliferation which is crucial for 
efficient tissue repair (Goh et al. 2013). Repeated delivery of CCl4 results in progressive 
fibrosis with bridging septa and ultimately cirrhosis. The fibrosis caused in this model is 
spontaneously reversible (Iredale et al. 1998; Ramachandran et al. 2012). CCl4 is used in this 
study as provides a unique model in which the same hepatotoxic agent can be administered 
to achieve either acute or chronic fibrotic injury, and to study the liver following spontaneous 
recovery.  
 
1.5.2 Kupffer Cells and recruited liver macrophages during liver injury 
1.5.2.1 Kupffer cells in liver injury 
The role of KC has not always been clearly distinguished from that of monocyte-derived 
macrophages which arise during inflammation. However, the loss of F4/80hi KC in the early 
phase post injury has been documented in both acute and chronic models (Zigmond et al. 
2014; Heymann et al. 2015; David et al. 2016; Ramachandran et al. 2012). The remaining KC 
are activated by the release of DAMPs including HMGB-1, HSP-70, histones and free DNA 
which are released by dying hepatocytes (Sitia et al. 2007; Martin-Murphy et al. 2010; Imaeda 
et al. 2009; Wen et al. 2013; Tsung et al. 2007). This stimulates KC to produce pro-
inflammatory cytokines, and one hour following APAP, FACS-sorted CD45+F4/80+CD11blo KC 
were shown to increase production of TNF-a, IL-6 and IL-1b (Martin-Murphy et al. 2010). 
Activated KC, along with hepatocytes, produce monocyte chemotactic protein (MCP-1), or 
CCL2 which recruits Ly6Chi monocytes to the liver (Karlmark et al. 2009; Dambach et al. 2002; 
Martin-Murphy et al. 2010). Depletion of KC prior to ischaemia-reperfusion injury (IRI) using 
gadolinium chloride has also demonstrated that they attract neutrophils through production 
of the chemokines CXCL1, CXCL2 and CXCL8 (Mosher et al. 2001). Following this initial 
inflammatory response, KC may also contribute to resolution of inflammation and injury 
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through phagocytosis of apoptotic hepatocytes. Depletion of KC using chlodronate 
liposomes, using a regime which the authors claim did not deplete circulating monocytes, 
resulted in increased HMGB1+ hepatocytes, which became secondarily necrotic, leading to 
enhanced DAMP release and increased neutrophil recruitment (Sitia et al. 2011). 
Interestingly, KC displayed a transcriptional profile which was almost indistinguishable from 
that of steady state KC 72 hours following APAP-induced acute liver injury (Zigmond et al. 
2014), suggesting that they may have resumed their homeostatic functions by this time 
point. 
 
1.5.2.2 Recruited macrophages in liver injury 
In many tissues, populations of both classical Ly6ChiCCR2hiCX3CR1lo and nonclassical 
Ly6CloCCR2loCX3CR1hi ‘patrolling’ monocytes can be found (Geissmann et al. 2003). Their 
roles are generally thought to be distinct, with Ly6Chi monocytes contributing to the 
inflammatory process whist Ly6Clo monocytes appear to be involved in processes such as 
clearance of endothelial cells, but may also differentiate into more pro-reparative 
macrophages (Geissmann et al. 2003; Carlin et al. 2013; Auffray et al. 2014). In the liver, 
however, nonclassical Ly6Clo monocytes could not be detected in the steady state, and 
instead Ly6Chi monocytes appeared to take on the ‘patrolling’ role, seen crawling through 
the sinusoids, along with a population of ‘patrolling’ natural killer cells (Dal-Secco et al. 2015). 
The Ly6Chi monocytes are recruited to the liver following both acute or chronic injury, where 
they mature into hepatic macrophages, identified variously by expression of CD68 (or 
microsialin) (Dambach et al. 2002; Mitchell et al. 2009), their CD11b+F4/80+GR1+ profile 
(Karlmark et al. 2009), or downregulation of Ly6C (Ramachandran et al. 2012; Dal-Secco et 
al. 2015). The CCR2/CCL2 chemokine axis has been demonstrated to be crucial for the 
recruitment of Ly6Chi monocytes following both acute and chronic injury.  
In acute injury, there were reduced numbers of Ly6Chi monocytes in Ccr2-/- mice following 
both acute CCl4 (Karlmark et al. 2009) and APAP (Mossanen et al. 2016; Zigmond et al. 2014). 
Prior depletion of circulating monocytes (and likely also resident KC) using chlodronate 
liposomes, did not affect the level of necrotic injury (Karlmark et al. 2009), and serum ALT 
levels were not affected in Ccr2-/- mice (Dambach et al. 2002) following APAP, indicating that 
monocytes do not contribute to the initial necrosis process. However, Ly6Chi monocyte-
derived macrophages do appear to contribute to continuing hepatic injury as Ccr2-/- mice 
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displayed reduced necrotic area and reduced ALT compared with WT mice 12 hours following 
APAP (Mossanen et al. 2016). However, like KC, monocyte-derived macrophages also 
contribute to tissue repair following acute injury, congregating at the site of injury (Dal-Secco 
et al. 2015; Mossanen et al. 2016). Monocyte-derived macrophages have been shown to 
induce phagocytosis of neutrophils through cell-cell contacts (Holt, Cheng, and Ju 2008), and 
blockade of monocyte recruitment using MC-21, an a-CCR2 antibody resulted in increased 
numbers of neutrophils (Graubardt et al. 2017), and prolonged hepatic damage with bridging 
necrosis at 24 and 48 hours post APAP (Zigmond et al. 2014).  
In chronic injury, recruited macrophages are associated with fibrosis progression and Ccr2-/- 
mice displayed reduced levels of fibrosis following 6 weeks of CCl4 treatment (Mitchell et al. 
2009), with reduced staining for collagen, hydroxyproline and a-SMA, a marker of hepatic 
stellate cell activation (Karlmark et al. 2009). Monocyte-derived macrophages were shown 
to produce TGFb (Karlmark et al. 2009) which promotes the differentiation of hepatic stellate 
cells into myofibroblasts, and PDGFb which is required for myofibroblast proliferation and 
survival (Wynn and Barron 2010). However, reversal of fibrosis following cessation of 
treatment was also delayed in Ccr2-/- animals (Mitchell et al. 2009) indicating that recruited 
macrophages also switch phenotype during the resolution phase following chronic injury. In 
agreement with this, depletion of recruited macrophages, but not resident KC, in CD11b-DTR 
mice at 48, 72 and 96 hours post chronic CCl4 resulted in failure of resolution of fibrosis at 
120 hours post injury (Ramachandran et al. 2012). Although the exact mechanism by which 
recruited macrophages enable fibrosis resolution is not clear, it likely involves their increased 
production of matrix metalloproteinases such as MMP2 and MMP13 which degrade extra 
cellular matrix. Consistent with this, there was reduced MMP2 and MMP13 production in 
Ccr2-/- mice following chronic CCl4 in mice (Mitchell et al. 2009) and mmp13-/- mice displayed 
reduced resolution of fibrosis following chronic CCl4 in rats (Fallowfield et al. 2007).  
 
1.5.2.3 Fate of Kupffer Cells and recruited macrophages following injury 
As described above, both resident KC and recruited macrophages are present during liver 
injury, and their differing roles have been at least partially elucidated. However, what 
happens to the two populations following complete resolution from injury is not clear. A key 
question which remained to be answered when I started my project was whether KC 
continue to be regulated autonomously and independently of monocyte-derived 
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macrophages after injury, or whether they are replenished by recruited cells, and if so, 
whether this affects their long-term function. The loss and replenishment of resident 
macrophages in other tissues had been addressed in a variety of inflammation scenarios, 
however. An almost 9-fold loss of LCs was detected 7 days following exposure to UV light, 
and replenishment occurred through recruitment of bone-marrow derived LCs. Donor LCs 
were still present 12 weeks after the injury, indicating that they had permanently replenished 
the LC population (Merad et al. 2002). The identity of the recruited LCs was later shown to 
be Ly6Chi monocytes (Ginhoux et al. 2006). Interestingly, LC were also reduced in number 
following inflammation driven by x-irradiation or through topical application of acetone and 
oil, but there was no replenishment by BM-derived cells in these contexts (Merad et al. 2002). 
However, the levels of inflammation caused with either x-irradiation or acetone and oil did 
not result in increased expression of CCL2 and CCL7 as was seen with UV radiation, indicating 
that monocytes were simply not recruited to the skin in these scenarios (Merad et al. 2002). 
Resident lung macrophages were depleted following infection with an influenza virus, but 
recovered to normal numbers 4 weeks later through local repopulation, as there was no 
evidence of their replacement by tdTomato+ monocytes (Hashimoto et al. 2013). However, 
monocyte-derived macrophages were still present in the lung one year after bleomycin-
induced lung fibrosis, and these recruited macrophages acquired a gene-expression pattern 
which differed by only 330 genes from that of the resident alveolar macrophages (Misharin 
et al. 2017). In the liver, Zigmond and colleagues concluded that KC replenished though local 
proliferation following APAP, as they did not see emergence of CX3CR1-GFPneg cells from 
CX3CR1-GFP+ transferred monocytes (Zigmond et al. 2014). However, at the 4 day time point, 
the donor cells that were present had in fact down regulated Ly6C and upregulated F4/80 
(Zigmond et al. 2014), which could be suggestive that they were, in fact, maturing into a KC 
phenotype. Following chronic CCl4 injury, labelling of circulating Ly6Clo monocytes with 
fluorescent latex beads 4 hours after the final CCl4 injection resulted in a small number of 
bead+ F4/80hiCD11blo cells indicative of their contribution to the KC population at 168 hours 
(7 days). However, a major caveat with this method is that bead+ KC may simply represent a 
KC which has phagocytosed a bead+ cell. Furthermore, whether the bead+ KC remained in the 
liver long-term, beyond the 7 day time point was not assessed, and could represent a 
transient emergence of F4/80+ recruited cells, which may not permanently replenish the 
resident KC population.  
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Thus the question of whether KC remain totally autonomous of monocyte-derived 
macrophages following acute and chronic liver injury remained to be determined, and is 
addressed in chapter 6, using more robust fate-mapping methods, and allowing for long-term 
recovery from injury to assess whether there is any long-term contribution of recruited 
macrophages to the resident KC compartment.  
Collectively, the studies detailed in this introduction which revealed that tissue macrophages 
are established during embryogenesis, proliferate in situ to self-renew and in many tissues 
require little or no contribution from monocytes to maintain the population were completely 
ground-breaking (Sieweke and Allen 2013). They significantly challenged the idea of the MPS 
which had held for decades and there was therefore much excitement to understand the 
importance of both origin and local tissue factors on macrophage function in both 
homeostasis and injury (Varol 2015; Ginhoux and Jung 2014; Epelman et al. 2014b; Hoeffel 
and Ginhoux 2015). 
 
1.6  Thesis aims  
Such massive diversity in the functions of tissue macrophages raises questions of the 
significance of their origin and how they are maintained. Although there was some evidence 
that KC do not require replenishment from monocytes in the steady state, I hypothesised 
that disruption of homeostatic conditions through exogenous administration of CSF1-Fc, or 
through acute or chronic liver injury would lead to their long-term replacement by circulating 
Ly6Chi monocytes. To test my hypothesis, my aims were as follows: 
 
v Establish a protocol to efficiently isolate liver leukocyte populations for flow cytometry.  
v Investigate the role of competition for CSF1 in the maintenance of KC autonomy. 
Ø Characterise the newly generated Csf1r-mApple mice and use a fluorescently 
labelled CSF1-FcAF647 fusion protein to determine comparative CSF1R transgene 
expression and CSF1 uptake across liver populations. 
Ø Administer CSF1-Fc to explore whether CSF1 availability is a limiting factor in 
determining KC population size and ability of monocytes to convert to long-lived KC. 
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v Establish whether monocyte-derived macrophages permanently replenish resident KC 
following liver injury, and if so, whether this leads to long-term changes in function of 
the population. 
 
These aims fall within the broader question of whether the functions of resident 
macrophages are defined by their genetic programming or by local tissue-specific factors, or 
both. To answer this over-arching question we must understand in detail the mechanisms 
which maintain tissue macrophage populations, focussing on individual tissues and 
populations within tissues in both homeostatic and infection/inflammation scenarios. This 
thesis adds to the emerging body of work by exploring parameters which surround 




Chapter 2:  Materials and methods 
 
2.1 Mice 
All mice were maintained in house under specific pathogen free (SPF) conditions at Little 
France Phase 1 (LF1) or Phase 2 (LF2) or Ann Walker units, with exceptions listed below. 
Transgenic mouse lines used in this study – Ccr2-/-, Csf1r-EGFP (MacGreen), Csf1r-mApple 
were bred and housed in the clean LF1 facility at Little France, and transferred to LF2 for 
experimental procedures and necropsies, except where specified otherwise. For Csf1r-
mApple or Csf1r-EGFP experiments conducted at Little France, WT littermate (C57BL/6) 
controls were used whilst for Ccr2-/- experiments, C57BL/6JCrl mice were obtained from 
Charles River and kept in house for 2 weeks prior to use in the same room as their transgenic 
counterparts. All other chimeric and C57BL/6 mouse studies were carried out in the Ann 
Walker animal facility on the King’s Buildings campus using mice bred in house. Part way 
through the study the Ann Walker facility switched from maintaining a C57BL/6JOlaHsd 
colony to a C57BL/6J colony. Anecdotally, there was no noted effect of this switch to results 
or their interpretation. All experiments were carried out under license granted by the UK 
Home Office and approved by the University of Edinburgh Animal Welfare and Ethical Review 
Body  
 
Table 2.1 Mouse strains and source 
Strain (alternative names) Source 
C57BL/6J (CD45.2+, Ly5.2) Bred in house in Ann Walker. Originally 
from Harlan UK (first half of study) or The 
Jackson Laboratory (second half of study) 
Ly5.1 Het (CD45.1+CD45.2+)  Bred in house in Ann Walker by crossing 
C57BL/6J with Ly5.1 Hom 
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Ly5.1 Hom (B6.SJL-Ptprca Pepcb/BoyJ, 
CD45.1+) 
Bred in house in Ann Walker. Originally 
from Harlan UK  (first half of study) or The 
Jackson Laboratory (second half of study) 
C57BL/6JCrl Obtained from Charles River and kept in LF2 
alongside transgenic mice for 2 weeks prior 
to use 
C57BL/6OlaHsd Obtained from Harlan UK for breeding with 
Csf1r-mApple mice 
Csf1r-mApple (Csf1r-mApple/Csf1r-rtTA) Generated in collaboration with David 
Hume by pronuclear injection and bred in 
house in LF1. Bred with C57BL/6OlaHsd to 
generate negative littermate controls 
MacGreen (B6.Cg-Tg(Csf1r-EGFP)1Hume/J, 
c-fms-EGFP, Csf1r-EGFP) 
Kindly provided by Prof. Philippa Saunders 
and Dr Takanori Kitamura (housed in LF1). 
Ccr2-/- (B6.129S4-Ccr2tm1lfc/J) Originally obtained from Jackson 
Laboratories and maintained in LF2.  
Or 
Kindly provided by Prof. Allan Mowat (The 




Bred in house in LF1 
 
2.2 Generation of protected, partially irradiated bone marrow chimeras 
Ly5.1 Hom or Ly5.1 Het mice were anaesthetised with 0.008mg/g Domitor (Medetomidine) 
and 0.8mg/g Veletar (Ketamine) mixed in sterile dPBS given sub-cutaneously (sc) in the flank 
of the animal (at a volume of 0.008ml/g). Mice were put into bubble wrap ‘sleeping bags’ to 
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maintain core body temperature during the irradiation process. The lower limbs and lower 
portion of the abdomen were exposed to 9.5Gy g irradiation for 19 minutes and 30 seconds, 
whilst the rest of the body, including the liver was shielded by a 2 inch thick lead block. For 
experiments where the resident macrophages of the peritoneal cavity were to be studied, 
less of the abdomen was exposed to the irradiation, to protect the cavity. Mice were given 
0.5mg of Antisedan (Atipamezole) in 100µl sterile dPBS sc, and placed into a heat box at 37°C 
for 10 minutes to aid recovery from anaesthetic. Mice were given broad spectrum antibiotics 
(Baytril) in their drinking water for 4 weeks post irradiation to reduce risk of bacterial 
infection, and mash for 2 weeks.  
 
2.3 Preparation of bone marrow cells for reconstitution of irradiated hosts 
C57BL/6 (Ly5.2 hom) mice bred in Ann Walker, or MacGreen mice bred in LF1 were culled by 
cervical dislocation. Skin was removed from the lower abdomen to expose the hind legs. 
Excess muscle and flesh was cut away, and the tibias and femurs were dissected from the 
animal, ensuring that bones were kept intact. Bones were discarded if there was any 
accidental breakage of bones or exposure of bone marrow in order to ensure bone marrow 
remained sterile. For mice bred in Ann Walker, dissection of the mice was carried out in the 
SPF dissection room B56, whilst for MacGreen animals, mice were dissected in a class II cell 
culture hood in LF1. Bones were collected into ice cold dPBS in a bijou.  
In sterile conditions, bones were transferred into ice cold 70% ethanol for 2 minutes to 
sterilize and wash bones. Bones were washed twice in sterile, ice cold dPBS and kept in dPBS 
on ice. The ends of each bone were removed using sterile scissors and sterile forceps to 
expose the bone marrow. Using a 23 gauge needle and a 10ml syringe, bone marrow was 
flushed from each bone with HBSS (Gibco) supplemented with 5% FCS (Gibco). A bone was 
considered to be fully flushed of its bone marrow when its colour changed from a pale pink 
to a translucent white.  
Flushed bone marrow was gently mixed to a single cell suspension using a 10ml syringe 
without a needle. The single cell suspension was poured through a sterile 40µm filter (VWR) 
into a 50ml falcon. Cells were centrifuged at 300g for 5 minutes at 4°C. Supernatant was 
discarded and cells were lysed in RBC lysis buffer on ice (Sigma; 5ml for 5 minutes). Cells were 
topped up to 10ml with HBSS + 5% FCS. Cells were centrifuged at 300g for 5 minutes at 4°C. 
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Supernatant was discarded and cells were resuspended in 10ml HBSS + 5% FCS for counting. 
Cells were counted using a haemocytometer and a light microscope. See section 2.13 for 
methods for haemocytometer counts. Cells were resuspended at 25x106/ml (but this could 
be reduced to 10x106/ml if an insufficient number of cells were recovered) in dPBS.  
 
2.4 Reconstitution of irradiated mice with donor bone marrow 
The day after irradiation mice were given 2-5x106 bone marrow cells from congenic C57Bl/6 
mice, or Macgreen mice intra-venously (iv) through the tail vein in a total volume of 200µl 
sterile dPBS (Gibco).  
 
2.5 Screening of chimeras 
Mice were placed into a heat box set at 37°C to ensure adequate vasodilation. The tail vein 
was punctured using a grey 27 gauge needle (BD) and tail vein blood (20µl) was collected 
with a pipette for analysis by flow cytometry to test the level of chimerism which had been 
achieved 6 weeks after reconstitution. Mice were left for a total of 8 weeks after irradiation 
before commencement of studies. Any mouse with blood chimerism below 10% in the Ly6Chi 
monocyte compartment was excluded from the study, and was culled.  
2.6 Isolation of leukocytes from the liver 
Mice were culled by increasing concentrations of CO2. Mice were slowly perfused through 
the inferior vena cava with 10ml of PBS. In most cases, 0.5g (±0.05g) of the left lobe of the 
liver was collected into RPMI for transport. If the left lobe weighed less than 0.45g then an 
extra piece of liver (usually from the right or caudate lobes) was added. Livers were put into 
60mm cell culture dishes (Scientific Laboratory Supplies Ltd.) and finely chopped using a razor 
blade until homogenised. A 5ml stripette with 5ml of enzyme cocktail (RPMI with 
0.625mg.ml-1 collagenase D (Roche), 0.85 mg.ml-1 collagenase V (Sigma-Aldrich), 1 mg.ml-1 
dispase (Gibco, Invitrogen) and 30U.ml-1 DNase (Roche Diagnostics GmbH)) was used to 
transfer the liver homogenate to a 50ml conical tube. Livers were digested for 22 minutes at 
37°C, 240rpm, with vigorous hand shaking every 5 minutes. Digests were poured through a 
100µm strainer, then cells were prepared according to one of the following protocols:  
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2.6.1 300g centrifugation method 
Tubes were topped up to 50ml with ice cold RPMI (Gibco) and centrifuged at 300g, max. 
break and accelerator for 5 minutes at 4°C. Supernatants were discarded, except when 
comparing protocols, in which case the supernatants were transferred to a fresh 50ml falcon, 
centrifuged at 400g and the pellet retained for analysis. Cell pellets were resuspended in 
30ml ice cold RPMI and centrifuged at 300g for 5 min. RBC lysis buffer (Sigma; 2ml) was added 
for 2 minutes and samples were topped up with another 2 ml FACS buffer (PBS supplemented 
with 0.5% BSA and 2mM EDTA (Life technologies)).  Cells were centrifuged at 300g for 5 min 
and the supernatant discarded. The pellet was resuspended in 2ml FACS buffer, passed 
through a 40µm strainer with a stripette, and counted using a CASY TT counter (Roche). This 
method was used for all experiments in this thesis except where clearly indicated in chapter 
3. 
 
2.6.2 33% Percoll gradient method 
Tubes were topped up to 50ml with liver wash buffer (PBS + 10% FCS) and centrifuged at 
443g for 6 min, max. break and accelerator, 4°C. The supernatant was discarded and the 
process was repeated. The pellet was resuspended in a 33% Percoll gradient (25ml per 
sample – 8.25ml Percoll, 0.925ml 10X PBS, 15.825ml 1X PBS) and spun at 600g for 12 min, 
with minimum break and accelerator, at room temperature. The resultant hepatocyte and 
percoll layers were discarded, except when comparing protocols, in which case they were 
centrifuged at 400g and the resultant pellet was stained. The leukocyte pellet was transferred 
to a fresh 50ml falcon and topped up to 30ml with liver wash buffer and centrifuged 300g for 
5 min, max. break and accelerator, 4°C. Red blood cells were lysed for 5 min in 5ml RBC lysis 
buffer (Sigma), topped to 30ml with liver wash buffer and washed at 300g for 5 min. Pellets 
were resuspended, strained and counted as above.  
 
2.6.3 50g centrifugation method 
Tubes were topped up to 50ml with RPMI supplemented with 10% FCS and centrifuged at 
50g for 10 min with accelerator set at 3 and breaks set at 1, 4°C. For comparisons of 
protocols, the pellet (normally discarded) was retained, whilst the supernatant was collected 
into a fresh tube and was centrifuged at 340g for 10 min, breaks 3;1.  The pellet was lysed 
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with RBC lysis buffer (Sigma; 2ml) for 5 min on ice, topped up with 2ml RPMI + 10% FCS and 
spun 340g for 10 min, breaks 3;1. Pellets were resuspended, strained and counted as above.  
 
2.7 Isolation of leukocytes from the peritoneal cavity 
Mice were culled by increasing concentrations of CO2. Skin was removed from the abdomen, 
carefully leaving the peritoneum intact. 5ml syringes were loaded with 3ml RPMI + 2mM 
EDTA + 10mM HEPES solution, and an extra 1ml of air was drawn into the syringe to aid 
inflation of the cavity. A 23 gauge (blue) needle (BD) was guided bevel upright into the cavity, 
taking care not to puncture any organs and the air and RPMI was expelled into the cavity. 
The needle was withdrawn and the mouse gently shaken to ensure distribution of media 
throughout the cavity. The needle was inserted to the side of the cavity and media was drawn 
back into the syringe. This process was carried out 3 times in total, yielding an average of 
around 8ml of peritoneal wash fluid in total. Cells were centrifuged at 300g, 5 mins, 4°C. The 
pellet was resuspended in 1ml FACS buffer and samples were counted using a CASY TT 
counter (Roche).  
 
2.8 Isolation of leukocytes from the lung 
Mice were culled by increasing concentrations of CO2. The thoracic cavity was opened and 
lungs were gently cut out using scissors. Lungs were not perfused. Lungs were stored in ice 
cold RPMI, then transferred to a 5ml bijou and cut into small pieces using scissors. Samples 
were digested in 2ml enzyme mix (see section 2.6) at 37°C, 240rpm for 45 mins with vigorous 
hand shaking every 10-15 minutes.  Digests were pushed through a 100µm strainer using a 
plunger from a 5ml syringe and tubes were topped up to 10ml with FACS buffer. Samples 
were centrifuged at 300g, 5 mins, 4°C. The pellets were resuspended in 10ml FACS buffer, 
strained through a 40µm strainer and counted using a CASY TT counter (Roche). 
 
2.9 Isolation of leukocytes from whole blood 
Blood for experimental analysis was collected either by tail vein puncture or cardiac puncture 
(see section 2.10). Leukocytes were then isolated from blood in two ways. Blood (20µl) was 
collected into V-bottomed culture plates (VWR) containing 180µl blood buffer (HBSS + 5% 
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FCS + 2mM EDTA). Samples were washed once in PBS before staining. After staining, RBC 
were lysed using 200µl 1X RBC lysis buffer (BD Biosciences) diluted in water for 8 minutes at 
room temperature.  
Alternatively, blood (100µl) was collected into 10µl of EDTA in a 15ml falcon tube. RBC were 
lysed twice in 1ml of 1X RBC lysis buffer diluted in water (Biolegend) for 5 mins on ice. Cells 
were washed in 9ml FACS buffer (PBS + 2mM EDTA + 0.5% BSA). Cells were plated into 96-
well V-bottomed tissue culture plates for staining with antibodies for flow analysis. 
Both methods anecdotally gave roughly equivalent ratios of different leukocyte populations, 
but the latter method gave far superior yields, and was used for all experiments performed 
by me in chapters 4 and 6.  
 
2.10 Processing of blood for serum analysis 
After euthanasia by increasing concentrations of CO2, cardiac puncture directly through the 
ribcage was used to collect large volumes of blood. The ribcage was steadied using the free 
hand, and a 1ml syringe with a grey 27 gauge needle (BD) was guided between ribs into the 
heart. The plunger was gently pulled to draw blood into the syringe. The needle can be 
moved gently in and out until the needle is in a chamber and blood can be drawn easily into 
the syringe. If no blood can be drawn on the first attempt, the needle can be withdrawn and 
the process attempted again. Blood was transferred to a microtainer tube (BD) and left at 
room temperature for 30 minutes to 2 hours. Blood was centrifuged at 100g for 1.5 min at 
room temperature. The serum was transferred to a 1.5ml microfuge tube and stored at -
80°C. Samples were analysed for serum ALT and AST levels by Dr Forbes Howie at the SURF 
service based at QMRI.   
 
2.11 Flow cytometry 
2.11.1 Surface staining 
2x106 liver cells, 5x106 lung cells, 1x106 peritoneal cavity cells were added to a 96 well V 
bottomed cell culture plate (VWR). If cells were to be stained with Zombie Aqua fixable 
viability dye (Biolegend) they were first washed in PBS to remove any protein (a wash 
indicates a spin at 300g for 5 minutes at 4°C). 10µl Zombie Aqua (see table 2.2 for all antibody 
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dilutions) was added for 10 minutes at room temperature, and samples were wrapped in foil 
to protect them from light. Cells were then incubated in the dark with 10µl anti-CD16/CD32 
+ 10% mouse serum (Life technologies) referred to as ‘block’, for 10 minutes on ice. Cells 
were then incubated with a mix of primary antibodies (30µl) for 30 minutes in the dark on 
ice. Cells were washed twice in FACS buffer. If required, cells were incubated with 
fluorochrome-conjugated streptavidin (50µl) for 20 minutes on ice, and washed twice in 
FACS buffer. Cells were resuspended in FACS buffer for acquisition on the same day. All 
samples were run live, the same day as necropsy throughout the study, unless they were to 
be fixed for additional intracellular staining. In this instance, pellets were resuspended in 
100µl Foxp3/transcription factor staining fixation reagent, diluted 1:3 with permeabilization 
reagent (eBioscience). Samples were left overnight at 4°C. The following morning, samples 
were washed into 1X Foxp3/transcription factor permeabilization buffer in dH2O 
(eBiosicence) and stored at 4°C for a maximum of one week before intracellular staining. 
Fluorescence minus one controls were used to determine gates, and where indicated isotype 
matched controls were used to determine specificity of binding. For some experiments, 
7AAD (Biolegend; 20µl  for liver/lung samples; 10µl for blood/peritoneal cavity samples 
added to 150µl cells in FACS buffer) was added either alongside, or instead of, Zombie Aqua 
5 minutes before acquisition. Samples were run on either a 5 or 6 laser LSR Fortessa flow 
cytometer (BD). Samples that formed part of a time course were always run on the same 
machine, using the same set up parameters. Data were analysed in FlowJo v9.9 
 
2.11.2 Ki67 and BrdU intracellular staining 
For Ki67 and BrdU staining, surface markers were stained and cells were fixed as detailed 
above. Cells were incubated at 37°C for 30 minutes with 100µl DNase mixture (master mix = 
30µl DNase [Sigma] + 970µl dPBS + 10µl MgCl2 [Sigma; from hexahydrate powder]). A no 
DNase control well was included for setting BrdU gating, and an isotype matched control was 
used to set the Ki67 gate. Cells were washed twice with 1X permeabilization buffer. BrdU and 
Ki67 antibodies diluted in 1X permeabilization buffer were added to samples (20µl) and 
incubated for 30 minutes at room temperature in the dark. Cells were washed twice with 1X 
permeabilization buffer and resuspended in FACS buffer. Samples were immediately 
analysed by flow cytometry.   
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2.11.3 Clec4f staining for flow 
For Clec4f staining, a polyclonal goat anti-mouse Clec4f antibody was included in the normal 
surface antibody cocktail. After washes, cells were incubated with a donkey anti-goat-AF647 
antibody for 20 minutes on ice in the dark. If necessary, the donkey anti-goat secondary was 
added at the same time as a streptavidin secondary to reduce the number of staining steps.  
 
2.11.4 Single stained control beads 
To generate a compensation matrix in the FACSDiva software (BD), single stained control 
beads were used. A few drops of Ultra-comp beads (eBioscience) were added to FACS buffer, 
and 100µl of this was added to 12x75mm polystyrene tubes (SLS Falcon). 0.5µl of a single 
fluorochrome-conjugated antibody was added to each tube and incubated in the fridge for 
30 minutes. Beads were washed with FACS buffer. For biotinylated primary antibodies, the 
streptavidin conjugated fluorochrome (0.5µl) was incubated at the same time.  
 
2.12 Flow assisted cell sorting 
For FACS, livers were split into two sections, each of which were digested with 5ml of enzyme 
cocktail and processed according to the standard liver protocol (see sections 2.6 and 2.6.1). 
Split livers were pooled in 5ml total volume prior to counting. The whole liver (40-50x106 
cells) was stained according to the surface staining protocol (see section 2.11.1) in 12x75mm 
polystyrene tubes (SLS Falcon). The total staining volume was scaled up to 1ml to account for 
the increased number of cells. 400µl block and 600µl antibody cocktail were added. 1ml of 
streptavidin secondary was added where appropriate. DAPI was added at 1:1000 
immediately prior to running of samples to exclude dead cells. FMO controls were used to 
set gates. Cells were sorted using a FACS Fusion (BD) sorter with a 70µm nozzle attachment.  
 
2.13 Haemocytometer counts 
10µl of cell suspension was mixed with 10µl 0.4% Trypan Blue and 20µl of this cell suspension 
was loaded into a haemocytometer. The total number of cells within the central 5x5 grid was 
counted. This number was multiplied by 20000 to find the total number of cells per ml.  
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2.14 CASY TT cell counter counts 
Cells were counted according to manufacturer’s instructions. 5µl cell suspension was added 
to 5ml of CASY ton in a CASY cup and gently shaken to mix. Cells were then run through 
CASY’s automated cell counting system. A size threshold was set from 5.3µm-15µm to 
exclude red blood cells and small bits of debris, and large clumps of cells.  
 
2.15 Storage of CSF1-Fc, IL-4 and anti-IL-4 Ab 
CSF1-Fc was given to the Jenkins lab by David Hume. When it arrived it was at a concentration 
of 3.96mg/ml in a total volume of 1ml. Vials were resuspended at 1mg/ml in sterile dPBS 
(Gibco) and aliquotted into 100µl aliquots, giving a total of 100µg of CSF1-Fc protein per 
aliquot. Both stock CSF1-Fc at 3.96mg/ml and aliquotted CSF1-Fc at 1mg/ml was stored at -
80°C.  
Recombinant murine IL-4 protein was bought from Peprotech and resuspended in dPBS to 
give a stock concentration of 1mg/ml, stored in 50µl aliquots at -80°C. Anti-IL-4 antibody 
(IIBII) was bought from Bio X Cell and resuspended in dPBS to give a stock concentration of 
7mg/ml, which was stored in 36µl or 72µl aliquots at -80°C. 
 
2.16 Administration of CSF1-Fc and IL-4c in vivo 
CSF1-Fc was resuspended in dPBS and mice were given 1µg/g sc in a volume of 5µl/g of dPBS. 
Recombinant murine IL-4 was mixed with recombinant anti-IL-4 (IIBII) in sterile conditions to 
form an IL-4 complex (IL-4c) at a ratio of 1:5 IL-4:anti-IL-4. Mice were given 0.05µg IL-4 + 
0.25µg anti-IL-4/g in a volume of 5µl/g of dPBS.  
 
2.17 Administration of carbon tetrachloride  
One part Carbon tetrachloride (CCl4, Sigma) was mixed with 3 parts olive oil (low endotoxin, 
Sigma) in a glass bottle in a fume cupboard. Male mice were treated with 1µl/g of body 
weight of the CCl4 in olive oil mixture ip to give a final dose of 0.25µl/g of CCl4. Control animals 
received 1µl/g olive oil ip. Mice received either one dose of CCl4 (acute model), or two doses 
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a week for 4 weeks (chronic model), in which case doses were given alternately 3 or 4 days 
apart.  
100µl Hamilton syringes were used allowing accurate dosing to the nearest 1µl, and separate 
Hamilton syringes were used for olive oil control and CCl4 treated mice to prevent any cross 
contamination. Control and CCl4 treated animals were kept in separate cages due to 
anecdotal evidence by pers. com. with others in the department that CCl4 can be excreted by 
animals through urine, which can contaminate bedding, leading to transfer of CCl4 to control 
animals via the inhalation route.  
Syringes and glass bottles were washed 5 times in 100% ethanol followed by 5 times with 
water, and were autoclaved after each day of injections.  
 
2.18 Administration of BrdU 
BrdU (Sigma) (1mg in 100µl dPBS) was administered sc in the flank 2 hours prior to necropsy. 
Cells were stained following the protocol in section 2.11.2. 
 
2.19 RNA extraction and quantification 
50,000 cells were FACS purified directly into 0.5ml RLT buffer (Qiagen) in RNase free 1.5ml 
eppendorfs (Qiagen) and kept on ice until RNA extraction. RNA was extracted the same day 
as the sort to avoid freeze-thaw. The sort volume was 200µl, giving a total  volume of 0.7ml 
per sample. An additional 200µl RLT buffer was added, giving a final volume of 0.9ml per 
sample. 9µl b-mercaptoethanol (Sigma) was added and tubes were gently mixed. RNA was 
extracted using reagents from the RNeasy plus Micro kit, according to manufacturer’s 
instructions (Qiagen), following the ‘purification of total RNA from animal cells’ protocol, 
with exceptions: gDNA eliminator columns were not used, and no DNase step was 
performed. RNA was quantified by Pamela Brown using the Perkin Elmer Labchip GX24 gel 
quantification. 2µl was loaded per sample, leading to one freeze-thaw cycle. Samples were 
run using the pico chip with a detection range of 5-50000pg/µl. Many of the samples had an 
RNA concentration greater than this maximum, but pers. com. with Pamela indicated that 
this should not greatly affect the accuracy of the predicted concentrations or the quality 
scores. Samples were also quantified using the Nanodrop 1000 (Thermo)  and for this 
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purpose separate 1.5µl aliquots were used which had been taken prior to freezing of the 
main sample, avoiding an additional freeze-thaw cycle.     
 
2.20 NanoString analysis 
RNA samples were delivered on frozen ice to the NanoString facility at the MRC Institute of 
Genetics and Molecular Medicine (IGMM), University of Edinburgh. Alison Munro performed 
hybridization reactions and ran 8µl per sample through the nCounter platform using the 
nCounter Mouse myeloid innate immunity panel (NanoString Technologies). 
The sample reporter code count (RCC) files were uploaded to nSolver Analysis Software 
v4.0.70 (NanoString Technologies) and quality checked using default settings. Tim4hipost 
replicate 1 exhibited an imaging QC flag due to a borderline “fields of view” success rate of 
70%. Alison Munro suggested this was acceptable, and further analysis showed near-perfect 
positive pairwise correlations (all correlations: r>0.99; p < 0.0001). Samples were individually 
normalised for background noise using the geometric means of negative controls, and 
sample-based variation using the geometric means of positive control RNA spike-ins and all 
housekeeping genes. Following the recommendations of the NanoString Gene Expression 
Data Analysis Guidelines (NanoString Technologies, 2017), fold change significance values 
were not corrected for multiple testing. Data were further explored using the nCounter 
Advanced Analysis Software v2.0.115 (NanoString Technologies) using R v3.3.2 (R Core 
Team).  
Volcano plots were generated using fold change for all assayed gene targets. Data were log2 
transformed and the top fifty genes with greatest absolute fold change between Tim4hi post 
and Tim4lo post populations were used to construct a heatmap (Morpheus, 2019). Samples 
were grouped using hierarchical clustering with Euclidean distance and average linkage. 
Gene function was annotated using information provided by the nCounter® Mouse myeloid 
innate immunity panel. Bioinformatic analysis was carried out by Dr Andrew Mason.  
 
2.21 Preparation of tissues for histological assessment 
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2.21.1 Fixation in 4% paraformaldehyde 
This method was used to preserve EGFP fluorescence in MacGreen whole mice, and chimeras 
with MacGreen donor bone marrow. 4% paraformaldehyde (PFA) was prepared in the lab, 
and stored at -20°C until use. A lobe of liver was fixed for 2 hours in 10ml 4% PFA on a roller 
in a cold room at 4°C. Livers were washed twice in dPBS. 10ml 15% sucrose in dPBS was 
added for 1 hour at room temperature. The 15% sucrose was drained and 10ml 30% sucrose 
in dPBS was added. Livers were left overnight at 4°C. The 30% sucrose was drained and livers 
were air dried. Livers were embedded into OCT (Fisher Scientific) in Peel-A-Way embedding 
molds (SLS). The OCT-embedded samples were snap frozen in a 100% ethanol + dry ice slurry. 
Blocks were stored at -80°C. 
 
2.21.2 Fixation in 10% formalin 
This method was used to fix livers before embedding in paraffin. A lobe of liver was fixed for 
12 hours in 10% formalin (3.7% formaldehyde) (diluted 1:10 in PBS from 37% formaldehyde 
solution; Sigma) at room temperature. Livers were washed twice in 70% ethanol and sent to 
The University of Edinburgh SURF histology service based at QMRI to be paraffin embedded 
and cut.  
 
2.21.3 Snap freezing of liver into OCT on dry ice 
This method was used to freeze livers due for cryosectioning, followed by fixation and 
immunofluorescence. A lobe of liver was immediately embedded in OCT in Peel-A-Way molds 
and snap frozen on dry ice within a minute of being removed from the animal. Blocks were 
stored at -80°C. 
 
2.22 Cryosectioning 
Samples were brought to -20°C at least 24 hours prior to cryosectioning. Blocks were 
removed from the molds and mounted on the cryostat chuck. 9µm sections were taken onto 
standard glass microscope slides (Leica). If tissues had already been fixed with 4% PFA, slides 
were immediately stored at -20°C for up to one week before staining. If tissues had been 
directly snap frozen, sections were allowed to air dry for one hour. Sections were fixed in ice 
 61 
cold 1:1 acetone:methanol for 5 minutes. Slides were dabbed dry and stored at -20°C for up 
to one week before staining.  
 
2.23 Periodic acid-Schiff staining 
10% formalin fixed, wax embedded tissues were used. PAS staining was carried out by staff 
at SURF histology service, following their standard protocols.  
 
2.24 Immunofluorescence 
Cryosectioned tissues were used. Slides from the freezer were air dried for 30 minutes and 
samples were drawn around with a hydrophobic pen (ImmEdge, Vector Labs). Slides were 
placed into a humidity chamber. Slides were washed twice in 120µl dPBS. Slides were blocked 
in 120µl 20% normal goat serum (NGS) (In-Vitro Diagnostics) in PBS for one hour at room 
temperature. The block was tipped off and the slides dabbed dry. Primary antibodies were 
diluted in antibody staining diluent (Invitrogen) at the relevant concentrations, and slides 
were incubated with 100µl antibody for 2 hours at room temperature (see table 2.3 for 
details of dilutions). Slides were washed twice in dPBS. Fluorochrome-conjugated secondary 
antibodies were diluted in 20% NGS and 100µl was added for 30 minutes at room 
temperature. Slides were washed twice in dPBS and mounted in Vectashield hard set 
antifade mounting medium with DAPI (Vector labs). Slides were sealed with clear nail varnish 
and stored wrapped in foil at 4°C for up to one week before imaging.  
 
2.25 Imaging 
PAS stained slides were imaged on a light microscope with 80X total magnification. Images 
were processed using Fiji ImageJ v 2.0.0.  
For immunofluorescence, stained slides were imaged using a LSM780 confocal microscope 
(Zeiss) with Zen Black software (Zeiss). All images from within the same data set were imaged 
with the exact same acquisition settings. Images were processed and analysed using Fiji 
ImageJ v 2.0.0. Where brightness and contrast was edited, this kept consistent across all 
images within a data set. 
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2.26 Calculation for contribution of endogenous KC to total proliferation rate 
(discussed in Chapter 5) 
To determine the proportion of the total KC proliferation that was attributable to 
endogenous, tissue-resident KC (of host origin) the following calculation was used: 




2.27 Statistical analysis 
Data were analysed in Prism 6 (GraphPad), and significance in cell frequencies was 
determined by One-way ANOVA with Tukey’s multiple corrections, Two-way ANOVA with 
Tukey’s multiple corrections, student’s t-test, multiple t-tests with Holm-Sidak correction 
applied or a paired t-test where appropriate and as indicated throughout the text. 
 
Table 2.2 Primary, secondary and streptavidin-conjugated antibodies used for flow cytometry 
Antibody Clone Dilution Supplier 
7AAD n/a 10-20µl/sample Biolegend 
BrdU Bu20a 1.25µl/sample Biolegend 
CD115 AFS98 1:200 Biolegend 
CD11b M1/70 1:200 Biolegend/eBioscience 
CD11c N418 1:200 Biolegend 
CD19 6D5 1:200 Biolegend 
CD26 H194-112 1:200 Biolegend 
CD3 17A2 1:200 Biolegend 
CD31 MEC13.3 1:200 Biolegend 
CD43 S11 1:200 Biolegend 
CD45.1 A20 1:200 Biolegend 
CD45.2 104 1:200 Biolegend 
CD64 X54-4/7.1 1:200 Biolegend 
CD80 16-10A1 1:200 Biolegend 
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Clec4f  polyclonal 1:100 R&D 
DAPI n/a 1:1000 Biolegend 
Donkey anti-goat 
AF647 
polyclonal 1:1000 Thermofisher 
F4/80 BM8 1:200 Biolegend 
Ki67 B56 7.5µl/sample BD Bioscience 
Ly6C HK1.4 1:400/1:200 Biolegend/eBioscience 
Ly6G 1A8 1:200 Biolegend 
PDCA-1 927 1:200 Biolegend 
PDL1 10F.9G2 1:200 Biolegend 
SiglecF E50-2440 1:200 BD Pharmingen 
SiglecF - biotin ES22-10D8 1.7µl/sample Miltenyi Biotech 
Streptavidin-
BV650 
n/a 1:200 (0.1mg/ml 
vial) 
Biolegend 
Tim4 RMT4-54 1:200 Biolegend 
Zombie Aqua 
viability dye 
n/a 1:100 Biolegend 
 
Table 2.3 Primary and secondary antibodies used for immunofluorescence staining 
Antibody Clone Dilution Supplier 
F4/80 A3-1 1:100 Abcam 
Tim4 RMT4-54 1:50 Biolegend 
Goat anti-rat IgG 
AF488 
polyclonal 1:200 Thermofisher 
Goat anti-rat IgG 
AF594 




Chapter 3:  Establishment of a robust method for the unbiased 




In order to explore the origin and maintenance of liver Kupffer Cells during homeostasis and 
liver injury I first needed to develop robust and sensitive techniques to isolate and analyse 
leukocytes in the liver. Flow cytometry is a powerful tool, as it provides a method to evaluate 
changes in frequency, number and phenotype of multiple cell populations in parallel, and is 
the main method used to analyse samples in this thesis.  However, the accuracy and validity 
of the conclusions made from flow cytometric studies depends on both the process used to 
isolate and prepare a single cell suspension, and the choice of markers and fluorochrome 
combinations used to identify populations of interest.  
The isolation of leukocyte populations from solid tissue which faithfully represented the 
ratios and phenotypes of the populations present in vivo was an important consideration 
before embarking on further study. There are multiple protocols published for the 
preparation of a single cell suspension of leukocytes from murine liver. Common to these 
methods is the manual and enzymatic digestion of solid tissue to release leukocytes from the 
parenchymal structure of the tissue. When I joined the Jenkins lab, we favoured a protocol 
employing a 33% Percoll gradient separation step designed to remove hepatocytes and 
debris from the liver digestion soup, which has been used previously (Phythian-Adams et al. 
2010). However, other members within the department were using an alternative protocol 
employing an initial 50g centrifugation step to pellet and discard hepatocytes and other 
parenchymal cells (Ramachandran et al. 2012). Additionally, Dr Calum Bain had recently 
joined the Jenkins lab as a post-doc and had previously published a study using a more simple 
method of multiple 300g centrifugation steps (Bain et al. 2014). Thus, comparison of these 
methods was a critical first step to determine the optimal method for my studies.  
At the time that I started my PhD, the most universally accepted marker for liver KC was 
F4/80, which was first identified for use as a general macrophage marker in mouse (Austyn 
et al. 1981) and the use of an F4/80hiCD11blo gate to identify KC had remained the gold 
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standard  despite a further 30 years of research in the macrophage field (Heymann and Tacke 
2016). During the course of the project, CLEC4F, a C-type lectin, was shown to be expressed 
specifically by KC (Scott et al. 2016; Yang et al. 2013; Lavin et al. 2014), whilst I and others 
found that Tim4, a phosphatidylserine receptor (Miyanishi et al. 2007) was useful in 
distinguishing KC from other myeloid cells in the liver (Beattie et al. 2016; Scott et al. 2016). 
In parallel to my studies, Dr Ruairi Lynch, another PhD student in the Jenkins lab, discovered 
what appeared to be a significant contamination of the F4/80hiCD11blo KC gate with 
endothelial cells using a tamoxifen inducible fluorescent reporter system to label cells 
expressing the endothelial marker CDH5. These findings, together with the data presented 
in this chapter were published in The Journal of Leukocyte Biology (Lynch et al. 2018). The 
experiments presented in this chapter were all performed by me, with the exception of one 
of the two repeat experiments that form figure 3.4B, which was carried out by Dr Calum Bain, 
and that the 50g spin protocol was performed by Dr Antonella Pellicoro for the steps after 
digestion of tissue up until the point of counting of cell suspensions.   
 
3.2 Identification of liver leukocytes by flow cytometry  
As flow cytometry was to be the major mode of analysis of liver KC in this project, it was first 
important to devise a robust gating strategy. Live, single cells were identified using viability 
markers and a FSC-A v FSC-H singlets gate. CD45+ leukocytes were then further divided into 
F4/80hiCD11blo KC and putative F4/80loCD11bhi cells as described by Schulz and colleagues 
(Schulz et al. 2012) (fig. 3.1A). The subdivision of this F4/80loCD11bhi population is further 
examined in chapter 4 (Hawley et al. 2018), but for simplicity is considered as a single 
population in this chapter. The marker CD31 was included in the staining panel for the 
majority of experiments which is examined in more detail later in this chapter. A ‘dump’ gate 
including CD3, CD19, Ly6G and Siglec F was used primarily for the exclusion T cell, B cell, 
neutrophil and eosinophil populations, although each population could be rudimentarily 
identified within the dump gate on the basis of their side scatter, and CD11b and MHCII 
expression (fig. 3.1A). Fluorescence minus one (FMO) controls were used to determine where 
gates should be set (fig. 3.1B).  
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3.3 Comparison of 3 protocols for the preparation of murine liver leukocytes 
for flow cytometry  
Before beginning to investigate parameters of liver KC origin and self-renewal, I first set 
about establishing the optimal method of isolating and analysing leukocytes in the liver for 
my studies. I compared the use of a 33% Percoll gradient, a 50g spin, or a 300g spin method 
to determine which would be most suitable for the study of KC biology. Full details of the 
methods used can be found in chapter 2. The criteria for appraisal of methods were multiple: 
cell yield and viability, amount of debris in the preparation, how well the cells recovered 
represented the in vivo population and how this affected interpretation of aspects of KC 
biology. 
 
3.3.1 Choice of method for isolation of liver leukocytes affects cell viability and 
retention of cell debris 
Cell debris can be a significant problem with solid tissue digests as preparations full of debris 
can easily block the flow cytometer, making assessment of cell yield problematic; unless a 
size threshold is set, events relating to debris can vastly outnumber cells of interest during 
sample acquisition. These events tend to be small and of low complexity, falling in the bottom 
left hand corner of a forward scatter versus side scatter (FSC-A v SSC-A) flow plot. Following 
enzymatic digestion, livers were processed following one of the 3 methods described briefly 
above, stained and run through the flow cytometer. Comparison of FSC-A v SSC-A, with a 
‘cells’ gate set at FSC-A greater than 25K, below which, no events were positive for the 
leukocyte marker CD45 (data not shown), revealed that the 50g centrifugation protocol 
retained the greatest proportion of debris, whilst the Percoll gradient had produced the 
preparation with the highest ratio of cells to debris. The 300g spin protocol fell in between 
(fig. 3.2A & 3.2B).  
To assess what proportion of the ‘cells’ gate was alive, two viability markers were included: 
7AAD which binds DNA of cells with compromised membranes, and Zombie Aqua which 
binds primary amine groups of proteins, such as the abundant intracellular protein accessible 
in dead and dying cells. After debris and doublets had been removed from analysis (fig. 3.2A 
& 3.2C), the proportion of cells which were negative for both 7AAD and Zombie Aqua was 
assessed (fig. 3.2D). There was only a small, albeit significant, difference in viability between 
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the Percoll and 300g centrifugation methods, with high viability found with both methods. 
However, there were significantly more dead cells with the 50g centrifugation protocol than 
with either other protocol, with less than 50% of cells viable (fig 3.2E). As it is impossible to 
exclude cell debris solely by FSC vs SSC characteristics, these data are consistent with a large 
amount of cell debris in the 50g preparation.  
 
3.3.2 Greater yield of KC and no selective enrichment of KC with 300g spin method 
Given the complex and intricate nature of interactions between immune cell subsets, I 
wanted to use a protocol which isolated immune cells in proportions which were 
representative of their relative abundances in vivo, and which was not selective for a specific 
immune cell type. I therefore considered the composition of the live cells recovered by each 
method. Leukocytes were identified using a CD45+CD31-/lo gate (fig. 3.3A) and there were no 
significant differences in the overall proportion of CD45+ cells as a frequency of the total live, 
single cell population between methods (fig. 3.3B). However, there were clear differences in 
the relative abundance of F4/80hiCD11blo KC, comprising ~35% of the total leukocyte 
population isolated with the 300g spin protocol, ~18% with the Percoll protocol and ~10% 
with the 50g spin method (fig. 3.3C). The frequency of F4/80loCD11bhi cells was more 
consistent between methods making up around 10-15% of the total leukocyte population 
(fig. 3.3C). With any protocol, there is an inevitable loss of the cells of interest during 
processing of samples. To determine whether this could account for the differences in the 
relative abundance of KC recovered with each method, the supernatant after the first 
centrifugation of the multiple 300g spin method, the discarded fraction after the Percoll 
gradient, and the pellet from the 50g spin – all of which would normally be discarded when 
processing livers – were retained, stained and run through the flow cytometer alongside the 
normal isolates. KC and F4/80lo cell populations could be identified in the discards (fig. 3.3D) 
using the same live, CD45+CD31-/lo gating strategy as used for the isolates. B cells, T cells, 
neutrophils and eosinophils could also be identified in both the isolates and the discards from 
a single lineage gate containing CD3, CD19, Ly6G and Siglec F, along with side scatter profiles 
CD11b and MHCII expression (gated following the strategy set out in fig. 3.1). Comparing the 
frequency of each cell type in the isolate to the frequency in the discard for each mouse 
demonstrated that there were no differences in relative abundance of any leukocyte 
population between the isolate and the discard using the 300g spin method (fig. 3.3E). This 
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indicated that this method did not select or enrich for any specific cell type. In contrast, KC 
were significantly enriched in the discards of both the Percoll gradient and 50g spin methods 
(fig. 3.3F & 3.3G). In other words, KC were being selectively lost using these protocols.  
In addition, cell suspensions were counted using a CASY TT cell counter which determines 
numbers of live cells on the basis of electrical resistance and a size exclusion threshold of 
5.3µm. This revealed that the 300g spin method yielded around 7-fold more KC than with the 
Percoll gradient (fig. 3.3H). Accurate cell counts could not be obtained from the 50g spin 
method due to the large proportion of debris, which the cell counter was unable to 
distinguish from live cell events. However, far fewer live cell events were acquired when 
running these 50g samples through the flow cytometer indicating that it is very likely that 
fewer live cells are recovered with this protocol. 
 
3.3.3 Choice of method affects biological interpretation of proliferation and origin 
of KC 
Finally, we investigated whether choice of protocol affected measures of KC biology. Two key 
readouts for my studies were macrophage proliferation and origin, and I noted that recent 
studies examining aspects of KC ontogeny and self-renewal had mainly used either Percoll 
gradient (Yona et al. 2013; Jenkins et al. 2011) or conventional centrifugation (Bain et al. 
2014; Schulz et al. 2012; Gomez Perdiguero et al. 2015; Scott et al. 2016). I therefore 
compared these readouts in the KC populations recovered by the Percoll and 300g spin 
methods respectively. The 50g spin was not considered further given the poor yield, low 
viability and high amount of debris obtained with this method.  
There was a significant difference in the proportion of KC that expressed the cell cycle marker 
Ki67 between methods, with higher levels of proliferation among the KC from the Percoll 
gradient method (fig. 3.4A), indicating that the Percoll gradient enriched for KC that were 
actively in cell cycle. 
 To assess cell origin, I used partially irradiated bone marrow chimeras that will be used 
extensively later in my thesis. In this system, CD45.1+CD45.2+ host mice are irradiated with 
the lower abdomen and legs shielded by a lead brick, then reconstituted with CD45.2+ only 
donor bone marrow (or fluorescent reporter bone marrow where relevant) to achieve partial 
chimerism which in blood Ly6Chi monocytes reaches a maximum of 20-30%. The level of 
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chimerism seen within individual populations in the tissues can then be assessed to measure 
the contribution of bone marrow derived cells to those populations. There was no difference 
in the non-host chimerism in the F4/80lo population between methods (fig. 3.4B), which is 
consistent with the short half-life and bone marrow origin of this population reported 
previously (Schulz et al. 2012). However, there was a significantly higher proportion of donor 
cells in the KC population isolated by the Percoll gradient compared with the 300g spin 
method (fig. 3.4B), showing that the Percoll gradient enriched for KC of the CD45.2 
homozygous donor origin over CD45.2 heterozygous host cells, which would grossly affect 
conclusions about whether bone marrow derived cells contribute to this population or not. 
In summary, whilst the Percoll gradient method produced a cell isolate with the greatest 
proportion of viable cells, the 300g spin method was superior to the 50g spin and Percoll 
gradient methods in terms of total numbers of cells recovered and in not being selective for 
any one population of leukocytes, thus allowing for a more accurate and unbiased analysis 
of KC biology. Hence, the 300g method was chosen as the superior method to be used in this 
project.  
 
3.3.4 Contamination of F4/80hiCD11blo KC gate with CD31+ cells 
The routine use of CD31 to exclude endothelial cells from the gating strategy (fig. 3.1) was 
introduced after another PhD student in the lab, Dr Ruairi Lynch, noted EGFP expression in a 
proportion of cells in the F4/80hiCD11blo KC gate in mice which express a tamoxifen inducible 
Cre recombinase under the control of the cadherin-5 (Cdh5) promoter. Cdh5 is more typically 
associated with endothelial cells (Zhang et al. 2016), and indeed these cells were also positive 
for another endothelial cell marker CD31 (or PECAM-1) (Lynch et al. 2018). This suggested 
that the GFP+CD31+ cells found in the KC gate may be endothelial cell contaminants. To 
confirm that this was the case, I performed flow cytometry with additional KC markers.  
Interestingly, cell surface staining for KC-specific markers CLEC4F or Tim4 was not able to 
adequately differentiate between CD31lo KC and CD31hi contaminants, even when compared 
to FMO controls (fig. 3.5A & 3.5B), which appeared at first to contradict the theory that the 
CD31hi cells were endothelial contaminants. In contrast, comparison of mApple fluorescence 
in transgenic mice which express mApple under the control of a Csf1r promoter (see chapter 
4; Hawley et al. 2018) with a negative littermate control mouse, revealed CD31lo KC to be 
very bright for the fluorescent reporter, whilst CD31hi cells were much lower, with only a 
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small shift in fluorescence compared to the control (fig. 3.5C), suggesting that they were not 
of myeloid origin.  
Liver sinusoidal endothelial cells (LSECs) have been demonstrated to bind small immune 
complexes via their high expression of the FcgRIIb (CD32b), (Ganesan et al. 2012) which might 
lead to non-specific binding to the CD45 and F4/80 flow antibodies. However, the expression 
of CD45 and F4/80 was shown to be specific in comparison to isotype control antibodies (fig. 
3.5D), and titration of the anti-CD16/CD32 blocking antibody, which was added to cells prior 
to staining with fluorochrome-conjugated antibodies to reduce non-specific background 
staining did not affect the mean fluorescence intensity of F4/80-PE on the CD31hi 
contaminating cells (fig. 3.5E). This confirmed that the F4/80 staining was not due to 
inefficient blocking of Fc receptors on the prepared single cell isolate.  
Finally, fluorescence microscopy of FACS-sorted F4/80hiCD11blo cells carried out by Dr Lynch 
revealed that some of the CD31hi contaminants were doublets with F4/80hiCD31lo KC, whilst 
the rest appeared to be CD31hi cells with small areas of punctate F4/80 and CD45 staining 
(Lynch et al. 2018). Hence, we found no solid evidence that the contaminating CD31hi cells 
were macrophages. These cells were therefore excluded from analysis of the F4/80hiCD11blo 
KC population in all experiments subsequent to this finding by first gating out all CD31hi cells. 
 
3.4 Contamination of F4/80hiCD11blo KCs with CD31hi endothelial cells is 
apparent regardless of protocol used to isolate cells 
The discovery that CD31hi endothelial cells were contaminating the F4/80hiCD11blo gate was 
made using the 300g centrifugation method and it was possible that this endothelial cell 
contamination could be an artefact specific to this protocol. However, CD31hi cells were 
present in the KC gate when cells were prepared with any 3 of the methods, forming around 
8% of the total F4/80hi population with the 300g centrifugation and Percoll gradient methods, 














































































































Figure 3.1 Gating strategy for the identification of murine leukocytes in liver. (A) Standard gating 
strategy used to identify murine leukocyte populations in the liver for this study and (B) fluorescence 
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Figure 3.2 Comparison of debris retention and cell viability between the 3 methods for isolation of 
murine leukocytes in liver. (A) Representative plots of FSC-A versus SSC-A of samples from each of 
the three protocols compared. Gates show the proportion of all events that were considered to be 
cells. (B) Replicate data showing the proportion of events that were cells for each method. (C) 
Representative plots showing the singlets gate used to exclude doublets from the analysis of liver 
prepared with each of the 3 methods. (D) Representative plots of two viability markers Zombie-aqua 
and 7AAD. Gates show the proportion of single cells which were negative for both markers and (E) 
replicate data showing proportion of single cells which were live for each method.  Two experiments 
were carried out in which the 3 protocols were compared side-by-side. In the first experiment, 
technical difficulties led to no data from the 50g spin method, but these issues were resolved by the 
preparation being performed by Dr A. Pellicoro for the repeat experiment. n=8 for 300g and Percoll 
gradient methods pooled from 2 independent experiments and n=4 for 50g spin from one experiment. 






















































































































































































































Figure 3.3 300g spin recovers the most KC and is not selective for the KC population. (A) 
Representative plots showing the CD45+CD31lo/- gate used to determine leukocyte populations for 
each of the 3 methods and (B) replicate data showing the proportion of CD45+CD31lo/- cells of the total 
single cell population. (C) Representative plots of F4/80 versus CD11b showing the proportion of 
F4/80hiCD11blo KC and F4/80loCD11bhi myeloid cells of the total CD45+CD31lo/- population. (D) 
Representative plots of CD11b versus F4/80 from the discarded fractions of each of the 3 methods. 
(E) The frequency of cell subsets in the cell isolate (black squares) linked to the frequency in the discard 
for the same sample (open squares) as a proportion of the total leukocyte population for the 300g 
spin method, (F) the Percoll gradient method and (G) the 50g spin method. (H) The total number of 
F4/80hiCD11blo KC per gram of liver tissue for the isolates and discards of the 300g spin method and 
the Percoll gradient method.  Significance determined by One-way Anova with multiple comparisons. 
* p<0.05 ** p<0.01 ****P<0.0001 (B, H), or multiple t-tests comparing the cells to the discard for each 
cell type, with the Holm-Sidak method applied to determine significance. *p<0.05 **p<0.01 
***p<0.001 ****p<0.0001 (E, F, G). n=4 (50g spin) or 8 (Percoll and 300g spin) per group from the 












































Figure 3.4 Choice of method affects interpretation of KC biology. (A) The frequency of the KC 
population that had high expression of the cell cycle marker Ki67 in the 300g and Percoll gradient 
preps. n=4, data are representative of 2 independent experiments. Significance determined using a 
Student’s t-test, ** p<0.01. (B) The proportion of the F4/80hiCD11blo KC and F4/80loCD11bhi 
populations that were CD45.2+ donor cells in a partially irradiated congenic bone marrow chimera 
system 8 weeks post reconstitution where the host mice were CD45.1+CD45.2+ genotype. n=8, pooled 
from 2 independent experiments, one repeat was performed by Dr Calum Bain. Significance 























































































Figure 3.5 Phenotype of CD31+ endothelial cells contaminating F4/80hiCD11blo gate. (A) 
Representative plot of Clec4f, (B) Tim4 and (C) Csf1r-mApple vs CD31 expression and their relevant 
controls. All representative of at least 3 independent experiments. (D) Representative histograms 
showing CD45-FITC and F4/80-PE binding profile of the bulk CD31+ population (no prior gating apart 
from to attain single, live cells) compared with the binding profile for isotype matched controls for 
each antibody. (E) The geometric mean fluorescence intensity (geoMFI) of F4/80 within the 
contaminating F4/80hiCD31hi population when anti-CD16/CD32 blocking antibody is titrated. Plots are 













































Figure 3.6 CD31hi endothelial cell contamination present with all 3 methods (A) representative plots 
and (B) replicate data showing the proportion of F4/80hiCD11blo cells which were CD31hi for each of 
the 3 methods compared. Significance determined by One-way Anova with multiple comparisons 
where ****P<0.0001. Data from the same experiments as figure 3.2. 
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3.5 Discussion  
In this chapter I set out to establish the optimal method to isolate and analyse liver 
leukocytes for my study. I compared the cell isolates produced from three protocols for the 
preparation of liver leukocytes for flow cytometry, which were considered to be 
representative of the three main methods used in the literature. The Percoll gradient 
separates cells on the basis of density, giving a distinct hepatocyte layer which can be easily 
discarded and separated from the leukocyte pellet following centrifugation (Stijlemans et al. 
2015), and it was therefore unsurprising that this method gave the preparation with the least 
debris. In my hands, two 300g spin steps removed more debris than the 50g spin protocol 
which comprised a 50g spin followed by a 340g spin. There were no significant differences in 
the frequency of leukocytes (defined as CD45+CD31lo/-) as a proportion of live, single cells 
between methods, which was surprising given that the slower spin was intended to pellet 
large parenchymal cells such as hepatocytes whilst leaving leukocytes in the supernatant, as 
has been shown with human liver preparations (Kegel et al. 2016). However, as frequency is 
a relative measure, differences in the proportions of other cell types, for example CD31hi 
endothelial cells isolated with each method could explain this finding. 
Whilst comparing the methods, it also became clear that there were differences in the ratios 
of leukocyte populations isolated from each method, with a greater frequency of KC isolated 
with the 300g spin method. Analysis of the discarded fractions for each method (the 
supernatants from the 300g spins, the pellet after the 50g spin and middle layers from after 
the Percoll density gradient separation) revealed that the Percoll and 50g spin methods led 
to the selective loss of KC. Further comparison of the 300g with the Percoll gradient revealed 
that a higher level of proliferation and increased non-host chimerism in those KC isolated 
with the Percoll method. It has been shown in yeast cells that cell density increases as a cell 
enters S-phase (Bryan et al. 2010), so it seems feasible that the density gradient preferentially 
isolated KC in cell cycle due to increased density, resulting in a higher overall readout for 
proliferation compared to the population isolated with the 300g spin method. A lower 
percentage of Percoll in the density column might rectify this problem. Likewise, it is possible 
that there are differences in density between donor and host cells in the chimeric system, 
perhaps due to differences in maturity or differentiation status between recently recruited 
donor cells and tissue-resident host cells, that meant that the ratio was affected by Percoll 
separation. Therefore, the method of isolation chosen significantly affected the 
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interpretation of KC biology. However, the fact that the 300g spin method recovered a 
significantly higher total number of cells, together with the fact that there was no selective 
loss of KC meant that I am confident that this method gives the cell isolate that is most 
representative of that found in vivo. Additionally, the 300g spin method was the simplest and 
fastest method to perform, thereby allowing more livers to be processed on a single day, 
facilitating the processing of large sample sizes critical throughout my project.  
It must be noted that I only compared one Percoll density, and the fact that the sum of the 
number of KC in the isolate and the discard with this method was significantly less than the 
total number isolated with the 300g spin method suggests that a large number of KC were 
retained in the Percoll itself. With careful optimization, it is possible that this method could 
be used to isolate representative samples of liver leukocytes with high viability, good yields 
and less debris than the 300g method, which could be more useful and suitable for 
alternative applications such as cell culture but this was not explored within the realms of 
this project. 
Alongside comparison of methods, it was important to establish a robust gating strategy to 
faithfully identify KC. As part of this work, it was discovered in the lab that the KC population 
identified using the F4/80hiCD11blo gating strategy contained a subset of cells which were 
CD31hi, compared to the bulk of the population which was CD31lo. Staining for markers that 
have subsequently be found to be more specific to KC in the liver, such as Clec4f and Tim4 
revealed that whilst the CD31lo population was very bright for these markers, the CD31hi cells 
also exhibited only slightly lower intensity of staining which was insufficient to distinguish 
between the two populations. This suggested that the CD31hi cells could in fact be 
macrophages, which supported RNA-seq data which identified the liver sinusoidal 
endothelial cell (LSEC) marker CDH5 (Zhang et al. 2016) as a ‘KC-specific’ gene (Lavin et al. 
2014; Scott et al. 2016). However, the fact that the Csf1r-mApple reporter system was able 
to clearly distinguish between CD31hi cells and CD31lo cells indicated that the CD31hi cells did 
not express this typical myeloid cell marker. Furthermore, imaging revealed that the 
F4/80hiCD11bloCD31hi cells were actually either doublets of F4/80-CD31hi endothelial cells 
with an F4/80hiCD11blo KC, or were F4/80-CD31hi endothelial cells with what is likely to be a 
fragment of F4/80hiCD11blo KC still bound. KC have been shown to be relatively sessile (Lee 
& Kubes, 2008), supporting the notion that they are strongly adhered to one another in vivo. 
The exact identity of these adhesion molecules are yet to be identified, but endothelial cells 
constitutively express intercellular adhesion molecule 1 (ICAM1, or CD54) (Sorensen et al., 
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2015), which may be involved in anchoring KC to the sinusoids through interaction with 
intergrins.  
 
In summary, I have extensively compared protocols for the isolation of murine liver 
leukocytes and determined that a simple 300g spin protocol gave a superior yield of cells 
which gave a true representation of the ratios of immune cell populations found in vivo. 
Additionally, I demonstrated that the use of CD31 to exclude endothelial cell contamination 
should be used routinely in the gating strategy to identify KC, as additional KC markers Clec4f 
and Tim4 were not sufficient to discriminate between these populations. With a robust 
method for identification of KC in place, I was equipped to begin exploring the factors that 








Having established a robust method to isolate liver leukocytes, and identify liver KC which 
were free from endothelial cell contamination, I could begin to investigate parameters 
surrounding KC maintenance. The macrophage colony stimulating factor receptor (CSF1R) is 
a type III tyrosine kinase receptor (Bonifer and Hume 2008) and binding with its ligands 
results in dimerization and autophosphorylation of up to 8 tyrosine residues which create 
docking sites for signalling molecules (Yu et al. 2012; Stanley and Chitu 2014). Many tissue 
resident macrophage populations are highly dependent on signalling through the CSF1R with 
its ligands CSF1 and IL-34 to regulate their differentiation and survival (Jenkins and Hume 
2014). Both antibody blockade of the CSF1R (MacDonald et al. 2010) and inactivation of the 
Csf1r gene in knock out mice (Dai et al. 2002) results in reduced tissue resident macrophage 
numbers in multiple tissues including the peritoneal cavity and liver. The Csf1r-EGFP or 
MacGreen mouse line which expresses the EGFP protein under the control of a transgenic 
Csf1r promoter region (Sasmono et al. 2003) has been used extensively to identify and image 
mononuclear phagocytes across tissues. However, EGFP is widely used in other fluorescent 
reporter lines, limiting the possibility to cross MacGreen mice with other reporters to analyse 
multiple cell lineages simultaneously or answer more complex experimental questions; thus 
Csf1r-mApple mice were generated in collaboration with David Hume which express the 
bright red fluorochrome mApple under the control of the same Csf1r transgene as was used 
for MacGreen mice.  
I took the opportunity to use the Csf1r-mApple mice to compare Csf1r transgene expression 
between discrete myeloid populations across blood, peritoneal cavity, lung and liver and 
explore whether the level of expression differed between populations, and what this could 
reveal about their biology. Of particular interest to me was the identity of the F4/80loCD11bhi 
population in the liver which has not been clearly defined, but has been previously assumed 
to be a macrophage population in line with CD11b+ macrophage populations present in other 
tissues (Schulz et al. 2012; Yona et al. 2013). Others have further defined at least a fraction 
of these as monocytes on the basis of Ly6C expression (Ramachandran et al. 2012). I 
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therefore used the Csf1r-mApple mice in combination with staining for macrophage- and DC-
associated cell surface markers to more clearly define the mononuclear phagocyte 
populations present in the liver in steady state. Alongside these experiments, another lab 
member analysed the origin of different macrophage populations using tissue protected 
chimeras given Ccr2+/+ or Ccr2-/- bone marrow to confirm the identity of CCR2-dependent 
populations indicating they are monocyte-derived, CCR2-independent cells of bone marrow 
origin likely to be DC and bone marrow independent tissue resident macrophages.  
Macrophages are reliant on CSF1 for differentiation, survival and proliferation, and CSF1R 
signalling also contributes to recruitment and chemotaxis. However, the level of signalling 
through the CSF1R receptor affects the signalling outcome. By adding varying concentrations 
of CSF1 to the media of cultured bone marrow derived macrophages it has been 
demonstrated that lower concentrations are required for survival whilst higher 
concentrations induce proliferation in a dose-dependent manner (Tushinski et al. 1982). 
Differing levels of signalling resulting in pleiotropic effects is not unique to the CSF1R, and is 
also known to occur within the EGF-EGFR signalling pathway (Krall et al. 2011). Thus, in 
addition to CSF1R expression, understanding how much CSF1 a cell is able to capture and 
utilize may give insight into how it may function, survive and compete with other CSF1R-
expressing cells. To explore this, we used injection of a CSF1-Fc conjugated to the 
fluorochrome alexa fluor 647 (AF647) to determine uptake of CSF1 on a per cell basis in vivo. 
CSF1-Fc is a fusion protein of porcine CSF1 conjugated to the Fc region of pig IgG1a which is 
more stable than CSF1 alone and has a longer half-life (Gow et al. 2014), and is used 
extensively in chapter 5 to study the effects of exogenous CSF1 on KC origin and maintenance 
and conversion of monocytes to macrophages. As with analysis of Csf1r-mApple expression, 
CSF1-FcAF647 uptake was analysed in conjunction with a staining panel that would allow 
distinction between resident macrophages, monocytes, monocyte-derived macrophages and 
dendritic cells.  
These studies formed the backbone of a paper published in The Journal of Immunology, of 
which I am joint first author, and which forms this chapter. In this paper I performed 
experiments and analysed data for all of figure 2, figure 3 (except fig. 3E & F), figure 4 (except 
fig. 4B), and figure 5 (except fig. 5E). I contributed extensively to figure 6A-C and I performed 
experiments for all of supplementary figure 2. This work allowed comparison of Csf1r 
transgene expression across various tissues, exploration of how this related to CSF1R protein 
expression and, in conjunction with data from BM chimeras, how this related to cell lineage. 
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Through this analysis, I provide a more clear definition of leukocyte populations in the liver, 
and demonstrate differences in their ability to capture and utilise CSF1.  
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Csf1r-mApple Transgene Expression and Ligand Binding
In Vivo Reveal Dynamics of CSF1R Expression within the
Mononuclear Phagocyte System
Catherine A. Hawley,*,1 Rocio Rojo,†,1 Anna Raper,†,1 Kristin A. Sauter,†
Zofia M. Lisowski,† Kathleen Grabert,† Calum C. Bain,* Gemma M. Davis,†,‡
Pieter A. Louwe,* Michael C. Ostrowski,x David A. Hume,*,†,{ Clare Pridans,*,† and
Stephen J. Jenkins*
CSF1 is the primary growth factor controlling macrophage numbers, but whether expression of the CSF1 receptor differs between
discrete populations of mononuclear phagocytes remains unclear. We have generated a Csf1r-mApple transgenic fluorescent
reporter mouse that, in combination with lineage tracing, Alexa Fluor 647–labeled CSF1-Fc and CSF1, and a modified DCsf1–
enhanced cyan fluorescent protein (ECFP) transgene that lacks a 150 bp segment of the distal promoter, we have used to dissect
the differentiation and CSF1 responsiveness of mononuclear phagocyte populations in situ. Consistent with previous Csf1r-driven
reporter lines, Csf1r-mApple was expressed in blood monocytes and at higher levels in tissue macrophages, and was readily
detectable in whole mounts or with multiphoton microscopy. In the liver and peritoneal cavity, uptake of labeled CSF1 largely
reflected transgene expression, with greater receptor activity in mature macrophages than monocytes and tissue-specific expres-
sion in conventional dendritic cells. However, CSF1 uptake also differed between subsets of monocytes and discrete populations of
tissue macrophages, which in macrophages correlated with their level of dependence on CSF1 receptor signaling for survival
rather than degree of transgene expression. A double DCsf1r-ECFP-Csf1r-mApple transgenic mouse distinguished subpopulations
of microglia in the brain, and permitted imaging of interstitial macrophages distinct from alveolar macrophages, and pulmonary
monocytes and conventional dendritic cells. The Csf1r-mApple mice and fluorescently labeled CSF1 will be valuable resources for
the study of macrophage and CSF1 biology, which are compatible with existing EGFP-based reporter lines. The Journal of
Immunology, 2018, 200: 2209–2223.
T he mononuclear phagocyte system (MPS) is a family offunctionally related myeloid cells comprising progenitorcells, monocytes, macrophages, and conventional den-
dritic cells (cDC) (1–5). Macrophages resident in tissues may be
derived from definitive hematopoiesis via circulating monocytes
or by self-renewal from cells seeded during embryonic or early
postnatal life (1, 2, 4, 5). cDCs have been classified as those cells
deriving from common dendritic cell (DC) progenitors via circu-
lating pre-DC (1, 6, 7). Regardless of their developmental origin,
macrophages and their precursors express the M-CSF receptor
CSF1R, and depend upon signals from two ligands, CSF1 or IL34,
for proliferation, differentiation, and survival (2, 3). Receptor-
mediated internalization and destruction of CSF1 controls its
availability (8) and provides a homeostatic control on macrophage
numbers (3). Accordingly, administration of recombinant CSF1
(9) or a more stable CSF1-Fc fusion protein (10–12) to mice
produces expansion of blood monocyte and tissue macrophage
populations, yet the degree to which CSF1R expression and ac-
tivity differ between populations of mononuclear phagocytes is
unclear.
cDC express high levels of a related tyrosine kinase receptor,
Fms-like tyrosine kinase 3 (Flt3). Their numbers are greatly in-
creased following treatment of mice with Flt3 ligand (Flt3L), and
depleted in Flt3L-deficient animals (7, 13–17). Two subsets of
cDC, cDC1 and cDC2, appear to differ in their expression of
Csf1r. cDC1 are not generally dependent upon CSF1 and lack
Csf1r mRNA (14). cDC2 have been more difficult to define be-
cause of major overlaps in cellular phenotype with other CD11b+
CD11c+MHC class II (MHCII)+ monocyte-derived APCs (18–20).
Genuine Flt3-dependent cDC2 of common DC progenitor origin
have been defined based upon migratory behavior and the lack of
the macrophage markers CD64 and F4/80 (6, 15, 21, 22). With
this definition, cDC2 in various tissues expressed lower levels of
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Csf1r mRNA than monocyte-derived APC (15, 22) and have been
considered CSF1R independent (1). The levels of surface CSF1R
largely distinguish Flt3L-dependent cDC2 from short-lived
monocyte-derived CD11c+/2 MHCII+ cells in the serous cavities
(23, 24). However, cDC2 isolated from spleen express high levels
of both Csf1r and Flt3 mRNA (www.biogps.org) and their num-
bers are controlled by CSF1 in vivo (25). Therefore, it remains
unclear whether there is a genuine dichotomy between Csf1r and
Flt3-dependent myeloid APC.
CSF1R on macrophages is continuously removed from the cell
surface by endocytosis and degraded following ligand binding. For
that reason, the detection of CSF1R protein by immunohisto-
chemistry or flow cytometry does not provide a clear indication of
functional expression. To identify Csf1r-expressing cells in situ,
regulatory elements of the murine Csf1r locus, including a 150 bp
segment of the distal promoter, were used to produce Csf1r-EGFP
reporter mice (26). The same promoter construct was used to
drive constitutive (27) and inducible cre-recombinase to support
macrophage-specific conditional mutations (28) as well as lineage
tracing (29), and these tools have been widely distributed among
the research community. However, new resources are required to
verify with single-cell resolution the extent to which Csf1r
transgene expression reflects that of functional CSF1R protein.
In addition to aiding our understanding of the regulation of
myeloid cells, visualization of Csf1r gene and protein expression
may also be useful to study cell interactions in vivo due to the lack
of tools to identify discrete MPS populations during multicolor
imaging. A binary enhanced cyan fluorescent protein (ECFP) re-
porter (DCsf1r-Gal4VP16/UAS-ECFP) transgene with a 150 bp
segment of the distal Csf1r promoter deleted, termed DCsf1r-
ECFP, has provided a novel tool to support in vivo imaging of
monocyte trafficking (30, 31), because expression was lost from
the large majority of tissue macrophages but remained in blood
monocytes, microglia, Langerhans cells, and cDC2 (32). In par-
ticular, dual reporter mice, such as those generated by crossing the
Cx3cr1-EGFP and Ccr2-RFP mice, have been valuable tools for
visualizing monocyte subsets and their differentiation in the brain
and liver (33), findings that would not have been obtainable using
single reporter mice. However, many other macrophage and
nonmacrophage reporter genes use EGFP, rendering the original
Csf1r-EGFP transgene of limited use for this purpose. Thus, ad-
ditional monocyte/macrophage reporter mice that are compatible
with existing EGFP-based reporters are needed.
Hence, we have created new tools and assays to image and assess
Csf1r gene and protein expression that can be combined conve-
niently with common fluorophores, EGFP transgenes, and the
DCsf1r-ECFP transgene for use in imaging and flow cytometry. In
particular, we characterize a new Csf1r-mApple line expressing
the red reporter gene mApple under the same promoter used in the
Csf1r-EGFP reporter, and apply this in combination with the
DCsf1r-ECFP transgene, lineage tracing, and labeled CSF1-Fc
and CSF1 proteins to distinguish different cellular compartments
within the MPS, and to dissect the homeostatic roles of CSF1.
Materials and Methods
Plasmid constructs
The 7.2 kb Csf1r reporter construct previously used to generate the Csf1r-
EGFP mice (26) was digested with ApaI and SalI (NEB) to remove EGFP
before gel purification using the QIAquick gel extraction kit (Qiagen).
Overhangs were removed with Mungbean nuclease (NEB) and DNA was
purified using QIAGEN MinElute columns (Qiagen), then dephosphory-
lated using thermosensitive alkaline phosphatase (Promega). A construct
encoding the fluorescent protein Csf1r-mApple (34) was digested with
SmaI and AflII, similarly purified, and overhangs removed before both
constructs were precipitated with EtOH/NaOAc and then ligated with T4
ligase (NEB) at 16˚C overnight. The resulting Csf1r-mApple construct was
transformed into DH5a competent cells. The Csf1r-rtTA-M2 construct
utilizing the same 7.2 kb mouse Csf1r promoter region was used previ-
ously to generate Csf1r-rtTA transgenic mice (35) For generation of
transgenic mice, plasmid backbones were removed by digestion with DrdI/
PvuI (Csf1r-mApple, NEB) and SalI/MluI (Csf1r-rtTA, Promega/NEB)
and then gel-purified using a QIAquick gel extraction kit. DNA was then
further purified using AMPure XP beads (Agencourt) according to the
instructions.
Generation of transgenic mice and animal maintenance
Animal experiments were permitted under license by the U.K. Home Office,
and were approved by the University of Edinburgh Animal Welfare and
Ethical Review Body. All mice including wild-type (WT) C57BL/6JOlaHsd
CD45.2+, congenic CD45.1+CD45.2+, Csf1r-EGFP (26), DCsf1r-
Gal4VP16/UAS-ECFP (36), and Ccr22/2 (37) lines were bred and housed
in specific-pathogen free facilities at the University of Edinburgh. Csf1r-
mApple/Csf1r-rtTA transgenic mice were generated at the University of
Edinburgh’s Central Biological Services Transgenic Core facility by mi-
croinjection of transgenes into the pronuclei of fertilized oocytes from
C57BL/JOlaHsd mice. The integration of the transgenes was determined
by PCR analysis of genomic DNA isolated from ear biopsy using primers
that amplified a 565 bp product between the c-fms promoter and rtTA
gene, and a 507 bp product between the c-fms promoter and Csf1r-mApple
gene, using primers 59-TTC CAG AAC CAG AGC CAG AG-39 (forward)
and 59-CTG TTC CTC CAATAC GCA GC-39 (reverse), and 59-CCTACA
TGT GTG GCTAAG GA-39 (forward) and 59-CTT GAA GTA GTC GGG
GAT GT-39 (reverse), respectively, and amplification temperatures of 35
cycles of 30 s at 94, 55, and 72˚C, after an initial denaturing step of 94˚C
for 5 min. Expression of Csf1r-mApple was verified by screening 10 ml
blood for the presence of Csf1r-mApple fluorescence by flow cytometry.
One founder positive for both transgenes transmitted the transgenes to
progeny and established the Csf1r-mApple/Csf1r-rtTA line (referred to as
Csf1r-mApple). The Csf1r-mApple line was maintained by breeding to
C57BL/6JOlaHsd mice, or where specified, bred to the DCsf1r-ECFP line,
for which subsequent analysis was performed on F1 progeny. For main-
tenance of the Csf1r-mApple line, transgenic progeny were initially
identified by PCR analysis of genomic DNA and flow-cytometric assess-
ment of the presence of Csf1r-mApple in blood cells, and subsequently by
flow cytometry alone. For identification of myeloid populations replen-
ished by CCR2-dependent bone marrow (BM) precursors, tissue-protected
BM chimeric mice were generated as previously described (23). Briefly,
anesthetized C57BL/6 CD45.1+CD45.2+ congenic mice were exposed to a
single dose of 9.5 Gy g-irradiation, while all but the hind legs and lower
abdomen were protected by a 2 inch lead shield. Animals were subse-
quently given 2–5 3 106 BM cells from CD45.2+ C57BL/6J mice or
Ccr22/2 animals by i.v. injection before being left for 8 wk prior to
analysis of chimerism in the tissue compartments. All experiments were
performed with age- and sex-matched littermate control mice and ap-
proved by the University of Edinburgh Animal Welfare and Ethical Review
Body under license granted by the U.K. Home Office.
Tissue digestion and FACS analysis
Unless otherwise stated, mice were culled by a rising concentration of CO2.
Then 100 ml of blood was collected by cardiac puncture into EDTA tubes.
The peritoneal cavity was lavaged with RPMI 1640 containing 2 mM
EDTA and 10 mM HEPES (Invitrogen). Cadavers were subsequently
perfused and lung and liver removed and chopped finely, and digested in
prewarmed collagenase mixture [0.625 mg ml21 collagenase D (Roche),
0.85 mg ml21 collagenase V (Sigma-Aldrich), 1 mg ml21 dispase (Life
Technologies, Invitrogen), and 30 U ml21 DNase (Roche Diagnostics) in
RPMI 1640] for 22 and 45 min respectively in a shaking incubator at 37˚C
before being passed through a 100 mm filter. Lung preparations were
washed in PBS containing 2 mM EDTA (Life Technologies, Invitrogen)
and 0.5% BSA (Sigma-Aldrich), termed FACS buffer, followed by cen-
trifugation at 300 g for 5 min, whereas liver preparations were washed in
50 ml then 30 ml of ice-cold RPMI 1640 followed by centrifugation at
300 g for 5 min. Erythrocytes in tissues and blood were lysed using RBC
lysis buffer from Sigma-Aldrich or BioLegend, respectively. All cells were
maintained on ice until further use. Cellular content of the preparations
was assessed by cell counting using a CASY TT counter (Roche). Equal
numbers of cells or equivalent volumes of blood were stained with Zombie
Aqua viability dye (Invitrogen) blocked with 0.025 mg anti-CD16/32
(2.4G2; BioLegend) and 1:10 heat-inactivated mouse serum (Invitrogen),
and then surface stained with a combination of Abs in FACS buffer. The
following Abs were used: F4/80 (BM8), Siglec-F (E50-2440), Siglec-F
(ES22-10D8), Ly6C (HK1.4), CD11b (M1/70), CD11c (N418), MHCII
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(M5/114.15.2), CD19 (6D5), CD3 (17A2), CD3 (17A2), CSF1R (AFS98),
CD45.1 (A20), CD45.2 (104), CD226 (10E5), CD64 (X57-5/7), Ly6G
(1A8), CD26 (H194-112), and PDCA-1 (927) (eBioscience, Miltenyi
Biotec, or BD Europe). Where applicable, cells were subsequently stained
with streptavidin-conjugated fluorochromes. Fluorescence minus one
controls confirmed gating strategies, whereas discrete populations within
lineage-negative cells were confirmed by omission of the corresponding
population-specific Ab. Samples were acquired on an LSRFortessa flow
cytometer (Becton Dickinson) at the Queens Medical Research Institute
Flow Cytometry and Cell Sorting Facility and resulting data were analyzed
using FlowJo V9 software. CD45+ cells were identified as live single cells
by excluding 7AAD+ or Zombie Aqua+ cells and using forward scatter area
versus forward scatter height characteristics. Cells positive for CD19,
CD3, Ly6G, and SiglecF, or CD19, CD3, and Ly6G were referred to as
Lineage+ and were excluded prior to analysis of liver, blood and cavity
cells, or lung cells, respectively, as shown in the respective figures.
For the processing of brain tissue, double transgenic mice were perfused
transcardially with physiological saline and brains were removed for re-
gional dissection into cerebellum, cortex, hippocampus, and striatum.
Mixed brain cell homogenates were prepared as described (32). The single-
cell suspension of each region was incubated with 1 mg ml21 anti-CD16/
32 and subsequently stained with rat anti-mouse/human CD11b (M1/70)
and rat anti-mouse CD45 (BioLegend). Flow cytometry was acquired us-
ing the Fortessa 320 (Becton Dickinson) and resulting data were analyzed
using FlowJo V10 software.
Inhibition of CSF1R signaling
The CSF1R kinase inhibitor GW2580 (LC Laboratories) was suspended in
0.5% hydroxypropylmethylcellulose and 0.1% Tween 20 using a Teflon
glass homogenizer. Diluent control or 160 mg/kg GW2580 was adminis-
tered daily for 4 d by oral gavage before mice were culled on day 5.
Alexa Fluor 647–labeled CSF1 and anti-CSF1R mAb
Preservative-free sterile anti-CSF1R mAb (clone AFS98) was purchased
from Bioserv (Sheffield, U.K.). Porcine CSF1 and CSF1-Fc was prepared as
described previously (12). CSF1 and CSF1-Fc were conjugated to Alexa
Fluor 647 (AF647) using the AF647 Microscale Protein labeling kit from
Thermo Fisher Scientific according to manufacturer’s instructions, and
sodium azide subsequently removed using 7k MWCO Pierce polyacryl-
amide spin desalting columns (Thermo Fisher Scientific). Mice were in-
jected i.v. with 0.5 mg anti-CSF1R mAb or PBS vehicle control, followed
by 5 mg CSF1-FcAF647 or PBS vehicle i.v. 10 min later. After a further 10
min, 60 ml of blood was removed by tail venipuncture, with the animals
then immediately culled by cervical dislocation, and tissues perfused with
PBS through the inferior vena cava. For study of CSF1 uptake in the
peritoneal cavity, mice were injected i.p. with or without 0.5 mg AFS98
followed by 0.5 mg CSF1AF647 or PBS vehicle 2 min later, and then culled
10 min later by exposure to increasing levels of CO2. The degree of
CSF1R-dependent uptake of CSF1AF647 or CSF1-FcAF647 is presented as
the D median fluorescence intensity (MFI) calculated as the MFI for in-
dividual samples from mice given labeled CSF1 minus the average MFI
from all samples pretreated with AFS98.
Imaging of tissues and cells
Whole-mount imaging of freshly isolated tissues from transgenic and WT
littermate control mice aged 12–15 wk was performed using a Zeiss
AxioZoom.V16 fluorescence microscope. Immediately after excision, tis-
sues were kept at 4˚C and protected from light. The fluorescent signal was
acquired at 500–550 and 590–650 nm for EGFP and Csf1r-mApple, re-
spectively. Acquisition of tissue background signal was performed by
imaging WT tissue with the filter used for detection of the Csf1r-mApple
protein.
Ex vivo confocal imaging of tissues
Male transgenic or WT male littermates were anesthetized, as per regu-
lations, and intravenously injected in the tail vein with 5 mg/g of weight of
Lectin-I [from Griffonia (Bandeiraea) simplicifolia] tagged with FITC
(Vector Labs). After 10 min, mice were perfused transcardially with HBSS
(Thermo Fisher Scientific), at a rate of 10 ml per min, and the left lobe of
the liver was excised. Lungs were inflated with a solution containing 1%
low melting-point agarose (Sigma-Aldrich) and, upon agarose solidifica-
tion, the left lung was excised. Detection of functional CSF1R in lung
myeloid subsets was performed by administering 5 mg CSF1-FcAF647 and
5 mg/g of weight of Lectin-I via i.v. injection. Mice were perfused with
HBSS, previous to lung excision and inflation with agarose, as described.
After dissection, liver and lung were placed on coverslip-bottom chambers
and covered with a sufficient volume of HBSS to prevent the surface of
tissues from drying. Chambers were kept on ice and protected from light
until tissues were imaged on a Zeiss LSM 710 microscope. Laser wave-
lengths for ECFP, FITC, and mApple were 405, 488, and 543 nm, re-
spectively. Fluorescence acquisition for ECFP, FITC, and mApple signals
in liver and lung was 400–480, 525–600, and 602–758 nm, respectively.
Acquisition settings for lung tissue treated with CSF1-FcAF647 were 400–
479, 525–583, 593–651, and 651–755 nm for ECFP, FITC, mApple, and
AF647, respectively. Postprocessing of images was performed by adjusting
the black/white thresholds in the software ZEN 2012 (blue edition) de-
veloped by Carl Zeiss as follows: ECFP: 0–175, FITC: 0–100, mApple:
0–75, AF647: 0–200.
Statistics
Statistical tests detailed in the figure legends were performed using
GraphPad Prism 6. Where necessary, data were log-transformed to achieve
equal variance.
Results
Generation of Csf1r-mApple mice
C57BL/6 mouse embryos were comicro-injected with a construct
containing the 7.2 kb Csf1r promoter region used to create the Csf1r-
EGFP mice (26) upstream of mApple, along with a construct
encoding the reverse tetracycline inducible transactivator rtTA-m2
under control of the same promoter (Csf1r-rtTA), previously used to
generate a Csf1r-driven Tet-on system (35). mApple was used be-
cause it is brighter than its parent mCherry, refractory to photo-
bleaching (38), suffers little from background autofluorescence, and
previously enabled whole-mount imaging of the avian response to
CSF1 in Csf1r-mApple reporter chickens (39). A single founder
positive by PCR for both transgenes and for mApple protein in blood
cells by flow cytometry was mated with a WT C57BL/6 mouse to
establish the Csf1r-mApple line. PCR analysis across 77 mice
revealed that Csf1r-mApple and Csf1r-rtTA transgenes were exclu-
sively coinherited, suggesting cointegration (data not shown). PCR
and flow cytometry analysis of blood demonstrated the Csf1r-mApple
transgene to be inherited at a frequency of 44.0% (n = 207). The
utility of the cointegrated Tet-on cassette is under investigation and is
not considered further in this study but preliminary data demonstrate
rtTA-m2 mRNA is expressed in peritoneal cells (data not shown).
Comparison of Csf1r-EGFP and Csf1r-mApple expression
across tissue
In whole-mount fluorescence microscopy of live organs from Csf1r-
mApple mice expression patterns of mApple recapitulated EGFP in
Csf1r-EGFP transgenic mice (Fig. 1A–F). Large stellate mApple+
cells were observed throughout the liver, lung, epidermis, and car-
diac muscle. Both transgenic strains highlighted the abundant
macrophage populations of the intestinal lamina propria (Fig. 1E),
and the red pulp of spleen (Fig. 1F) (26). Background fluorescence
in littermate control mice was negligible (Fig. 1A–F, left panel).
The Csf1r-EGFP and DCsf1r-ECFP transgenes have been used
extensively for in vivo imaging with multiphoton and spinning disc
microscopes (e.g., Refs. 20, 30, 31, 40–43), providing high-
resolution analysis of macrophage motility and the extent of their
ramified processes. Multiphoton imaging of whole mounts of the
muscularis externa of the intestine demonstrated the high signal-to-
noise ratio obtainable with the Csf1r-mApple reporter (Fig. 1G),
enabling visualization of the regular network of microglial-like
macrophages in this site (44, 45). Furthermore, the impact of ex-
ogenous CSF1-Fc, which regulates the function of these cells (44),
could be directly visualized as an increase in cell size.
Csf1r-mApple expression by blood myeloid cells
To determine efficiency, reliability, and specificity of transgene
expression, flow cytometry was performed on the blood of a
The Journal of Immunology 2211














cohort of Csf1r-mApple mice and littermate controls. Circu-
lating CSF1R+CD11b+ monocytes (Fig. 2A) were uniformly
Csf1r-mApple+ in both Ly6C+ and Ly6C2 subsets (Fig. 2B,
2C). As reported for the expression of EGFP in Csf1r-EGFP
mice, neutrophils and eosinophils, which express Csf1r mRNA
but not protein (46), were also Csf1r-mApple positive (Fig. 2B,
2C). The Csf1r promoter is active in B cells, which like mac-
rophages, express the key transcription factor, PU.1, albeit at
lower levels (47). Accordingly, ∼70% of B cells had very low,
but detectable, Csf1r-mApple (Fig. 2B, 2C). Similar expression
of EGFP in Csf1r-EGFP mice is not detectable by confocal
microscopy on spleen sections (46). The intensity of Csf1r-
mApple expression was consistent between animals, with
equivalent levels expressed by monocytes and neutrophils and
lower levels in eosinophils and B cells (Fig. 2D). Hence, the
pattern of Csf1r-mApple expression reproduced that reported
for EGFP in Csf1r-EGFP mice.
The level of Csf1r-mApple expression distinguishes monocytes,
macrophages, and cDC in different tissues
To determine if transgene expression distinguished cDC and
macrophages across multiple tissues, we first confirmed the identity
of marker-defined MPS populations before surveying transgene
expression in Csf1r-mApple mice. In the peritoneal cavity, we
have demonstrated that recruited monocytes continuously re-
plenish rare short-lived F4/80lo MHCII+ macrophages that include
both CD11c+ and CD11c2 cells (23), although only slowly
replacing the more abundant F4/80hi resident macrophages of
embryonic origin (23). Both CD11c+ and CD11c2 short-lived and
F4/80hi peritoneal macrophage populations express detectable
surface CSF1R. In contrast, Flt3-dependent cavity cDC of non-
monocyte BM origin also express CD11c+ and MHCII+ and can
be found among F4/80lo/2 cells, but can be distinguished as
CSF1R2 (23, 24, 48, 49). Based upon this published gating
strategy and previously assigned ontogenies (Fig. 3A) (23), Csf1r-
mApple was detected in Ly6C+ monocytes, all macrophage pop-
ulations, and in CD11b2 cDC1 and CD11b+ cDC2 (Fig. 3B, 3C)
(24). There was a progressive increase in Csf1r-mApple intensity
between Ly6C+ monocytes, CD11c-defined subsets of short-lived
F4/80loMHCII+ macrophages, and long-lived F4/80hi macro-
phages (Fig. 3D), consistent with the linear developmental rela-
tionship between these populations and monocytes in adult mice
(23, 48, 50). Csf1r-mApple fluorescence in both CD11b2 cDC1
and CD11b+ cDC2 was lower than in monocytes (Fig. 3D), con-
sistent with the lack of surface CSF1R (Fig. 3A). EGFP expres-
sion in Csf1r-EGFP mice replicated this pattern (Fig. 3E, 3F).
In the lung, alveolar macrophages are readily identified based
upon high levels of CD11c and SiglecF (Fig. 4A) (51, 52). In-
terstitial cells are more heterogeneous. Some MHCII+ cells with
varying levels of CD11c have been defined as macrophages based
upon their expression of the Fc receptor CD64 and CSF1R de-
pendence (51, 53), which contrasts the Flt3 dependence of CD642
interstitial cDC2 (15). To verify that CD64 expression distin-
guishes pulmonary interstitial macrophages from CD11b+ cDC2,
we assessed the turnover kinetics of CD64-defined MHCII+ cells
and their dependence on CCR2, an established method for de-
termining the likely monocyte dependence of tissue MPS cells
(23, 54). We used a BM chimeric system in which WT mice were
irradiated with organs of interest shielded to prevent irradiation-
induced injury and reconstituted with congenic WT or Ccr22/2
BM. This approach results in stable nonhost chimerism in blood
leukocytes of ∼30% in recipients of WT BM (23, 55) (Fig. 4B,
short-dashed line) and allows the turnover kinetics of tissue
populations to be assessed. Importantly, in recipients of Ccr22/2
BM chimerism in monocytes (Fig. 4B, long-dashed line) but not
other circulating leukocytes is largely abolished (23). Notably,
putative CD642CD11b+MHCII+ cDC2 were completely replaced
within 8 wk, consistent with the short half-life of DCs (14).
This occurred in a completely CCR2-independent manner, with
identical chimerism in recipients of WT and Ccr22/2 BM
(Fig. 4B). In contrast, relatively few CD64+MHCII+ cells were
replaced over 8 wk, although this was completely dependent on
CCR2, suggesting slow replenishment from monocytes. Thus,
consistent with previous work (15), CD64 accurately defines
distinct CD11b+ MPS populations. Alveolar macrophages showed
no evidence of chimerism (Fig. 4B), consistent with self-
maintenance (52, 56, 57). Surprisingly, replenishment of cells
FIGURE 1. Distribution of the Csf1r-mApple and Csf1r-EGFP transgenes
is similar throughout tissues. Whole-mount imaging of freshly isolated liver
(A), lung (B), skin epidermis (C), cardiac muscle (D), jejunum (E), and cross-
section of spleen (F) from WT (left panel), Csf1r-mApple (central), and
Csf1r-EGFP (right panel) mice, or from muscularis (G) of Csf1r-mApple
mice treated with PBS (left panel) or CSF1-Fc (right panel). In (C), a region
of interest has been further magnified to better show Langerhans cells (white
arrows), and hair follicles can be detected as highly autofluorescent struc-
tures (white circles). Scale bars in skin represent 100 mm; 200 mm in liver,
spleen, and cardiac muscle; 500 mm in lung and jejunum; and 10 mm in the
muscularis.
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defined as cDC1 was also dependent upon CCR2. However, these
cells express CCR2 within the lung environment (58) and thus
may require this receptor for tissue retention. Based upon the
verified ontogenies, Ly6C+ monocytes, CD64+ interstitial macro-
phages, and alveolar macrophages in the lungs were all Csf1r-
mApple+ (Fig. 4C, 4D), but expression increased progressively
between monocytes and mature macrophages (Fig. 4C, 4E). Both
cDC populations also expressed Csf1r-mApple, but at lower levels
than monocytes (Fig. 4C–E).
In the liver, the largest phagocyte population is the Kupffer cells
(KC), but a minority CD11b+F4/80lo BM-derived population may
include monocytes, cDC2, and possibly F4/80lo BM-derived
macrophages (14, 29, 57). KCs [F4/80hiCD11blo (29, 59, 60)]
(Fig. 5A) exhibited uniformly high expression of Csf1r-mApple
(Fig. 5B–D). The minority CD11b+F4/80lo compartment was
subdivided based upon Ly6C and MHCII (Fig. 5A). The Ly6C+
cells and Ly6C2MHCII2 cells resembled Ly6C+ and Ly6C2
blood monocytes in size and marker expression (Fig. 5F). Unlike
blood monocytes, MHCII+ cells among CD11b+F4/80lo cells were
larger, exhibited high levels of CD11c, and must include the Flt3-
dependent CSF1R-independent CD11b+ cDC2 described previ-
ously (14); hence, we provisionally assigned these cDC2 (Fig. 5F).
All CD11b+ populations expressed high levels of Csf1r-mApple
(Fig. 5B, 5C). In the same CCR2-dependent tissue-protected BM
chimera system used for the lung, the putative CD11b+ cDC2
population was replenished almost entirely by CCR2-independent
BM precursors (Fig. 5E). They also expressed the highest levels of
CD26, a marker of cDC conserved across species (61), and were
negative for CD64 (Fig. 5F), confirming them as cDC2. CD11b2/lo
F4/802 cells were also positive for Csf1r-mApple, but expressed
markers of cDC1 (Ly6C2MHCII+CD11c+CD26+) and plasmacy-
toid DC (pDC) (Ly6C+MHCII+PDCA-1+) (Fig. 5A, 5F), and were
replenished by CCR2-independent precursors (Fig. 5E). Hence, in
liver the Csf1r transgene did not distinguish cDC from monocytes,
but was highest in mature macrophages.
Detection of functional CSF1R using fluorescent CSF1-Fc
Csf1r mRNA may be posttranscriptionally regulated (62) and the
protein may be cleaved from the cell surface in response to TLR
signals (63). To assess functional CSF1R expression, we investi-
gated the ability of MPS cells to take up labeled pig CSF1-Fc
fusion protein, which produces a large increase in tissue macro-
phage populations when injected into mice (12) or pigs (64).
CSF1-Fc conjugated with AF647 (CSF1-FcAF647) was found to
bind specifically to monocytes in vitro (65). CSF1-FcAF647 was
injected intravenously 10 min before mice were sacrificed. In the
liver, the uptake of CSF1-FcAF647 was detected in KC, monocytes,
and cDC2, but not in cDC1, pDC (Fig. 6A, 6B), or neutrophils
(data not shown). Within cDC2, CSF1-FcAF647 binding was
prevalent in CD11chi cells (Fig. 6C) precluding any possible
confusion with the CD11cdim MHCII+ subcapsular macrophages
described recently (42). In the lung, the majority of Ly6C+
monocytes and interstitial macrophages bound CSF1-FcAF647,
whereas both cDC populations were negative (Fig. 6A, 6B). Up-
take of labeled CSF1-Fc by myeloid populations was reduced or
abolished by the anti-CSF1R Ab, AFS98 (Fig. 6A, 6B), a weak
inhibitor of receptor-ligand binding (66), and an identical labeling
profile was observed following injection of a non–Fc-fused
AF647-labeled porcine CSF1 (CSF1AF647) (data not shown).
No detectable CSF1-FcAF647 was bound by alveolar macrophages
(Fig. 6A, 6B) and these cells also failed to bind appreciable levels
in vitro (data not shown). Labeled anti-CD45 Ab was able to
access all other myeloid populations in lung (data not shown) (67)
and liver (Fig. 6D), suggesting a lack of CSF1-FcAF647 or
CSF1AF647 uptake by certain cDC reflects an absence of surface
CSF1R expression rather than the inaccessibility of the sites they
may occupy (31, 53).
Consistent with previous population-level data on CSF1 clear-
ance (68), KC bound the highest level of labeled CSF1 per cell in a
receptor-dependent manner (Fig. 6B), and considerably more per
FIGURE 2. Csf1r-mApple transgene expression in blood leukocytes. (A) Flow cytometric strategy to identify blood leukocytes. (B) Expression of Csf1r-
mApple in venous blood leukocytes from a representative Csf1r-mApple (right) and WT littermate control (left) mouse. (C) Frequency of cells positive for
Csf1r-mApple and (D) geometric mean fluorescence intensity (GeoMFI) of Csf1r-mApple gated on Csf1r-mApple+ cells for different blood leukocytes.
(B–D) Representative data from one of three experiments. Data are presented as mean 6 SD of four mice (C and D).
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cell than blood monocytes (Fig. 6E). In turn, Ly6C+ monocytes in
lung and liver were more intensely labeled than interstitial lung
macrophages or liver CD11b+ cDC2 and liver Ly6C2 monocytes
(Fig. 6B), although distinct intravascular versus parenchymal lo-
cations of these cells (31, 53) means exposure to circulating CSF1
cannot be controlled in this comparison. Of note, Ly6C+ blood
monocytes, identified independently of CSF1R expression
(Supplemental Fig. 1A), were more intensely labeled than the
Ly6C2 subset (Fig. 6E), despite equivalent surface expression of
CSF1R (Fig. 6F) (69, 70). Thus, novel differences in capacity to
bind CSF1 were revealed using this ligand-binding approach.
The relationship between Csf1r-mApple activity and CSF1R-
mediated ligand uptake was also examined in the peritoneal cavity
following i.p. injection. Monocytes and CD11c+ and CD11c2F4/
80loCD226+ macrophages (49, 50) were identified as described in
Supplemental Fig. 1B, avoiding the use of Abs to CSF1R. Neither
Csf1r-mApplelo cDC population bound appreciable levels of
CSF1AF647, whereas all three macrophage populations had higher
levels of receptor-dependent uptake of CSF1AF647 than Ly6C+
cavity monocytes (Fig. 7A). Surprisingly, the CD11c2F4/80lo
macrophages exhibited the greatest uptake. These differences
were not explained by differential levels of receptor-independent
macropinocytosis as uptake of injected OVA–Texas Red was
largely equivalent between populations (Fig. 7B). Anti-CSF1R
mAb inhibited CSF1 uptake to a similar degree in each pop-
ulation, with a reduction between 63 and 75%. The difference in
receptor activity appeared to have functional significance, as
treatment of mice daily for 4 d with a CSF1R kinase inhibitor,
GW2580 (71), which has been shown to inhibit proliferation of
microglia (41) and pleural macrophages (11), partly depleted the
CD11c2 subset of F4/80loMHCII+ peritoneal macrophages alone
(Fig. 7C, left graph), despite inhibiting proliferation (as evidenced
by Ki67 staining) of all macrophage populations (Fig. 7C, right
graph).
Csf1r-mApple:DCsf1r-ECFP mice allow in situ imaging of
distinct mononuclear phagocytes
The DCsf1r-ECFP transgene was crossed previously to the
Cx3cr1+/gfp or Itgax (CD11c)-EYFP mouse to distinguish pul-
monary monocytes from other myeloid lung populations (31). To
determine the utility of the Csf1r-mApple mouse to facilitate
in vivo imaging of different myeloid populations, we crossed it to
FIGURE 3. Csf1r transgene and CSF1R protein expression in the peritoneal cavity. (A) Flow cytometric strategy to identify peritoneal cavity myeloid
cells as recently described (23). (B–D) Expression of Csf1r-mApple in peritoneal cavity myeloid populations determined by flow cytometry, showing a
representative WT littermate control (left) and Csf1r-mApple (right) mouse (B), and graphs depicting the mean frequency of Csf1r-mApple+ cells in each
population (C) and geometric mean fluorescence intensity (GeoMFI) of Csf1r-mApple for different peritoneal leukocytes gated on Csf1r-mApple+ cells (D).
(E and F) Expression of Csf1r-EGFP in peritoneal cavity myeloid populations from Csf1r-EGFP mice, showing a representative flow cytometric overlay (E)
and graphs depicting the frequency and GeoMFI of Csf1r-EGFP+ cells in each population (F) across multiple mice. Representative data from one of three
experiments (B–D) or a single experiment (E and F). Data are presented as mean 6 SD of four mice (C, D, and F).
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the DCsf1r-ECFP line (32, 36). As in the intestine (32), the ma-
jority of cDC1, cDC2, and Ly6C+ and Ly6C2 monocytes in the
liver expressed high levels of ECFP, whereas pDC expressed in-
termediate levels. Neutrophils, eosinophils, and lymphocytes were
negative (data not shown) as were F4/80hi KC (Supplemental Fig. 2A).
All ECFP+ cells expressed intermediate levels of mApple
(Supplemental Fig. 2B, cyan gate), whereas all mApplehi cells
were ECFP2 and represent KC (Supplemental Fig. 2B, red gate).
We combined the two Csf1r reporters with detection of endothelial
cells by injection of FITC-labeled Lectin I. In confocal images
the mApple+ cells were almost completely restricted to the liver
sinusoids (e.g., pink boxes), consistent with KC (Fig. 8). In con-
trast, ECFP+mApple+ double-positive cells were rarely detected
(e.g., white box), despite the presence of numerous ECFP+
mApple2 cells (e.g., yellow box) (Fig. 8). These data suggest the
intermediate levels of Csf1r-mApple expressed in ECFP+ cDC and
monocytes (Fig. 5B, Supplemental Fig. 2A) are apparently below
the threshold of detection of confocal imaging. This conclusion
was supported by only weak detection of mApple expression
when peripheral blood was imaged using identical microscope
settings (Supplemental Fig. 3A). The Csf1r-ECFP+ cells in the
liver (e.g., yellow box) were mainly detected outside the sinusoids
and likely include the subcapsular liver macrophages that also
express the DCsf1r-ECFP transgene (42). The high level of
mApple expression in KC therefore allows imaging of these cells
without detection of monocytes and other mApple+ cells in the
liver.
In the lung, interstitial macrophages and DCwere ECFP negative
(Supplemental Fig. 2C) whereas the majority of alveolar macro-
phages and Ly6C+ monocytes expressed ECFP, as reported pre-
viously (31, 32). Combined, all ECFP+ cells were mApple+
(Supplemental Fig. 2D, cyan gate) and encompassed alveolar
macrophages and Ly6C+ and Ly6C2 monocytes, whereas ECFP2
mApplehi cells (Supplemetal Fig. 2D, red gate) comprised
CD64+ interstitial macrophages and a minor fraction of ECFP2
alveolar macrophages. In confocal images of transverse lung
sections, parenchymal populations broadly divided into
rounded ECFP+mApple+ cells (Fig. 9, yellow box) consistent
with alveolar macrophages or interstitial migratory monocytes
(31, 67) and elongated stellar-shaped ECFP2mApple+ cells
(Fig. 9, white box). Injection of CSF1-FcAF647 into the double
transgenic mice selectively labeled the extravascular interstitial
ECFP2mApple+ cells (Supplemental Fig. 4, white box), visible as
punctate staining indicative of internalization of labeled ligand,
FIGURE 4. Lineage-restricted Csf1r-mApple transgene expression in the lung. (A) Flow cytometric strategy to identify lung leukocytes. (B) Frequency
of donor cells within each lung population from tissue protected BM chimeric mice 8 wk after receiving BM from WT (white) or Ccr22/2 (black) mice.
Mean donor chimerism for circulating Ly6C+ monocytes is presented as short- or long-dashed lines for recipients of WT or Ccr22/2 BM, respectively. (C)
Expression of Csf1r-mApple in lung leukocytes from a representative WT littermate control (left) and Csf1r-mApple (right) mouse. (D) Frequency of cells
expressing Csf1r-mApple and (E) geometric mean fluorescence intensity (GeoMFI) of Csf1r-mApple gated on Csf1r-mApple+ cells for different lung
leukocytes. Data are from one of two independent experiments. Data presented as mean6 SD of four mice (D and E) or mean 6 SEM of five mice (B). The
asterisk (*) indicates significant differences using multiple t tests corrected for multiple comparisons using the Holm–Sidak method.
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FIGURE 5. Csf1r-mApple transgene expression in the liver. (A) Flow cytometric strategy to identify liver leukocytes. (B) Expression of Csf1r-mApple in liver
leukocytes with histograms from a representative Csf1r-mApple (right) and WT littermate control (left) mouse. (C) Frequency of cells expressing Csf1r-mApple and (D)
geometric mean fluorescence intensity (GeoMFI) of Csf1r-mApple gated on Csf1r-mApple+ cells for different liver leukocytes. (E) Frequency of donor cells within each
hepatic population from tissue protected BM chimeric mice 8 wk after receiving BM fromWT (white) or Ccr22/2 (black) mice. Mean donor chimerism for blood Ly6C+
monocytes is presented as short- or long-dashed lines for recipients of WT or Ccr22/2 BM, respectively. (F) Representative histograms showing forward scatter area
(FSC-A) characteristics and CD26, CD11c, CD64, and PDCA1 expression (tinted) overlayed with FMO controls (open) for liver leukocytes and blood monocytes. (B–D)
Representative data from one of three or (E) two experiments, with data presented as mean6SD of four mice (C andD) or mean6SEM of five (E) mice. The asterisk (*)
indicates significant differences using multiple t tests corrected for multiple comparisons using the Holm–Sidak method.
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and confirmed them to be interstitial macrophages rather
than ECFP2mApplelo pulmonary DC. Many extravascular
ECFP+mApple+ cells also took up CSF1-FcAF647 (Supplemental
Fig. 4), most likely migratory monocytes identified previously by
live imaging (30, 31). In contrast, the most frequent cells ob-
served within the pulmonary capillaries were ECFP2mApple+
(Fig. 9D, cyan box) and failed to label with injected CSF1-
FcAF647 (Supplemental Fig. 4), consistent with pulmonary
neutrophils (72). Consistent with this, imaging of blood cells at
identical power settings confirmed strong detection of mApple
in ECFP+ monocytes and ECFP2 neutrophils (Supplemental
Fig. 3B).
Heterogeneous expression of Csf1r reporter genes in the brain
Macrophages in the mouse embryo are ECFP positive in the
DCsf1r-ECFP line from their earliest appearance in the yolk sac
(32). In addition to alveolar macrophages, one of the few locations
in adults in which transgene expression is retained is in microglia.
FIGURE 6. Tissue-specific con-
sumption of CSF1 by cDC2 in vivo.
(A) Histograms of AF647 fluorescence
of leukocyte populations from lung
and liver following i.v. injection of
anti-CSF1R mAb AF-S98 or PBS ve-
hicle before subsequent i.v. delivery of
CSF1-FcAF647 or PBS vehicle. (B)
Geometric mean fluorescence intensity
(GeoMFI) of AF647 of cells from
mice in (A) (left graph) and change in
MFI between mice given CSF1-
FcAF647 alone or after AFS-98 pre-
treatment (right graph), with data
presented as mean 6 SEM of four
mice per group (left), or with data
points for individual mice shown
(right). Data are from one of two re-
peat independent experiments. (C)
Representative plots showing CSF1-
FcAF647 uptake versus CD11c expres-
sion or FMO control on hepatic cDC2
from mice in (A). (D) PE fluorescence
of liver leukocytes from C57BL/6
mice injected i.v. with anti–CD45-PE
mAb or PBS vehicle 2 min prior to
necropsy, showing data from one rep-
resentative mouse of two per group.
(E) Histograms of AF647 fluorescence
of Ly6C+ and Ly6C2 blood monocytes
from mice treated as in (A) but given
CSF1AF647, and a graph showing
change in GeoMFI of blood mono-
cytes and liver KC between mice given
CSF1AF647 alone or after pretreatment
with AFS98, and a dot plot showing
Ly6C versus AF647 uptake on all
CD32CD192Ly6G2 blood cells with
data points representing individual
mice. (F) Conventional surface CSF1R
(CD115) and Ly6C staining on CD32
CD192Ly6G2 blood cells from naive
mice. Data are from one representative
experiment of two (B–D and F) or
three (E) independent repeats. The as-
terisk (*) indicates significant differ-
ences between CSF1-FcAF647 alone
and AFS98 + CSF1-FcAF647 using t
tests corrected for multiple compari-
sons with the Holm–Sidak method (B,
left graph), whereas lines indicate
significant differences using one-way
ANOVA (B, right graph).
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Grabert et al. (73) reported differences in microglia numbers and
gene expression profiles in different mouse brain regions, and
changes in gene expression with age. We used the Csf1r-mApple:
DCsf1r-ECFP cross to further dissect microglial heterogeneity in
different brain regions. CD45loCD11b+ classical microglia were
uniformly strongly positive for mApple (Fig. 10A). Like blood
monocytes and alveolar macrophages, microglia in cortex, hip-
pocampus, and striatum were largely positive for ECFP, but in the
cerebellum the percentage was much lower (37.4%, Fig. 10B).
The level of ECFP in these cells was also lower, and lacked a clear
peak, reminiscent of the ECFP profiles of macrophages and DC in
the gut (32). The brain also contains a separable CD11b+, CD45hi
macrophage-like microglial population, a subset of which oc-
cupies perivascular locations and expresses higher levels of Csf1r
than monocytes (74). By contrast to the classical microglia and
blood monocytes, the CD11b+CD45hi cells were .50% ECFP
negative in all brain regions (Fig. 10B).
Discussion
We have developed a novel Csf1r-mApple reporter line. The
Csf1r promoter construct used has been remarkably consistent
in generating location and copy-number–independent expression
of transgenes (75), further confirmed by the comparable pattern of
Csf1r-mApple and Csf1r-EGFP transgene expression. Expression of
Csf1r-mApple had no impact on numbers of tissue macrophages or
circulating blood leukocytes (data not shown). With optimal mi-
croscope settings, the distinct profile of transgene expression across
subsets of MPS cells allowed exclusive detection of mApplehi cells.
When combined with the DCsf1r-ECFP reporter gene, which se-
lectively labels subsets of Csf1r-positive cells, CSF1-Fc labeled
with AF647, and FITC-labeled Lectin, we could identify and image
lung interstitial macrophages and liver KC, and distinguish them
from other myeloid cells. Despite high levels of Csf1r-mApple and
Csf1r-EGFP (46) transgene expression, neutrophils are identifiable
by injection of labeled Abs to Ly6G, a molecule with a negligible
role in neutrophil trafficking or function (76, 77). Thus, there are
numerous possibilities to produce live images of macrophage be-
havior and heterogeneity, particularly by combining with other
established EGFP-based reporter mice.
In common with the Csf1r-EGFP reporter (78), Csf1r-mApple
expression was uniformly higher in resident macrophages com-
pared with monocytes, a difference reflected in the ability of at
FIGURE 7. Consumption of CSF1 differs between monocytes and resident peritoneal macrophage populations. (A) Representative histograms of AF647
fluorescence in cavity leukocytes 10 min after i.p. injection of CSF1AF647 or PBS vehicle alone or in combination with pretreatment with AFS98, and
graphs showing MFI of AF647 (right of histogram) and change in MFI between mice given CSF1AF647 alone or after AFS98 pretreatment (below his-
togram), with data presented as mean 6 SEM of three to four mice per group. Data are from one of three independent repeat experiments. (B) Repre-
sentative histograms of Texas Red fluorescence in cavity leukocytes 10 min after i.p. injection of OVA–Texas Red conjugate from a single experiment. (C)
Total number of cavity leukocytes and proportion expressing high levels of Ki67 from mice treated for 4 d with GW2580 (open) or vehicle control (closed),
with data points depicting individual mice. Data representative of two independent experiments. The asterisk (*) indicates significant differences using
multiple t tests corrected for multiple comparisons using the Holm–Sidak method.
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least liver and cavity macrophages to capture more CSF1 on a per-
cell basis than monocytes in vivo. Consistently, peritoneal mac-
rophages compete effectively for available CSF1 in mixed culture
with proliferating BM-derived macrophages (79). The rapid up-
take of CSF1AF647 by KC is consistent with their role in regulating
the circulating CSF1 concentration (68). Hence, upregulation of
CSF1R expression may be a general feature of macrophage dif-
ferentiation that allows them to compete for or control bioavail-
able CSF1. The apparent inability of alveolar macrophages to
capture CSF1 is a notable departure from this tenet. However,
alveolar macrophages are unaffected in adult CSF1-deficient op/
op mice (80) and their replenishment from BM following irradi-
ation is largely independent of CSF1R (81). Thus, our data are
consistent with a lack of role for CSF1 in maintenance of the
alveolar macrophage niche. However, it remains unclear why both
alveolar macrophages and granulocytes express high levels of
Csf1r transgene despite lacking a surface receptor. In the blood,
Ly6C+ monocytes more readily took up CSF1 than their Ly6C2
progeny, a feature consistent with the suggestion that Ly6C+
monocytes regulate the availability of CSF1, thereby controlling
the lifespan of the Ly6C2 population (57). Interestingly, higher
consumption of CSF1 by classical monocytes is also evident in
PBMCs from Csf1r-EGFP transgenic sheep (65), suggesting this
feature is conserved across species.
Intensity of fluorescence in Csf1r-mApple mice also largely
distinguished long-lived tissue-resident macrophages (KC, alveo-
lar macrophages, and F4/80hi peritoneal macrophages) from those
of more recent monocyte-origin (F4/80lo resident peritoneal and
lung interstitial macrophages) but was not correlated with the
ability to take up labeled CSF1. In the peritoneal cavity, the re-
ceptor activity was greatest in F4/80loCD11c2 cells. Notably,
these cells were selectively depleted following treatment with the
CSF1R kinase inhibitor GW2580. Dynamics of loss of labeled
histone 2B-GFP from peritoneal F4/80lo macrophages places the
half-life for replenishment of both CD11c+ and CD11c2 subsets
from monocytes at around 2 wk (23), much longer than the 4 d
treatment regimen in this study. Hence, selective loss of F4/80lo
CD11c2 cells likely results from reduced survival or retention in
FIGURE 8. Csf1r-mApple and DCsf1r-ECFP transgenes allow imaging
of distinct lineages of hepatic myeloid cells. Confocal image of the surface
of the left lobe of the liver of a DCsf1r-ECFP (A), Csf1r-mApple (B), WT
(C), and Csf1r-mApple/DCsf1r-ECFP (D) mouse imaged ex vivo. FITC-
Lectin I was injected i.v. to reveal liver sinusoidal endothelium. Scale bars
represent 20 mm (A–C) or 50 mm (D).
FIGURE 9. Csf1r-mApple and DCsf1r-ECFP transgenes allow imaging
of distinct lineages of pulmonary myeloid cells. Confocal image of a
transverse section of lung from a DCsf1r-ECFP (A), Csf1r-mApple (B),
WT (C), and Csf1r-mApple/DCsf1r-ECFP (D) mouse imaged ex vivo.
FITC-Lectin was injected i.v. to reveal pulmonary vasculature. Scale bars
in all panels represent 50 mm.
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the cavity rather than a failure of monocytes to differentiate and
replenish these cells. Both F4/80hi and F4/80lo populations of
peritoneal macrophages are rapidly lost upon Ab-mediated neu-
tralization of CSF1 (24), suggesting only partial blockade of
CSF1R signaling occurred with the oral inhibitor used in this
study. Higher levels of CSF1R signaling are generally required for
proliferation than survival of macrophages (8) and hence the
uniform inhibition of Ki67 expression observed across the peri-
toneal macrophage compartment is consistent with a reduction of
high-level CSF1R-signaling by GW2580 treatment. In light of
this, our data suggest the F4/80loCD11c2 subset require a higher
threshold of CSF1R signaling for survival and consequently
exhibit greater CSF1R activity. Thus, different populations of
peritoneal macrophages would appear to pursue distinct survival
strategies. Short-lived cells are more reliant on high levels of
CSF1 signaling, whereas long-lived cells are better adapted to
efficiently use CSF1, possibly explaining the predominance of the
latter under homeostatic CSF1-limited conditions (82). Either
way, our data reveal fine-tuning of CSF1R activity but not nec-
essarily Csf1r transgene or gene expression between distinct
macrophage populations.
Relatively low, or absent, expression of the Csf1r-mApple
reporter also provided a useful marker delineating peritoneal
and pulmonary CCR2-independent cDC from CCR2-dependent
CD11c+/2MHCII+ APC, likely of monocyte origin. Monocyte-
derived CD11c+ APC have also been described within the der-
mis, kidney, and gut (6, 21, 54, 83), in which tissue cDC also
expressed lower levels of Csf1r (22). In the liver, MHCII+
CD11c+ cells were largely replenished by CCR2-independent
BM precursors, uniformly expressed the candidate cDC
marker CD26, and lacked the candidate macrophage marker
CD64. Consistent with a cDC nature, these cells also uniformly
express the transcription factor Zbtb46 (84). Nevertheless, these
cells showed similar levels of Csf1r-mApple transgene expres-
sion to monocytes, and the CD11b+ cDC2 fraction bound la-
beled CSF1-Fc. Although juvenile Csf1r2/2 mice have normal
numbers of hepatic cDC2 (14), unlike in other tissues, these
cells also do not require CSF2 for survival (85), indicating
possible redundancy between these growth factors. In adult mice
the impact of Csf1 and Csf1r mutations are more apparent (86)
and anti-CSF1R treatment produced an almost complete deple-
tion of liver cells expressing a Csf1r-EGFP transgene (87).
Hence, in general, our data do not support an absolute division
between Csf1r and Flt3-dependent APC populations. By anal-
ogy with the functional diversity of classical macrophages in
different organs (51, 88–90), APC differentiation is likely also
organ specific. Because CSF1 drives a largely immunoregula-
tory program (91), the responsiveness of cDC2 to CSF1 may
underlie the relatively weak APC activity in liver (92) and
contribute to a tolerogenic environment in the liver (93). Simi-
larly, competition of CSF1R+ cDC2 together with KC and
classical patrolling monocytes (94) for available CSF1 could
provide an explanation for the relative absence of hepatic
monocyte-derived MHCII+ APC.
In adult mice, labeling of cDC and macrophages in the DCsf1r-
ECFP reporter is tissue specific (32). Using the DCsf1r-ECFP
transgene, we highlighted the utility of the Csf1r-mApple strain to
be crossed to existing reporter lines, visualizing distinct MPS
populations in the lung and liver. Moreover, combined analysis of
the Csf1r-mApple and DCsf1r-ECFP transgenes highlighted het-
erogeneity among microglia. Intriguingly, the percentages of
DCsf1r-ECFP negative microglia correlated with the retention of
microglia in the IL-34–knockout mouse in the same brain regions
(95). Similarly, in other tissues, ECFP expression occurs pre-
dominantly in locations where macrophages are more reliant on
IL-34 (for example, Langerhans cells) or CSF2 (alveolar macro-
phages). Hence, the graded expression of the DCsf1r-ECFP
transgene in microglia may reflect its induction during differen-
tiation or the proximity of individual cells to the tissue-specific
factors that control its expression.
In overview, the Csf1r-mApple mouse recapitulates the ex-
pression profile of the widely used Csf1r-EGFP reporter. In
combination with other reporters, and labeled CSF1, the Csf1r-
mApple mouse provides a new tool to dissect the differentiation
and function of the heterogeneous populations of mouse tissue
mononuclear phagocytes and the homeostatic roles of CSF1.
How different mononuclear phagocytes regulate CSF1R activity
remains an important question given the continued interest in
macrophages as possible vehicles for delivery of gene therapies
and as targets of therapeutics.
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FIGURE 10. The expression of Csf1r-mApple and DCsf1r-ECFP
transgenes in regional brain homogenates. Cerebellum, cortex, hippo-
campus, and striatum were processed to generate a single-cell suspension.
(A) Compared are CD11b+CD45lo microglia and CD11b+CD45hi cells of
the cerebellum and cortex regarding their expression of Csf1r-mApple and
ECFP. (B) Percentage of double transgene positive CD11b+CD45lo and
CD11b+CD45hi cell populations across all selected regions.
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In this collaborative study, a new transgenic fluorescent reporter mouse line, the Csf1r-
mApple mouse, was generated. Using this line, I compared mApple expression across 
multiple tissues, revealing mature macrophages to express the highest levels of the 
transgene. A combination of mApple expression, expression of additional markers and bone 
marrow- and CCR2-dependence in chimeras allowed clear definition of myeloid cell subsets 
present in the liver, revealing the mixed identity of the F4/80loCD11bhi population. Analysis 
of CSF1-FcAF647 uptake revealed that monocytes, KC and cDC2 bind CSF1 in the liver, with KC 
binding the most on a per cell basis than any other cell across all tissues analysed.  
As has been shown previously with Csf1r-EGFP (MacGreen) mice (Sasmono et al. 2003), the 
Csf1r-mApple transgene was expressed across macrophages and monocytes, but also in 
neutrophils, eosinophils and a proportion of B cells. However, in the latter 3 cell types, 
mApple expression did not equate to functional uptake of CSF1-FcAF647. Thus either the CSF1R 
protein is not functional in these cell types, or it is not expressed altogether; indeed 
neutrophils have been shown previously to produce CFS1R mRNA but not protein (Sasmono 
et al. 2007).  In the blood and peritoneal cavity, where it is possible in our hands to detect 
CSF1R (CD115) expression by flow cytometry using an a-CD115 antibody, CSF1R staining was 
detectable on monocytes and macrophages, but not neutrophils, eosinophils or B cells. 
mApple expression in these cell type may thus be a relic of expression of the CSF1R in 
upstream precursor cells, since granulocyte-monocyte progenitors (GMPs) constitutively 
express the CFS1R (Endele et al. 2017).  
Monocytes, dendritic cells and macrophages could broadly be distinguished across tissues by 
their level of mApple expression. In particular, the level of mApple expression correlated to 
macrophage maturation status in the peritoneal cavity, with long-lived F4/80hi resMf 
expressing higher levels than the more short-lived F4/80lo macrophages (Bain et al. 2016) 
and Ly6Chi monocytes expressing lower levels still. Characterisation of the populations in the 
liver was particularly pertinent to the rest of my project, and to the wider field, since the 
F4/80loCD11bhi population in the liver had been labelled a macrophage population by several 
other groups (Schulz et al. 2012; Yona et al. 2013). In the study by Yona and colleagues, 
immunofluorescent imaging of CX3CR1gfp mice revealed the perivascular location of these 
cells (Yona et al. 2013), although this did not prove their macrophage identity since 
monocytes (Auffray et al. 2007) and DCs (David et al. 2016) also express CX3CR1, nor did GFP 
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expression account for the entire F4/80loCD11bhi population. Whilst KC were uniformly very 
bright for mApple transgene expression, there was no evidence for a secondary macrophage 
population with intensity greater than monocytes as observed in the peritoneal cavity. 
Dissection of the F4/80loCD11bhi gate revealed a heterogeneous population which could be 
split into at least 3 populations of the basis of Ly6C and MHCII expression. Further analysis of 
expression of the macrophage marker CD64 (Tamoutounour et al. 2012; Gautier et al. 2012), 
CD11c, and the dendritic cell marker CD26 (Guilliams et al. 2016), along with bone marrow- 
and CCR2-depedence allowed us to define Ly6Chi monocytes and cDC2s within the F4/80lo 
population. The F4/80loCD11bhi  gate also contained a Ly6C-MHCII- population which were 
likely Ly6Clo monocytes, although additional positive markers for this population would be 
required to ensure that this was not a mixed population. Ly6Chi monocytes in the liver 
displayed a different CD26 and CD11c expression profile to blood monocytes suggesting 
these had been actively recruited to the liver and were not simply blood monocyte 
contaminates present due to inefficient perfusion of the livers. This was in keeping with the 
suggestion that CCR2+Ly6Chi monocytes patrol the liver sinusoids (Dal-Secco et al. 2015), 
rather than Ly6Clo monocytes which are reported to patrol the vasculature in other 
anatomical sites (Auffray et al. 2007). Interestingly, cDC2, cDC1 and pDC (defined by their 
PDCA1 expression) also expressed mApple to almost equivalent levels as Ly6Chi monocytes, 
in contrast to the much more limited expression of transgene found in cDC2 and cDC1 in the 
peritoneal cavity and lung.  
While conventional flow cytometric analysis of CSF1R (CD115) protein expression using a-
CD115 antibodies was possible on blood and peritoneal cavity cells, we were not able to get 
any satisfactory CSF1R staining in the liver (data not shown). A combination of CSF1 
bioavailability along with the number of CSF1R-expressing cells in a tissue, and the number 
of CSF1R molecules on the surface of each cell affects the level of signalling achieved by each 
cell. Thus the total uptake of CSF1 is likely a better measure of CSF1R activity than CSF1R 
expression alone. Signalling through the CSF1R generally results in internalisation of the 
CSF1R-CSF1 complex, followed by its incorporation into lysosomes and degradation of both 
ligand and receptor (Stanley and Chitu 2014). Using radioactive Iodine-labelled CSF1 (125I-
CSF1) it was shown that 6 out of 7 binding events of CSF1 to CSF1R result in internalisation 
of the complex rather than dissociation and release of the ligand back into the media by bone 
marrow derived macrophages (Guilberts and Stanley 1986). Furthermore, degradation of 
ligand was found not to begin until after 10 minutes after uptake. Thus, the intensity of AF647 
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detected in my assays likely reflects close to total CSF1-Fc uptake over 10 minutes in vivo. 
Transgene expression by cDC2 was reflected in their ability to capture CSF1-FcAF647, but this 
did not hold true for cDC1 or pDC, indicating that of the DCs, only cDC2 actively compete for 
CSF1 in the liver. In keeping with their ability to efficiently clear CSF1 (Bartocci et al. 1987), 
KC bound the most CSF1-FcAF647 on a per cell basis than any other cell in the liver or lung, and 
10 times as much CSF1-FcAF647 as either Ly6Chi or Ly6Clo macrophages in the liver. Hence it is 
possible that monocytes arriving and patrolling in the liver under homeostatic conditions 
may simply not receive sufficient signalling through the CSF1R to facilitate differentiation, 
survival or proliferation. Indeed, a lack of monocyte differentiation due to CSF1 ‘starvation’ 
might provide an explanation for why no second population of macrophages could be 
identified in the liver. In contrast, direct injection of CSF1AF647 into the peritoneal cavity 
revealed that F4/80lo monocyte-derived peritoneal macrophages (also known as small 
peritoneal macrophages) seemed to rapidly increase in their ability to capture CSF1 above 
that of the mature resident F4/80hi macrophages, potentially explaining why they survive in 
this site. Therefore in the next chapter I will explore whether CSF1 availability is a limiting 
factor in the differentiation and survival of recruited monocytes into long-lived, mature 
resident KC, and whether exogenous administration of CSF1-Fc can therefore affect the 
origin of the resident KC population, and compare this with peritoneal cavity macrophages. 
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Chapter 5:  Role of CSF1 in maintenance of KC population and 
conversion of monocytes to KC 
 
5.1  Introduction 
The development of a robust method to isolate and study macrophages in the liver, along 
with a more detailed understanding of their CSF1R expression, and CSF1 uptake enabled me 
to begin investigating the role of CSF1 in maintaining KC population size and origin, and 
whether CSF1 is a limiting factor in the conversion of monocytes in to KC. At the start of the 
project, recent studies had shown that primitive macrophages from the yolk sac, together 
with varying contributions from foetal monocyte-derived macrophages from the foetal liver 
went on to seed resident macrophage populations in all embryonic tissues (Schulz et al. 
2012b; Hoeffel et al. 2012; Ginhoux et al. 2010; Hoeffel et al. 2015; Gomez Perdiguero et al. 
2015; Epelman et al. 2014a; Bain et al. 2014). The survival of resident macrophages of 
embryonic origin in adult mice is highly tissue-dependent. For example, macrophages in the 
intestine are continually replaced by adult monocyte-derived cells (Bain et al. 2014), whilst 
the murine brain is colonized almost exclusively by yolk-sac derived macrophages during the 
earliest stage of foetal development, and this lineage is maintained independently of adult 
monocytes post-birth through local self-renewal (Ginhoux et al. 2010; Ajami et al. 2007, 
2011; Schulz et al. 2012b). The survival and maintenance of the embryonic lineage of KC had 
been less well studied. A key initial study using parabiosis and genetic labelling of progenitor 
cells found that resident macrophages across multiple tissues including the lung, peritoneum 
and spleen did not require significant adult monocyte contribution, but unfortunately the 
liver was not included in this work (Hashimoto et al. 2013). Other groups had shown only 
minimal contribution of YFP-labelled CX3CR1+ monocytes to the KC population in adult mice 
using a tamoxifen inducible system (Yona et al. 2013). Consistent with this, it had been 
reported that there was no deficit in the number of KC in Ccr2-/- mice, which due to defective 
egress from the bone marrow have a 10-fold reduction in circulating monocytes (Bain et al. 
2014; Serbina and Pamer 2006). These studies provided some initial evidence that KC do not 
require any major contribution from adult monocytes in mice, though they were limited in 
that they only looked in young adult mice. I therefore set out initially to further establish 
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whether there is any requirement for monocyte replenishment of liver KC, taking age into 
account.  
I then turned to explore what factors might control the KC niche, and thus what regulates 
the size and origin of the KC population. CSF1 availability has been postulated previously as 
a possible limiting factor in the control of the tissue macrophage niche (Jenkins and Hume 
2014), and CSF1 has long been studied as a key regulator of macrophage differentiation and 
survival. The op/op mouse, which has a natural mutation in the coding region of the CSF1 
gene, has provided an invaluable tool for the study of CSF1 biology (Yoshida et al. 1990). 
Using this system, it has been formally demonstrated that whilst KC are initially independent 
of CSF1, they become highly dependent from 2 weeks of age (Cecchini et al. 1994), and there 
is a clear deficit in resident macrophage numbers in many tissues in op/op mice, including 
liver KC and F4/80hi resMf in the peritoneal cavity (Wiktor-Jedrzejczak et al. 1982).  
CSF1 can be expressed in multiple forms, either presented on the surface of cells which 
synthesize it, or it can be secreted and transported through the circulation as a proteoglycan 
(Price et al. 1992; Cecchini et al. 1994), and different tissue macrophage populations appear 
to differ in their dependence for the excreted versus the cell surface form. Through 
exogenous administration of murine CSF1 (Cecchini et al. 1994; Yamamoto et al. 2008), or 
transgenic expression of CSF1 (Ryan et al. 2001) in op/op mice it has been shown that some 
tissue macrophage populations, including liver Kupffer Cells, can be fully restored, indicating 
that their survival is dependent on the circulating form of CSF1, whilst the density of tissue 
macrophages in other tissues including the peritoneal cavity was not restored, implicating 
local presentation of CSF1 for their survival. More recently, a study in which the cell surface 
form, but not the circulating form of CSF1 was restored in 3 month old op/op mice led to only 
incomplete recovery of liver Kupffer Cell density, again implicating circulating CSF1 as crucial 
for maintaining population size (Dai et al. 2004). 
A study in which trace amounts of radiolabelled CSF1 was injected into mice showed that the 
majority of the circulating CSF1 is cleared in the liver, specifically by Kupffer Cells (Bartocci et 
al. 1987). Furthermore, both peritoneal macrophages ex vivo and more importantly, Kupffer 
Cells in vivo have both been shown to degrade radiolabelled CSF1 through CSF1R-mediated 
internalization and lysosomal degradation (Stanley et al. 1983; Bartocci et al. 1987), thus 
directly breaking down their own growth factor, in a negative feedback loop which may be 
critical for the control of overall population size.  
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CSF1 signals to macrophages through the CSF1 receptor (CSF1R) and mice in which the csf1r 
gene has been knocked out also displayed reduced macrophage numbers in multiple tissues 
including the peritoneal cavity and the liver (Dai et al. 2002). Equally, antibody blockade of 
the CSF1R led to depletion of resident macrophages in many tissues including in the liver 
(MacDonald et al. 2010), whilst administration of an anti-CSF1 antibody confirmed that CSF1 
is key for the regulation of peritoneal resMf proliferation in both inflammation and steady 
state (Davies et al. 2013). Our own study using cfs1r-mApple transgenic mice (chapter 4; 
Hawley et al. 2018) demonstrated that KC express much higher levels of the CSF1R than 
circulating monocytes in the blood, and exogenous administration of a fluorescently labelled 
CSF1-Fc conjugate showed that this translated into a significant difference in uptake of 
circulating CSF1, with KC able to bind more CSF1 than monocytes. Although a direct role for 
CSF1 in monocyte differentiation and maturation is less clear, I hypothesized that monocytes 
may not mature into KC in the steady state due to the limited availability of CSF1 that results 
from the efficient clearance of this growth factor by KC. I therefore set out to explore 
whether administration of exogenous CSF1-Fc (Gow et al. 2014), which has a longer half-life 
(between 12 and 24 hours) (Gow et al. 2014) than CSF1 (around 1.6 hours) due to its recycling 
via the neonatal Fc receptor (FcRn) (Roopenian and Akilesh 2007; Sockolosky et al. 2012), 
would drive monocyte survival and differentiation into mature macrophages, thereby 
allowing them to engraft and replace the endogenous KC. 
Proliferation is thought to contribute to the maintenance of the KC population in steady 
state, as low but detectable basal levels of cells in S-Phase can be detected in naïve adult 
mice (Jenkins et al. 2011; Crofton et al. 1978). Furthermore, exogenous administration of 
CSF1-Fc has been shown previously to increase proliferation and numbers of liver 
macrophages (Gow et al. 2014). Basal proliferation can be detected in many resident 
macrophage populations. In the heart, however, progressive influx of blood monocyte-
derived macrophages post birth parallels the loss of proliferation and the subsequent loss of 
the embryonic-derived macrophage population (Molawi et al. 2014). These observations led 
the authors to  hypothesise that replenishment from the BM may occur due to exhaustion of 
the embryonic cells. Thus, I also set out to determine whether the autonomy of the KC 
population could be broken by driving exhaustion of the incumbent cells, and whether this 
might ultimately lead to replenishment through monocyte recruitment.  
Finally, it also remains unclear whether all KC have an equal ability to proliferate. In the skin, 
it has been suggested using multicolour fate mapping and imaging techniques that 
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Langerhans cells do not proliferate equally (Ghigo et al. 2013), implying the presence of local 
tissue progenitors and hence a hierarchy. In contrast, proliferation of alveolar macrophages 
is reported to occur stochastically following infection (Hashimoto et al. 2013). Hierarchical 
proliferation of haematopoietic stem cells has been formally demonstrated in the bone 
marrow by looking at rate of loss of fluorescence in genetically labelled, histone 2B-GFP+ cells 
(Foudi et al. 2009). In this model, slowly dividing stem cells retained the fluorescent label for 
over a year whilst the label was more quickly diluted in their rapidly dividing daughter cells, 
in a process hypothesized to protect the genomic integrity of the stem cell.   
In this chapter I aimed to investigate parameters that control KC autonomy under steady 
state conditions. Specifically, does the mechanism for maintenance of KC change over time 
with respect to proliferation versus monocyte recruitment? How does bioavailability of CSF1 
affect KC population size, proliferative capacity and monocyte to macrophage conversion? 
And finally can all KC proliferate equally or is there any evidence of quiescent KC progenitor 
cells present in the liver? 
 
5.2 KC maintain autonomy in aged Ccr2-/- mice despite decline in proliferation 
with age 
Kupffer Cells have been shown to proliferate in the steady state (Edwards and Klein 1961; 
Wisse 1974; Jenkins et al. 2011), and self-renewal is thought to be an important mechanism 
through which they maintain population size independently of monocyte recruitment. 
However, studies assessing proliferation have focused only on young adult mice or rats. We 
therefore assessed KC proliferation in C57BL/6 mice aged up to 33 weeks. Mice were injected 
with the thymidine analogue BrdU 2 hours before necropsy in order to assess the proportion 
of the population in S phase. Leukocytes in the liver were identified following the gating 
strategy established in chapter 3, with the exception of CD31, as these experiments were 
conducted before its utility in removing contaminating endothelial cells had been 
established. There was a 50% decrease in the proportion of the KC population that was BrdU+ 
between 11 and 33 weeks of age, which appeared to plateau between 25 and 33 weeks (fig. 
5.1A), suggesting that KC proliferation in the steady state may wane over time. This plateau 
coincided with a plateau in liver weight gain, measured in a separate experiment with 
similarly aged mice (fig. 5.1B). A decline in proliferation of the F4/80hi resMf in the peritoneal 
cavity was also observed, suggesting this may be a more wide-spread phenomenon (fig. 5.1C; 
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see chapter 4 for peritoneal cavity gating strategy). It must be noted that the overall levels 
of proliferation recorded in the liver were particularly low compared to steady state 
observations in the rest of this study, and may be because it was carried out before the liver 
protocol was fully optimized. 
Although limited studies in young mice had suggested relative autonomy of KC from 
circulating adult monocytes, we hypothesized that the possible decline in proliferative 
potential with age might represent exhaustion of the incumbent population, leading to 
increased requirement for monocyte input into the population. To examine this possibility, I 
first looked at the effect of prolonged monocytopenia by aging Ccr2-/- mice to one year. There 
was around a 10-fold reduction in the frequency of circulating Ly6Chi monocytes (see chapter 
4 for blood gating strategy) compared to C57BL/6 WT controls (fig. 5.2A). Equally, there was 
a large and significant reduction in the total number of Ly6Chi monocytes that could be 
recovered from the liver (fig. 5.2B). However, there was no difference in KC number between 
WT and Ccr2-/- mice (fig. 5.2C), in keeping with the notion that the KC population can self-
renew independently of monocytes derived from circulation. I also looked at maintenance of 
the F4/80hi resMf population in the peritoneal cavity which showed around 5% non-host 
chimerism after 5 months of parabiosis (Hashimoto et al. 2013). Interestingly, here there was 
a slight deficit in the size of the total F4/80hi resMf in Ccr2-/- mice compared to WT at one 
year of age (fig. 5.2D). Alongside the aged Ccr2-/- experiments, and as part of a wider study 
within the lab, tissue-protected bone marrow chimeras were used to fate map the 
contribution of circulating adult monocytes to resident macrophage populations in multiple 
tissues over time. CD45.1+CD45.2+ host mice were irradiated from the hips down and were 
reconstituted with CD45.2+ bone marrow giving around 20-30% chimerism in Ly6Chi 
monocytes in blood. This showed that F4/80hi resMf in the peritoneal cavity were gradually 
replaced by monocyte-derived macrophages over time, whilst liver KC were relatively 
autonomous with only a small and non-significant increase in chimerism from 7% to 10% 
between 8 and 33 weeks of age (Bain et al. 2016). Thus, despite the reduction in the 
proliferation rate in the KC population with age, our Ccr2-/- and aged chimera experiments 
supported the idea that KC retain autonomy from monocytes, even with age.  
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5.3 CSF1-Fc causes conversion of circulating bone marrow cells into highly 
proliferative F4/80hi KC-like cells.   
Given this relative autonomy of KC in the steady state, I explored whether CSF1 bioavailability 
could be a potential limiting factor in the conversion of monocytes to resident KC. It was 
shown previously that exogenous CSF1-Fc administration led to the recruitment of Ly6Chi 
monocytes in the peritoneal cavity (Jenkins et al. 2013), and CSF1R blockade led to reduced 
recruitment and conversion of Ly6Chi monocytes into macrophages in the myometrium of 
pregnant mice (Tagliani et al. 2011). Thus elevated bioavailability of CSF1 can cause increased 
monocyte recruitment, and we hypothesized that surplus CSF1 might allow these recruited 
monocytes to mature and contribute to the resident KC population. In an initial pilot 
experiment, female, tissue-protected bone marrow chimeric mice were given 2 doses of 
CSF1-Fc at day -2 and day 0 (fig. 5.3A). The livers were harvested at day 2 and weighed. This 
showed that CSF1-Fc treatment led to increased liver weight (fig. 5.3B) and increased 
liver:body weight ratio (fig. 5.3C), as previously described (Gow et al. 2014). CSF1-Fc 
treatment did not overtly affect the phenotype of immune cells in the liver by any of the 
markers we had measured (fig. 5.4A), but it led to a general increase in the total number of 
KC, monocytes, neutrophils, eosinophils and lymphocytes per gram of liver compared with 
PBS control injections (fig. 5.4B). Hence, CSF1-Fc appeared to affect not only monocytes and 
macrophages, but leukocytes of multiple lineages, through either direct or indirect 
mechanisms.  
Consistent with previous observations (Gow et al. 2014), treatment with CSF1-Fc stimulated 
elevated proliferation of F4/80hiCD11blo KC cells in the liver, as determined by a 2 hour BrdU 
pulse before necropsy. Approximately 13% of KC were double positive for BrdU along with 
the cell cycle marker Ki67 with CSF1-Fc treatment, compared to just 1% of the population in 
the PBS treated control group (fig. 5.5A). Proliferation of the F4/80loCD11bhi bulk population 
has been reported previously in response to CSF1-Fc treatment (Stutchfield et al. 2015). 
However, in contrast we found that CSF1-Fc did not increase proliferation of the Ly6Chi 
monocytes that comprise the majority of these cells (fig. 5.5B) indicating that CSF1-Fc did not 
stimulate proliferation in all cells of myeloid origin at least with the dose and delivery regime 
used here.  
To examine whether this increased rate of proliferation in the F4/80hiCD11blo KC population 
fully accounted for the expansion in the size of the population following CSF1-Fc treatment 
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or whether generation of new BM-derived KC had occurred, donor bone marrow chimerism 
was assessed. In the blood, the overall level of chimerism was comparable between groups 
prior to treatment (fig. 5.6A) with around 20-30% of circulating Ly6Chi monocytes of donor 
origin. The chimerism of the Ly6Chi monocytes in the liver normalized to the total chimerism 
of Ly6Chi monocytes in the blood was 100% in both groups (fig. 5.6B). This was as expected 
given that monocytes in tissues are considered recently derived from the blood, and should 
therefore show maximal levels of chimerism. In PBS treated control mice, KC were 
predominantly of tissue origin revealed by <2% normalized chimerism (fig. 5.6C). In contrast, 
CSF1-Fc treatment led to around 15% of the KC population having originated from the bone 
marrow (fig. 5.6C). Intriguingly, a greater proportion of the donor KC population were 
proliferating following CSF1-Fc treatment (fig. 5.6D). Hence, treatment with CSF1-Fc 
stimulated both proliferation and accumulation of endogenous tissue-derived KC and 
conversion of bone-marrow derived cells into a highly proliferative population that bore the 
crude F4/80hiCD11blo hallmarks of KC.  
 
5.4 Tim4 expression differentiates donor and host F4/80hiCD11blo KC 
Until this point, KC were defined solely on their CD45+F4/80hiCD11blo expression profile. Tim4 
is a phosphatidyl serine receptor which is highly expressed by resident KC according to 
microarray data available from the Immunological Genome Project (Heng et al. 2008; 
www.immgen.org). We therefore looked at Tim4 expression in order to gauge how faithfully 
the donor bone marrow-derived KC acquired other phenotypic markers typical of resident 
KC. Whilst the majority of the host KC expressed very high levels of Tim4, the donor cells 
uniformly expressed only low levels of Tim4 in both PBS and CSF1-FC-treated mice, although 
they still appeared dimly positive for this marker when compared to the FMO control (fig. 
5.6E). Given that these donor cells did not fully recapitulate the expression pattern of the 
host KC, they will be referred to as KC-like cells for the rest of the chapter.   
 
5.5 The emergence of recruited KC-like cells is transient 
The appearance of donor-derived F4/80hiCD11blo KC-like cells following treatment with CSF1-
Fc prompted me to assess the long-term survival of these newly arrived cells. To do so, tissue 
protected BM chimeric mice were treated with PBS or CSF1-Fc twice as before, and a group 
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of mice was left for 2, 8 or 14 days after the final treatment respectively (fig. 5.7A). CSF1-Fc 
treatment again drove increased numbers of leukocytes without affecting their basic 
phenotype (fig. 5.7B). The increased number of KC seen at day 2 post treatment with CSF1-
Fc remained elevated by 8 days, but returned to normal by 14 days (fig. 5.7C), suggesting a 
period of substantial contraction of the population between 8 and 14 days. Consistent with 
this, the enhanced levels of proliferation of KC detected at 2 days post final treatment was 
followed by a complete cessation of proliferation at 8 days before restoration of the basal 
rate at 14 days (fig. 5.7D). The total number of Ly6Chi monocytes in the liver was significantly 
increased at day 2, but returned to normal by day 8 (fig. 5.7E). The elevated frequency of 
bone marrow-derived KC-like cells evident at day 2, again revealed by ~20% normalized non-
host chimerism, was transient, as the chimerism returned to the basal levels seen in PBS-
treated control mice by day 14 (fig. 5.7F). This indicated that the enhanced rate of 
proliferation of the donor KC compared to host KC (fig. 5.6D), did not convey a survival 
advantage, and the autonomy of the embryonic-derived KC population was maintained, with 
the transient KC-like cells being lost, presumably through death or migration from the liver. 
To determine if recruitment of bone marrow derived KC-like cells was a feature unique to 
CSF1 or shared by other macrophage mitogens, an additional group of mice was given two 
doses of IL-4 in the form of IL-4 complex (IL-4c). IL-4c treatment drove reduced CD11b 
expression in KC as has been seen previously (Jenkins et al. 2011), but the population was 
still clearly identifiable (fig. 5.7B). IL-4c has been shown previously to induce accumulation of 
resident peritoneal macrophages through proliferation with an absence of recruitment of 
inflammatory monocytes (Jenkins et al. 2011), and in this same study KC were also shown to 
proliferate in response to IL-4c treatment. In my IL-4c treated group, I was able to replicate 
this elevated proliferation and accumulation of KC (fig. 5.7C & 5.7D). In keeping with the 
published results in the peritoneal cavity, there was no elevated recruitment of Ly6Chi 
monocytes (fig. 5.7E), and no contribution of recruited cells to the liver KC population with 
IL-4c treatment, as there was no significant change in the level of chimerism compared to 
the PBS vehicle control group at day 2 (fig 5.7F). This demonstrated that although IL-4c and 
CSF1-Fc both caused an increase in the total number of KC, the kinetics through which this 
was achieved was different.  
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5.6 CSF1-Fc does not induce differentiation of BM-derived cells to resident 
macrophages in the peritoneal cavity  
To determine if CSF1-Fc administration could also drive transient recruitment of resident-like 
macrophages in other tissues, cells were washed from the peritoneal cavity in the time 
course experiments. There was no change in the level of chimerism of the F4/80hi resMf 
population with either IL-4c or CSF1-Fc treatment (fig. 5.8A), despite induction of 
proliferation and accumulation of macrophages at day 2 in both sexes (fig. 5.8B & 5.8C) Thus, 
it appears that exogenous CSF1-Fc is not sufficient to drive conversion of bone-marrow cells 
to a resident macrophage phenotype in the peritoneal cavity.  
 
5.7  Repetitive CSF1-Fc treatment recruits BM-derived KC-like cells without 
causing exhaustion of endogenous KC 
My data indicated that liver KC persist autonomously from circulating Ly6Chi monocytes in 
steady state and remained autonomous following an acute high dose of exogenous CSF1-Fc 
despite recruitment of KC-like monocyte-derived macrophages to the liver. However, in light 
of our data which suggested that KC proliferation may wane with age, I hypothesized that 
multiple rounds of expansion of the population through proliferation followed by contraction 
might exhaust the endogenous KC and cause replenishment by monocyte-derived 
macrophages recruited from circulation. 
Given that CSF1-Fc is a porcine fusion protein, it was possible that its repeated administration 
may provoke a neutralising antibody immune response in mice. Therefore, I first trialled the 
delivery schedule in which CSF1-Fc was given twice two days apart, then mice were allowed 
to recover for 12 days before the process was repeated a further 2 times with two mice per 
group. The efficacy of CSF1-Fc was assessed two days after each round of administration (1x, 
2x and 3x on fig. 5.9A). The fold-change in liver:body weight ratio over each animal’s starting 
weight increased with each subsequent treatment (fig. 5.9B) and the number of KC was 
elevated after each round of treatment (fig. 5.9C). The level of proliferation in KC was also 
elevated after each round of CSF1-Fc (fig. 5.9D), and when this was expressed as fold change 
over the PBS control at each time point it appeared that there was no decline in the level of 
proliferation induced (fig. 5.9E). Together, these results demonstrated that CSF1-Fc retained 
its efficacy even after the third round of administration. 
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I then gave partial chimeric mice 3 rounds of CSF1-Fc treatment and assessed livers at day 2 
and day 14 after the final injection (fig. 5.10A). Again, CSF1-Fc caused an increase in liver 
weight at day 2 compared with PBS controls, which returned to the level of the control group 
at day 14 (fig. 5.10B). The CSF1-Fc caused a robust increase in proliferation within the KC 
compartment at day 2 (fig. 5.10C), correlating with the large increase in the total number of 
KC (fig. 5.10D) of a similar magnitude to the increase seen after only one round of treatment 
previously (fig. 5.4B & 5.7C) and which returned to baseline by day 14 (fig. 5.10D). Finally, I 
assessed the chimerism in the KC compartment. Two days after the third and final round of 
CSF1-Fc, the chimerism was just over 30% when normalized to the chimerism in the blood 
(fig. 5.10E), which was higher than the total chimerism seen with only a single round of CSF1-
Fc treatment before (fig. 5.6C & 5.7F). After 14 days, unlike with a single round of treatment, 
chimerism had not returned to baseline levels (fig. 5.10E), and approximately 20% of the 
donor cells had acquired the KC marker Tim4 (data not shown) suggesting that at least some 
recruited cells had fully matured into KC at this time point. However, given that the level of 
chimerism underwent a significant reduction between day 2 and 14 after the final treatment, 
it was not possible to say whether the recruited KC would engraft permanently. 
Unfortunately, the length of these experiments, the time constraints of my PhD, and the 
need to focus on other aspects of my PhD project, meant it was not possible to repeat this 
experiment with a longer chase period to address this issue. However, analysis of 
proliferation of donor and host-derived KC revealed that although the newly recruited donor 
KC-like cells proliferated more than their host-derived counterparts both at day 2 and day 
14, the host-derived cells still exhibited significant levels of proliferation (fig. 5.10F). After 
accounting for the levels of chimerism in the total KC population, the proliferation rate that 
could be attributed to the endogenous KC 2 days following the final dose of CSF1-Fc was 5.9% 
in the acute and 6.5% in the chronic experimental systems. Thus, even when the frequency 
of monocyte-derived cells within the host population is accounted for, it would appear that 
the incumbent tissue-derived KC exhibit similar levels of proliferation in response to repeated 
delivery of exogenous CSF1-Fc as observed after a single dose. Hence it would appear that 




5.8 Search for progenitor cells in liver using CSF1-Fc and IL-4c with H2B-GFP 
mice 
My data suggested that resident, embryonic-derived host KC were able to self-maintain, 
despite the transient appearance of monocyte-derived F4/80hiCD11blo KC-like cells. Even 
after multiple doses of CSF1-Fc over several weeks, the endogenous KC were able to continue 
to proliferate, and were largely not replaced by monocyte-derived donor cells. To determine 
whether proliferation of KC was random or hierarchical, possibly including a quiescent 
progenitor-like KC population, I used mice which express a doxycycline-inducible histone 2B 
– GFP fusion protein (Foudi et al. 2009) that becomes stably incorporated into chromatin 
during the labelling period, but which is lost after removal of doxycycline as cells proliferate 
during a subsequent chase period (fig. 5.11A). Two weeks on doxycycline chow gave uniform, 
bright labelling of Ly6Chi monocytes in the blood (fig. 5.11B). I therefore put mice on 
doxycycline chow for two weeks before giving two doses of CSF1-Fc, IL-4c or PBS and 
assessing loss of GFP within the KC population two days later (fig. 5.11C).  
As a surrogate method to identify cells in S phase, I arbitrarily gated only on those with very 
high levels of Ki67 expression. Both CSF1-Fc and IL-4c gave robust increases in proliferation 
rate in this system (fig. 5.12A), confirming that neither mouse strain nor doxycycline 
treatment affected the normal response to these macrophage mitogens. The geometric 
mean fluorescence intensity of GFP expressed by Ly6Chi monocytes in the blood was lower 
with both IL-4c and CSF1-Fc than the PBS-injected vehicle control mice (fig. 5.12B). There was 
also an enhanced rate of loss of GFP in the KC treated with either IL-4c or CSF1-Fc (fig. 5.12B 
& 5.12C) in accordance with the elevated level of proliferation induced. However, the flow 
plots and histograms showed that there was no evidence of a ‘peak’ of label retaining cells 
with any treatment (fig. 5.12C). Thus I found no evidence for any quiescent sub-population 



























































Figure 5.1 Proliferation of KC wanes with age. (A) Proportion of KC and (C) F4/80hi resident peritoneal 
cavity macrophages which were BrdU+ after a 2-hour pulse in 11, 18, 25 and 33 week old C57BL/6 
mice. n=6 per group pooled from two experiments. (B) Liver weights of 10, 18, 21 and 29 week old 
mice where n=4-6 per group pooled from two separate experiments. Significance determined by one-





















































































































Figure 5.2 Maintenance of resident macrophage populations in year old Ccr2-/- mice. (A) Frequency 
of Ly6Chi monocytes in blood as a proportion of total CD45+ population in year old male C57BL/6 (WT) 
and Ccr2-/- mice. (B) Total number of Ly6Chi monocytes, (C) total number of KC in the in liver and (D) 
total number of F4/80hi resident peritoneal macrophages in male WT and Ccr2-/- mice expressed as a 
ratio to the mean value in WT mice (Ccr2-/-/WT). n=9 pooled from 3 independent experiments. 
































































Figure 5.3 Exogenous CSF1-Fc administration causes increased liver weight. (A) Male CD45.1+ 
CD45.2+ host mice were irradiated with the upper body shielded by lead then reconstituted with bone 
marrow from CD45.2+ donor mice. Mice were left for 8 weeks before s.c. injection with CSF1-Fc or PBS 
vehicle control at day -2 and day 0, and mice were culled on day 2. (B) Total liver weight and (C) 
Liver:body weight ratio n=4 (PBS) or 3 (CSF1-Fc) from 1 experiment. Significance determined by t-test 


















































































































































































Figure 5.4 Increase in liver leukocyte numbers following exogenous CSF1-Fc administration. (A) 
Gating strategy to identify leukocyte populations in the liver with representative plots from PBS and 
CSF1-Fc treated animals. (B) Total number of Kupffer Cells, Ly6Chi monocytes, neutrophils, eosinophils 
and lymphocytes per gram of liver tissue with PBS and CSF1-Fc treatment. Significance determined by 



















































Figure 5.5 Enhanced proliferation of KC following exogenous CSF1-Fc administration. (A) Proportion 
of Kupffer Cells and (B) Ly6Chi liver monocytes which were BrdU+Ki67+ double positive 2 hours 
following BrdU pulse (1mg). Significance determined by t-test where ***p<0.01, ***p<0.001. From 


































































































































































Figure 5.6 Exogenous CSF1-Fc administration leads to chimerism in KC population with donor cells 
with a high proliferation rate. (A) Representative flow plots of non-host chimerism and replicate data 
of absolute chimerism (% CD45.2+) in Ly6Chi monocytes circulating in blood with PBS and CSF1-Fc 
treatment. (B) Representative flow plots of non-host chimerism and replicate data of chimerism in 
Ly6Chi monocytes in liver normalized to Ly6Chi monocytes in blood and (C) as in (B) but for Kupffer 
Cells. (D) Proportion of donor (squares) versus host (circles) derived KC which were BrdU+Ki67+ double 
positive after PBS or CSF1-Fc treatment. (E) Representative histograms for Tim4 expression by donor 
KC (red) and host KC (brown) and Tim4 FMO control. Significance determined by t-tests either 
unpaired (A-C) or paired (D) where **P<0.01, ***p<0.001. (A-C, E from same experiment as figure 


























































Figure 5.7 Chimerism in KC population is transient following exogenous CSF1-Fc administration. (A) 
CD45.1+CD45.2+ host mice (male and female) were irradiated with the upper body shielded by lead 
then reconstituted with bone marrow from CD45.2+ donor mice. Mice were left for 8 weeks before 
being injected s.c. twice with PBS, CSF1-Fc or IL-4c and were culled on day 2, 8 or 14 following the 
second dose. (B) Representative flow plots of F4/80 versus CD11b for each treatment at day 2. (C) 
Number of KC per gram of liver tissue, (D) proportion of KC which were BrdU+Ki67+ double positive, 
(E) number of Ly6Chi monocytes per gram of liver and (F) normalized non-host chimerism in the KC 
population at each time point. One repeat of the day 2 timepoint of (F) has been published in 
Stutchfield et al. 2015. Significance determined by one-way ANOVA compared to the PBS control for 














































































Figure 5.8 Effect of sub-cutaneous CSF1-Fc administration on peritoneal F4/80hi resMf. (A) Total 
number, (B) proliferation and (C) normalized non-host chimerism in the peritoneal F4/80hi resMf 
population at each time point. n=6-11 per group pooled from 3 experiments. Significance determined 
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Figure 5.9 CSF1-Fc retains efficacy after multiple doses. (A) Female C57BL/6 mice were given 3 rounds 
of two doses of CSF1-Fc or PBS vehicle control at the indicated time points. Mice were culled at day 2 
after each round of two injections, indicated by 1x (one round of injections), 2x (two rounds) and 3x 
(three rounds). (B) Fold change in liver:body weight ratio for each treatment after each round of 
injections. (C) Total number of KC per gram of liver. (D) Proportion of KC population which was 
BrdU+Ki67+ double positive and (E) fold increase in BrdU+Ki67+ double positive cells in the CFS1-Fc 
treated mice over PBS control (where PBS = 1 for each time point). n=2 per group from a single, pilot 



















































































































































Figure 5.10 Multiple round of CSF1-Fc administration leads to non-host chimerism of KC and donor 
cells with high proliferative capacity. (A) Female CD45.1+CD45.2+ host mice were irradiated with the 
upper body shielded by lead then reconstituted with bone marrow from CD45.2+ donor mice. Mice 
were injected s.c. with PBS of CSF1-Fc at the indicated timepoints and culled 2 and 14 days after the 
final injection. (B) Total liver weight. (C) Proportion of KC which were BrdU+Ki67+ double positive. (D) 
Total number of KC per gram of liver. (E) Normalized non-host chimerism in KC population at each 
time point after final injection. (F) Proportion of donor (squares) versus host (circles) derived KC which 
were BrdU+Ki67+ double positive after CSF1-Fc treatment at day 2 or day 14 following the final dose 
of CSF1-Fc. n=4 per group from one experiment. (B-E) *p<0.05, **p<0.01, ***p<0.001, ***p<0.0001 








































Figure 5.11 System to assess proliferative heterogeneity of KC. (A) H2B-GFP mice were given 
doxycycline in their chow resulting in expression of histone 2B –GFP fusion protein, which dilutes over 
the chase period. (B) Representative flow plots of GFP versus Ly6C showing GFP intensity in mice given 
no doxycycline, maximal labelling of Ly6Chi monocytes in blood after 2 weeks on doxy chow and 
intensity after a 2-week chase period. (C) After 2 weeks on doxy chow, mice were injected twice with 













































































































Figure 5.12 No evidence of slowly cycling or quiescent KC sub-population (A) % of KC which were 
Ki67hi with each treatment. (B) The geometric mean fluorescence intensity (geoMFI) of GFP with each 
treatment in Ly6Chi monocytes in blood (left) and Kupffer cells in the liver (right). (C) Representative 
flow plots of GFP versus F4/80 and histogram of GFP fluorescence of KC after each treatment. 
Representative of 2 independent experiments with n=6-7 per group. Significance determined by one-




In this chapter I found that in contrast to F4/80hi resMf of the peritoneal cavity, KC appeared 
capable of self-maintenance even in year old mice, despite a reduction in rate of proliferation 
with time. Administration of exogenous CSF1-Fc caused the appearance of transient KC-like 
macrophages to be recruited from circulation, but withdrawal of the CSF1-Fc led to their loss 
from the liver. Repeated treatments with CSF1-Fc did not appear to cause exhaustion of the 
incumbent KC population, which raised the question of whether there was a slowly cycling 
KC progenitor cell in the liver. However, experiments using a genetic label dilution system 
did not reveal a population of quiescent KC and suggested that proliferation in the liver may 
not be hierarchical. 
5.9.1 Maintenance and origin of KC in steady state 
To understand further whether KC were able to self-maintain even in aged I we used Ccr2-/- 
mice. There was no deficit in KC number in year old Ccr2-/- mice, suggesting that the KC 
population established during embryogenesis can be maintained independently of 
contribution from circulating adult monocytes, even with age. Although Ccr2-/- mice 
displayed significant monocytopenia, with approximately 10-fold reduction in the frequency 
of circulating monocytes, this is not a definitive lineage tracing system, and it remained 
possible that the few monocytes which are able to egress from the bone marrow into the 
blood may be sufficient to replenish the resident KC population. However, we also took a 
chimeric fate-mapping approach to assess monocyte contribution to resident macrophage 
populations with age (Bain et al. 2016), and found no significant increase in chimerism to the 
KC population between 8 and 36 weeks post-irradiation. Around the time of these 
experiments, another study was published in which Flt3Cre-YFP mice were used to label all 
foetal and adult HSCs and their progeny, which demonstrated only a small initial contribution 
of these cells to KC up to 8 days of age, after which there was no further increase in the 
proportion of YFP+ cells up to one year of age (Gomez Perdiguero et al. 2015). Thus, our 
results are supported by this study and strongly indicate that resident KC in the liver do not 
require any major contribution from recruited monocytes to maintain their numbers in the 
steady state. As a comparison, we also assessed F4/80hi resMf in the peritoneal cavity in both 
the chimeric and Ccr2-/- studies, which showed a reduction in resident macrophage numbers 
in the Ccr2-/- system, and an increased level of chimerism with age (Bain et al. 2016), 
indicating that, at least in males, this population does rely on monocytes as mice age.  
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5.9.2 Role of CSF1 in maintaining the embryonic KC population and conversion of 
monocytes to KC 
The tight self-maintenance of KC in the steady state raised the question of what constitutes 
the KC niche, and in particular what controls the niche size. A hypothesis of ‘niche availability’ 
has recently been put forward which predicts that resident macrophage niche space is 
restricted, and can be full (Guilliams and Scott 2017), and CSF1 has previously been put 
forward as a possible limiting factor in macrophage niche size (Jenkins and Hume 2014). The 
delivery of exogenous CSF1 in the form of CSF1-Fc and the resultant increased availability of 
CSF1 led to a general expansion of all leukocyte populations assessed. The expansion of cell 
populations which do not express the CSF1R (eosinophils, neutrophils and lymphocytes) is 
likely a knock on effect of direct signalling to KC and monocytes (chapter 4; Hawley et al. 
2018). The expansion of the KC population was concurrent with an initial increase in 
proliferation. Withdrawal of further CSF1-Fc then resulted in a complete shut off of 
proliferation and a contraction of the artificially expanded KC population which then 
returned to its steady state size within 2 weeks following treatment, at which point 
proliferation returned to steady state levels. Low, but detectable levels of proliferation could 
been seen in the Ly6Chi monocyte subset, indicating that they had begun the process of 
differentiation having arrived in the liver (Swirski et al., 2014). However, CSF1-Fc did not 
induce further proliferation of Ly6Chi monocytes, in contrast with another recently published 
study (Stutchfield et al. 2015). However, in this study, the livers were analysed at day 2 
following a single CSF1-Fc dose rather than at day 4 following 2 doses in our model, so it is 
conceivable that we missed any early spike in proliferation of recruited Ly6Chi monocytes in 
our study. Differences in dose of CSF1-Fc may also provide an explanation. Overall, our data 
are consistent with the model in which local CSF1 levels tightly regulate KC numbers through 
local proliferation (Jenkins and Hume 2014).  
Alongside the increase in KC numbers and proliferation, the partial bone marrow chimera 
system confirmed the emergence of donor KC-like macrophages which expressed the 
classical F4/80hiCD11blo KC profile. Hence CSF1 would appear to be a limiting factor in the 
differentiation of bone marrow derived cells – likely classical Ly6Chi monocytes – into a 
mature KC phenotype. However, the mechanism through which CSF1 achieves this remains 
unanswered. It is possible that CSF1 directly instructs monocytes to mature into 
macrophages, or that the increased availability of CSF1 through exogenous administration 
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may simply allow monocytes, which express lower levels of the CSF1R than KC (chapter 4; 
Hawley et al. 2018) to survive for longer in the tissue, allowing local tissue-specific signals to 
direct their acquisition of a mature macrophage phenotype. Either way, these monocyte-
derived macrophages largely did not express Tim4, indicating that they had not fully 
differentiated into resident KC, although others have shown that monocyte-derived cells 
recruited after depletion of KC take between 7 days to over a month to express Tim4 (Scott 
et al. 2016a). It would have therefore been beneficial to include additional markers such as 
the KC-specific marker Clec4f (Yang et al. 2013; Lavin et al. 2014), which has more recently 
been shown to be switched on by newly recruited monocytes within 4 days following 
depletion of the endogenous KC population (Scott et al. 2016). Regardless, my data suggest 
that exogenous CSF1 is a limiting factor in monocyte differentiation in the liver.  
5.9.3 Why is the emergence of recruited BM-derived KC-like cells only transient? 
Intriguingly, the BM-derived KC-like cells were only found transiently in the liver, and 
appeared to be lost by 14 days post treatment, as chimerism in the KC population had 
returned to PBS control levels. This suggested that 4 days of elevated CSF1-Fc levels alone 
was insufficient to support full conversion of monocytes to a resident KC phenotype, or that 
there was simply not enough time for donor cells to switch on the full KC gene expression 
program. A further experiment in which mice are given a prolonged CSF1-Fc treatment would 
be required to determine if this is the case, although the length of time chosen for treatment 
to be given may be somewhat arbitrary. The transient donor KC-like cells did proliferate, 
however, indicating that they had acquired a key feature of mature resident KC. It is 
particularly interesting to note that the donor KC-like cells proliferated at a higher level than 
their host KC counterparts, and yet were still unable to outcompete the endogenous KC, 
which is perhaps surprising given that changes in the balance between embryonic-derived 
and monocyte-derived resident macrophages in the heart over time coincides with dynamic 
changes in rates of proliferation due to both a general reduction in proliferation of 
macrophages of embryonic origin and replacement with non-renewing bone-marrow 
derived macrophages (Molawi et al. 2014). However, our data also demonstrated a general 
decline in proliferation of resident macrophages with age in the liver and peritoneal cavity, 
suggesting that loss of proliferative capacity over time may be a general effect across tissues. 
Thus, the transient nature of the donor KC-like cells was unexpected, and suggests that 
additional parameters limit the conversion of monocytes into long-lived liver KC.  
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In addition to dependence on CSF1, KC sit in close association with liver sinusoidal endothelial 
cells (LSECs) (chapter 3; Lynch et al. 2018) and mice with a deficiency in the endothelial 
molecule PLVAP can barely support adult KC (Rantakari et al. 2016). Blood continually passes 
through the sinusoids which are formed by LSECs, and it might therefore be expected that 
monocytes should not have a problem in accessing this physical KC niche. Indeed, this lack of 
physical barrier may be a reason why bone marrow-derived F4/80hi cells accumulated in the 
liver but not the peritoneal cavity in response to CSF1-Fc treatment. So why then do these 
bone marrow-derived cells not appear to engraft? It is possible that only specific LSECs have 
the capacity to support KC, and these LSECs were already in contact with host KC when we 
delivered CSF1-Fc, preventing the long-term survival of the donor KC-like cells. Consistent 
with this hypothesis, KC have been shown to be immotile cells in the steady state over short 
time frames (Egen et al. 2008; McDonald and Kubes 2016), further supporting the fact that 
they inhabit a very specific, spatially restricted niche. Alternatively, the donor BM-derived 
cells could have an altogether different identity, perhaps in the form of recently described 
liver capsular macrophages (LCM) (Sierro et al. 2017). These cells were found to be 
dependent on CSF1R signalling, and parabiosis experiments suggest they had a faster 
turnover from monocytes than KC over an 8 week period (Sierro et al. 2017). Although LCM 
were described as Tim4-CX3CR1+ cells, there is no specific marker which truly distinguishes 
them from monocytes. However, a future approach in which the location of the BM-derived 
donor cells in our model could be identified by imaging of the liver would be highly 
informative in terms of whether they are found in the capsule or the sinusoids of the liver. A 
different spatial location of these BM-derived cells could also provide an explanation for why 
they proliferate more than endogenous KC in response to CSF1-Fc. This is in contrast to the 
observation that both embryonic and bone-marrow derived F4/80hi resMf in the peritoneal 
cavity responded equally to CSF1-Fc treatment (Bain et al. 2016). However, this could be 
because there was no additional recruitment of bone-marrow derived cells to the peritoneal 
cavity with CSF1-Fc treatment, so most donor cells would have been in the cavity for longer 
than 4 days, giving time to mature into a true resident phenotype. Alternatively, the lack of 
physical restricted niches in the peritoneal cavity would allow equal access of donor and host 
cells to CSF1-Fc resulting in equivalent proliferation. 
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5.9.4 Do KC become exhausted with age? 
The plateau in proliferation of KC in the steady state between 25 and 33 weeks of age was 
intriguing, and one explanation for this was that prior to the 25-week time point, the liver 
was still growing, requiring a higher rate of KC proliferation to fill the expanding physical 
niche. An alternative explanation was that KC became exhausted over time, and given that 
CSF1-Fc appeared to tightly regulate proliferation of KC, I used CSF1-Fc as a tool to induce 
multiple rounds of enhanced proliferation to try to accelerate any possible exhaustion of KC. 
Although the donor KC-like cells displayed higher levels of proliferation than the host cells 2 
days following the final dose of CSF1-Fc, host KC still proliferated at the basal rate of 1% two 
weeks following the final dose of CSF1-Fc, suggesting that they had not become exhausted. 
The maximum non-host chimerism in the blood of the partial chimeras was around 30% 2 
days following this treatment regime, meaning that it was possible that these proliferating 
host ‘KC’ were those of host monocyte origin. However, even accounting for the recently 
recruited fraction of the host KC population there was still robust and equivalent 
proliferation of the endogenous resident KC after both acute and chronic CSF1-Fc treatment. 
This strongly argues that the endogenous KC population did not become exhausted. Although 
there was a significant reduction in chimerism in the KC population two weeks after the final 
dose of CSF1-Fc, it did not return to PBS control levels, so I was unable to conclude as to 
whether there was a low level of permanent engraftment of donor cells, and a longer 
recovery period would be necessary to determine this. 
5.9.5 Search for liver resident KC progenitor cell 
To examine heterogeneity of proliferation within the KC population I used the H2B-GFP mice 
which have been used previously used by the Jenkins group to determine heterogeneity in 
the proliferative capacity of cells in the peritoneal cavity (Bain et al. 2016). In this system the 
fluorescent GFP tag is progressively diluted as cells proliferate. However, in experiments 
carried out in the Jenkins lab, the rate of loss of the label in the liver KC over 14 weeks under 
steady state conditions was faster than the loss in F4/80hi resMf in the peritoneal cavity, 
despite the basal rate of proliferation of KC being much lower than cavity macrophages in 
our hands (data not shown). These data suggest that proliferation alone could not account 
for the rate of GFP loss in KC over long time frames. However, when I gave CSF1-Fc or IL-4c, 
the rate of loss appeared to roughly mirror the rate of proliferation induced over the short 
time course, providing greater confidence that over short time frames GFP-loss does 
 134 
measure proliferative history of KC. However, no ‘label-retaining’ cells could be identified in 
the F4/80hiCD11blo KC population, nor within any other CD45+ population with either mitogen 
treatment, suggesting that this approach could not reveal any possible cells with progenitor 
potential in the liver. Furthermore, the entire KC population lost GFP uniformly, suggesting 
the population had proliferated equally in response to the mitogen stimuli. However, I 
cannot conclusively say that all KC have an equal ability to proliferate as I could only detect 
a shift in GFP intensity at the population level following induction of proliferation.  
5.9.6 Concluding remarks 
In summary, the data presented in this chapter reveal that the KC niche appears to be well 
protected from replenishment by monocyte-derived macrophages under steady state 
conditions, and that CSF1 availability may be a contributing factor for the maturation of 
monocytes in the liver, but is likely not the only limiting factor preventing their full conversion 
and persistence as resident KC. Furthermore I found no evidence for a quiescent KC 
progenitor in the liver, and although further investigation would be required to confirm this 
my data is entirely consistent with a model whereby rather than the presence of a specific 
tissue progenitor of macrophages, it is the niche that controls the regenerative capacity of 
the KC suggested by recent depletion and repopulation studies (Scott et al. 2016). However, 
the question of how tissue damage and inflammation affect control of the KC niche 
autonomy remains to be determined and will be explored in the next chapter. 
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Chapter 6:  Maintenance of Kupffer Cells and recruitment of 




In the previous chapter I explored the role for CSF1 in maintenance of the KC niche and found 
that addition of exogenous CSF1 was not sufficient to cause permanent engraftment of 
recruited monocyte-derived cells in long-lived, self-renewing KC, indicating that KC ontogeny 
is tightly regulated even with monocyte influx to the liver. It had been shown, however, that 
experimentally-induced depletion of the KC population using whole body irradiation led to 
repopulation through both proliferation of the remaining few radioresistant KC, but also 
significant recruitment of adult monocytes which were able to differentiate into new KC 
(Klein et al. 2007). However, the fate of KC and monocyte-derived macrophages in the more 
clinically relevant context of liver injury had not yet been explored. Liver injury represents a 
serious global health and economic burden (Asrani et al. 2019), and both resident KC and 
monocyte-derived recruited hepatic macrophages are highly implicated in both the injury 
and repair phases of liver disease and damage. In many liver injury and infection models, 
there is a reported ‘macrophage disappearance reaction’ and a loss of KC following injury has 
been reported previously after chronic CCl4-induced injury expressed as relative loss in 
frequency (Ramachandran et al. 2012) or absolute number (Heymann et al. 2015). Similarly, 
a reduction in both the frequency (Zigmond et al. 2014) and total number (David et al. 2016) 
of KC has been demonstrated after acute paracetamol (APAP) overdose in mice. However, 
none of these studies have clearly detailed when or whether the KC population returns back 
to its original absolute size, and none have looked following CCl4-driven acute injury.  
Following injury there is also vast recruitment of monocytes to the liver which mature into 
macrophages. Although initially inflammatory, these macrophages have been shown to 
down-regulate inflammatory genes and acquire a ‘pro-restorative’ phenotype 
(Ramachandran et al. 2012; Dal-Secco et al. 2015). However the dynamics of whether 
recruited macrophages ultimately convert into KC following recovery from injury is poorly 
understood. Following acute paracetamol overdose there was proliferation of the remaining 
endogenous KC, and concurrent recruitment of CX3CR1+ monocyte-derived macrophages at 
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day 3 after injury (Zigmond et al. 2014). Adoptive transfer of GFP+ bone marrow from 
CX3CR1+/GFP mice into wild type mice prior to liver injury indicated that there were no GFP+ 
KC at any time point examined and the authors concluded that monocytes recruited to the 
liver therefore do not contribute to the resident KC population  (Zigmond et al. 2014). 
However, CX3CR1 is not expressed by KC to any high degree, so this was not a robust method 
to track the fate of monocytes to KC. After chronic CCl4-induced fibrotic damage, again the 
depleted KC population was found to replenish through local proliferation, and there was 
some evidence that latex bead-labelled Ly6Clo monocytes in the circulation went on to 
mature into KC 7 days following the cessation of injury (Ramachandran et al. 2012). However, 
bead-labelled monocytes may simply be cleared by KC due to their high phagocytic capacity 
and again is not a robust fate-mapping method. Additionally, the long-term fate of 
monocyte-derived macrophages was not assessed in either study. 
Thus the premise for this chapter was to answer the outstanding question of whether Kupffer 
Cells are replaced long-term by BM-derived macrophages following disturbance due to injury 
and if so, whether the resultant change in KC ontogeny would have long-term implications 
on the function of the population after injury had fully resolved. I used the CCl4-driven model 
of injury as this same hepatotoxic agent can lead to both an acute centrilobular necrosis (Shi 
et al. 1998; Weber et al. 2003), or reversible periportal fibrosis following prolonged exposure 
to low doses (Ramachandran et al. 2012). This had the added advantage of allowing me to 
compare the dynamics of KC maintenance after single versus iterative injury using the same 
injurious toxin. I also combined flow cytometry and immunofluorescent imaging to quantify 
the absolute changes in the number of KC following injury, as this was pertinent to the idea 
of niche availability, which is discussed further at the end of this chapter.  
 
6.2 Analysis of hepatic KC and recruited macrophage populations during 
injury and repair following CCl4-driven acute liver injury 
6.2.1 CCl4-driven acute liver injury drives dynamic changes in the liver myeloid 
compartment  
To assess the effect of acute liver injury on monocyte and macrophage dynamics in the liver, 
CCl4 or olive oil alone was given intra-peritoneally to 8 week old, male C57BL/6 mice and 
livers harvested 24 hours, 3, or 6 days later (fig 6.1A). Liver sections were stained using 
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Periodic Acid Schiff (PAS), a reagent which binds glycogen and stains hepatocytes a deep 
magenta, revealing clear areas representing necrotic damage around the central veins at 24 
hours post injury that largely persisted at day 3 but were resolved by day 6 (fig. 6.1B). This 
confirmed that CCl4 induced acute hepatocyte damage that rapidly resolved within a week, 
consistent with published data using CCl4 at a variety of concentrations (Kovalovich et al. 
2000; Nakamura et al. 2004; Yu et al. 2002).  
To assess the effect of injury on the hepatic myeloid compartment, flow cytometric analysis 
following the gating strategy established in chapter 3 was used. Live, single cells of myeloid 
lineage were identified as CD45+CD31-Dump-. At 24 hours and 3 days after injury there was a 
clear increase in relative abundance of the F4/80loCD11bhi population compared with those 
in olive oil control mice (fig. 6.2A) that corresponded to greater than a 10-fold increase in 
total number (fig. 6.2B). However, this increase was transient, with numbers returning to 
normal by day 6 (fig. 6.2A and 6.2B). I then sub-divided this population further using Ly6C 
and MHCII expression, and identified Ly6Chi monocytes, MHCII+Ly6C- cells which had been 
identified as cDC2s previously in the steady state (chapter 4; Hawley et al. 2018), and an 
emergent population with a Ly6CmidMHCIImid phenotype, which was most apparent at day 3 
(fig 6.2C). Based on these gates, it was clear that the majority of the increase in 
F4/80loCD11bhi cells at 24 hours and 3 days was due to the vast increase in Ly6Chi monocytes 
recruited to the tissue (fig 6.2D), while the cDC2s increased in frequency following recovery 
from the injury (fig. 6.2E). In contrast, the Ly6CmidMHCIImid cells were only elevated at day 3, 
returning to normal at day 6 (fig. 6.2F). Further characterization of these populations 
revealed the transient Ly6CmidMHCIImid cells appeared to express higher levels of F4/80 (fig. 
6.2G, left, blue population) than Ly6Chi or Ly6Clo monocytes or cDC2s. Although these cells 
also appeared to express Tim4 (fig. 6.2G, middle), a Tim4 FMO control sample (data not 
shown) indicated that this was not genuine staining, and could possibly be attributable to 
increased autofluorescence due to increased forward scatter (fig. 6.2G, right) (Tzur et al. 
2011). However, they did appear to express CD64 when compared to an FMO control in a 
pilot experiment (data not shown), which together with their greater size would suggest the 
Ly6CmidMHCIImid cells represent mature CD11bhi macrophages transiently present in the 
injured liver. 
I next turned my attention to the dynamics of the resident KC population. Although a 
reduction in both the frequency and number of KC has been reported after iterative CCl4-
induced injury, this has not been formally demonstrated after only a single dose of CCl4, and 
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neither has any study directly combined both flow cytometry with imaging to directly 
enumerate KC following CCl4-induced acute liver injury. By flow cytometry, there was a 
reduction in frequency of KC at 24 hours and 3 days after acute injury (fig. 6.2A & 6.3A), that 
translated to a reduction in the total number of KC per gram of liver by around 50% at 24 
hours (fig. 6.3B). The loss of KC persisted for at least 3 days post-injury, although this did not 
reach statistical significance likely due to high variance in the data, but numbers had returned 
to pre-injury levels by day 6 (fig 6.3B). To complement the flow cytometry analysis, and to 
ensure that the differences in KC number between olive oil and CCl4-treated mice at 24 hours 
and 3 days were not an artefact of the digestion and staining process, immunofluorescence 
staining for the macrophage marker F4/80 was performed on fixed frozen sections of liver. 
Enumeration of the number of F4/80+ events per field of view at each time point (fig 6.3C) 
indicated ~40% reduction in KC number at both 24h and 3 days following CCl4, which returned 
to olive oil control levels by 6 days after injury (fig 6.3D). Unfortunately this did not reach 
statistical significance likely due to low sample number, but the data clearly mirrors that seen 
with the flow cytometric analysis. KC appeared to be lost specifically from the areas around 
blood vessels which was assumed to be regions of necrotic damage with a dense 
inflammatory infiltrate indicated by dense DAPI staining (Cummings et al. 2004) (fig 6.3C, 
dotted region). By day 6 the necrotic regions appeared to have been largely repopulated, but 
clusters of F4/80+ cells not normally found in uninjured liver were also apparent (fig. 6.3C, 
white arrows). Thus, both flow cytometry and immunofluorescent staining of liver sections 
indicated that approximately half the KC population is lost from the liver by 24 hours after 
injection of CCl4 and numbers do not recover until sometime between day 3 and day 6.  
 
6.2.2 Transient elevated proliferation of KC 3 days post injury 
Murine KC proliferate following acetaminophen overdose (Zigmond et al. 2014) and elevated 
Ki67 expression suggests this also occurs after chronic exposure to CCl4 (Ramachandran et al. 
2012). Thus I assessed proliferation of KC following acute CCl4. As previously, mice were 
pulsed with BrdU prior to necropsy, and proliferating KC defined at each time point as BrdU 
and Ki67 double positive (fig 6.4A). From this point on I have shown only a single olive oil 
control which was taken from the 24 hour time point to represent all olive oil controls. Gates 
were determined using a Ki67 isotype control antibody, and a sample given no DNase 
treatment, preventing access of the anti-BrdU antibody to the BrdU incorporated into the 
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nucleus (fig. 6.4B and 6.4C). Ki67 isotype staining and the no DNase control were carried out 
on both a pool of samples given olive oil and a separate pool given CCl4 to ensure that 
treatment did not affect the baseline of where to set gates. Only the pooled olive oil staining 
controls are shown as there was no difference between olive oil and CCl4. Dynamic changes 
in the rates of KC proliferation across the time course were apparent. There was a peak in 
proliferation at 3 days post-injury (fig 6.4D), in keeping with the notion that proliferation may 
contribute to  maintenance of the population following injury. There was also notable a 
reduction in proliferation at the 24h time point compared its to olive oil control group. This 
suggested that switching off of proliferation may also be a mechanism for controlling the KC 
population size during the acute injury phase. Notably there was fluctuation in the olive oil 
control level of proliferation, indicating that olive oil itself may have an effect on KC 
proliferation rate, though this idea was not explored further within the scope of this project.  
 
6.2.3 The F4/80hiCD11blo KC gate contains a population of bone-marrow derived, 
recruited cells 6 days after injury 
 Although elevated proliferation of KC was evident following injury, I hypothesised that 
monocyte-derived macrophages recruited from bone marrow could also contribute to the 
restoration of KC number by 6 days. Hence, tissue-protected BM chimeras constructed from 
CD45.1+CD45.2+ host mice given CD45.2+ bone marrow were again used to definitively fate 
map cells recruited to the liver from bone marrow following administration of CCl4. Eight 
weeks after irradiation mice were given a single dose of CCl4 or olive oil control (fig 6.5A). To 
confirm injury, serum was analysed for the presence of two acute hepatocyte damage 
markers, alanine aminotransferase (ALT) and aspartate transaminase (AST). Both markers 
were elevated in the serum at 24 hours after injury, indicative of hepatocyte necrosis, but 
had returned to normal by 6 days (fig. 6.5B). I also confirmed that changes in macrophage 
numbers in these mice were consistent with those seen in non-irradiated C57BL/6 mice. By 
flow cytometry, a vast recruitment of F4/80loCD11bhi cells (fig. 6.5C) was again apparent at 
24hrs, as was the reduction in KC number, albeit with high variation within the control group, 
that resolved between 3 and 6 days after injury (fig. 6.5D). F4/80 staining of fresh frozen 
sections was also consistent with that seen in non-irradiated mice, with loss of F4/80+ cells 
in the areas of necrotic damage (fig. 6.6A), that again equated to a 50% reduction in number 
when enumerated in ImageJ (fig. 6.6B). The F4/80 staining, acquisition of images and 
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enumeration in figure 6.6 was carried out by Alíz Owolabi, an honours project student whom 
I co-supervised. The editing of images and statistical analysis of counts was performed by me. 
Chimerism was first assessed in all F4/80loCD11bhi cells, with donor cells identified as CD45.1-
CD45.2+ (fig. 6.7A). Consistent with them being of bone marrow origin, these cells exhibited 
the same degree of chimerism as blood monocytes, translating to ~100% chimerism when 
normalized to the maximum chimerism of Ly6Chi monocytes in blood for each mouse (fig 
6.7B), and this remained consistent across all treatment groups. When donor cells were 
identified in the KC population (fig. 6.7C), a low basal level of chimerism of around 2% was 
evident in the olive oil control group (fig.  6.7C & 6.7D), in keeping with the low levels of bone 
marrow contribution to the KC population in the absence of injury found using this technique 
(Bain et al. 2016). However, with CCl4 treatment, there was a clear contribution from cells 
recruited from bone marrow, which gradually increased over time after injury (fig 6.7C & 
6.7D). The complete time course was performed only once in chimeric mice, but the 
significant contribution of donor cells to the KC population at day 6 post-injury was validated 
a further two times. Mice in these experiments displayed even higher levels of chimerism at 
day 6, with around 25% of the KC population of bone marrow origin (fig 6.7E). These results 
indicated that although acute damage markers, necrosis, and numbers of inflammatory cells 
and KC had returned to baseline by 6 days, the origin of the KC population was a mix of 
endogenous, host cells which are likely largely of embryonic origin, and recently recruited 
cells of adult bone marrow origin, which constituted approximately one fifth to one quarter 
of the population. Thus the ontogeny of the KC population was altered by CCl4-driven acute 
liver injury.  
 
6.2.4 Bone-marrow derived F4/80hiCD11blo cells do not express KC markers Tim4 or 
Clec4f, but do express the macrophage marker CSF1R 
To determine if newly recruited F4/80hiCD11blo cells expressed markers of mature KC I first 
stained cells for additional known markers of mature KC. Assessment of Tim4 expression 
within the F4/80hiCD11blo population in non-chimeric mice revealed an emergent Tim4lo/- 
population that was most pronounced at day 6 (fig. 6.8A). Further investigation at the day 6 
time point in chimeras revealed that almost all donor cells were Tim4lo/-, whilst approximately 
80% host cells were Tim4hi (fig. 6.8 B & 6.8C). The remaining 20% of host cells were Tim4lo 
(fig. 6.8B) and represent the recently recruited BM-derived macrophages of host origin, since 
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these animals only have partial chimerism due to the protected irradiation.  Thus resident KC 
could be defined by their F4/80hiCD11bloTim4hi expression profile whilst recruited cells were 
F4/80hiCD11bloTim4lo. Staining for the KC-specific marker Clec4f (Yang et al. 2013; Lavin et al. 
2014) was also assessed, as its expression can be detected as early as 4 days by monocyte-
derived macrophages recruited to the liver following experimental depletion of KC (Scott et 
al. 2016). Although detection of Clec4f was limited in this experiment, there was there was 
an apparent shift in Clec4f staining within the F4/80hiCD11bloTim4hi  KC compared with to the 
FMO control, whilst the F4/80hiCD11bloTim4lo recruited cells remained largely negative (fig. 
6.8D). Consistent with this, host cells in chimeric mice expressed higher levels of Clec4f at 
day 6 than donor cells (fig. 6.8E). Equally, gating on KC and assessing Tim4 expression in non-
chimeric mice revealed an emergent Tim4lo/- population that was most pronounced at day 6 
(fig. 6.8C). To confirm that the recruited cells were indeed macrophages, CSF1R expression 
at the day 6 time point following acute injury was assessed in a separate experiment using 
csf1r-mApple reporter mice. The F4/80hiCD11bloTim4lo recruited cells expressed high levels 
of the Csf1r, though expression was a half-log lower than in F4/80hiCD11bloTim4hi KC (fig. 
6.8F). Thus the recruited fraction of the F4/80hiCD11blo population represents a mature 
macrophage population which is phenotypically distinct from F4/80hiCD11bloTim4hi KC, and 
will be referred to as  F4/80hiCD11bloTim4lo recruited mf from this point on. In light of the 
knowledge that the F4/80hiCD11blo was a mixed population at the day 6 time point, I re-
evaluated changes in the number of these cells over the time course. Enumeration of the 
F4/80hiCD11bloTim4lo recruited mf by flow cytometry revealed that there were 
approximately 400,000 recruited cells at the day 6 time point (fig. 6.9A). Deducting the 
number of these cells from the total of  F4/80hiCD11blo population allowed me to re-evaluate 
whether the endogenous F4/80hiCD11bloTim4hi KC population had returned to normal size, 
as indicated previously (fig. 6.3). Even with the contribution of the F4/80hiCD11bloTim4lo 
recruited mf removed, there was no significant difference in F4/80hiCD11bloTim4hi KC 
number between CCl4-treated and olive oil controls at day 6 (fig. 6.9B).  
 
6.2.5 Use of Tim4 as a marker of recently recruited F4/80hiCD11blo mf  
Once it became clear that the F4/80hiCD11blo cells of donor origin were Tim4lo, I considered 
the possibility that Tim4 expression could be used as an alternative way to bone marrow 
chimeras of distinguishing resident KC which are largely of embryonic origin from newly 
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recruited F4/80hiCD11blo macrophages of bone marrow origin. When data from control olive 
oil- (chapter 6) or PBS-treated (chapter 5) control mice were pooled, no linear relationship 
was found between the normalised chimerism in the F4/80hiCD11blo population and the 
proportion that were low or negative for Tim4 (r2=0.0824; p=0.2801) (fig. 6.10A). The lack of 
correlation between bone marrow origin and lack of Tim4 expression in control mice may be 
because cells of bone marrow origin recruited to the KC compartment gradually acquire Tim4 
expression over a time period of around a month (Scott et al. 2016), and there is no sudden 
influx of recruited cells in these control mice since they are intended to be close to steady 
state conditions. However, when the same comparison was performed on cells from CCl4 or 
CSF1-Fc treated mice, there was a highly significant positive correlation between normalised 
chimerism and frequency of Tim4lo cells in the population (r2=0.8007; p<0.0001) (fig. 6.10B), 
suggesting that lack of Tim4 expression is a good surrogate marker for identifying cells of 
recent BM (<1 month) origin in the liver.  
 
6.2.6 BM-derived Tim4lo mf are largely spatially distinct from Tim4hi KC  
The finding that Tim4 expression distinguishes endogenous KC from F4/80hiCD11blo 
macrophages recruited to the liver upon injury led me to examine whether Tim4 and F4/80 
co-staining could allow visualization of the location of each population, thereby providing 
insight into possible differences in the function and regulation of these cells. A standard dual 
immunofluorescence staining protocol was trialled in which the staining was carried out in a 
sequential manner. The order of addition of antibodies was a-F4/80 1°, AF594-conjugated 
2°, a-Tim4 1°, AF488-conjugated 2° (fig. 6.11A). Washing steps were included after 
incubation with each antibody, as was an additional blocking step between staining for F4/80 
and Tim4. An initial problem was that both the a-F4/80 and a-Tim4 1° antibodies were raised 
in rat, meaning that the AF488-conjugated 2° bound to both the a-F4/80 1° and a-Tim4 1° 
antibodies resulting in false Tim4 staining even when the a-Tim4 1° antibody was not added 
to the tissue on a control slide (fig. 6.11A & 6.11B). Unfortunately, there was a lack of 
antibodies available which had been raised in an alternative species and use of directly 
conjugated 1° antibodies resulted in no visible staining (data not shown). Development of a 
suitable protocol to circumvent this issue of cross reactivity became the focus of 
undergraduate student’s honours project that I co-supervised. We identified that a goat anti-
rat F(ab) fragment bound to FITC may be a suitable secondary for the Tim4 antibody. The 
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F(ab) fragment is polyclonal and when used at saturating concentrations ensures that no 
available binding sites remain on the a-Tim4 1° antibody. It is also monovalent meaning there 
are no potential exposed binding sites left which can cross react with the goat-a-rat 2° 
antibody intended to detect the F4/80 staining (fig. 6.11C). Note that the order of staining 
was reversed at this point as the Tim4 and F(ab) fragment staining was required to be carried 
out first in order to prevent the cross reactivity. This protocol was successful, and there was 
no staining for F4/80 on the staining control slide where the a-F4/80 1° antibody was not 
added (fig. 6.11D).  
Staining of livers at day 6 post olive oil injection revealed cells within the normal liver 
parenchyma to be both F4/80 and Tim4 double positive, identifying them as KC. Following 
CCl4-driven acute liver injury, double positive cells were still found in the parenchyma, but 
there were clear clusters of F4/80 single positive cells focused around blood vessels (fig. 6.12, 
indicated by white arrows). Whilst there also appeared to be some F4/80+Tim4hi KC within 
the clusters, F4/80+Tim4lo recruited mf were found exclusively within clusters. Images shown 
are from chimeric mice, and are representative of images taken of both chimeric and non-
chimeric livers. Thus, F4/80+Tim4hi KC and F4/80+Tim4lo recruited mf are largely spatially 
distinct following CCl4-driven acute liver injury.  
 
6.2.7 Transcriptional differences between F4/80hiCD11bloTim4hi KC and 
F4/80hiCD11bloTim4lo mf 
Given the fact that the F4/80hiCD11bloTim4lo cells were a transient macrophage population 
that were largely present in the liver during the tissue repair phase, I focused my attention 
on the possible functions of these cells. The ability to use Tim4 as a discriminator between 
true KC and recruited macrophages was an important finding as it allowed me to FACS-sort 
the entire recruited mf population from C57BL/6 mice. This saved time and money in 
comparison to using chimeras, and was superior in that I would only have been able to 
identify a subset of recruited macrophages since the nature of the protected chimera system 
means that recruited macrophages are a mix of donor and host phenotype. The 
transcriptional profiles of F4/80hiCD11bloTim4hi KC and the F4/80hiCD11bloTim4lo recruited mf 
populations were compared using NanoString, a technology akin to microarray but which 
utilises a smaller pre-determined panel of genes. For this purpose, I chose the ‘nCounter 
myeloid innate immunity panel’ (nanostring.com), a panel of 734 macrophage-related genes. 
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F4/80hiCD11bloTim4hi KC and F4/80hiCD11bloTim4lo recruited mf at day 6 post acute CCl4 
injury, and F4/80hiCD11bloTim4hi  KC from control mice receiving olive oil injection were FACS 
purified and post-purity checks confirmed that each population was >95% pure (fig. 6.13A). 
In total between 3.6-6.9ng/µl of RNA was recovered per sample, all of which achieved high 
RNA quality scores (fig. 6.13B), except for sample ‘Tim4hi 4’, which appeared to have very low 
RNA content when assessed by size fractionation. Limited sample volume prevented repeat 
analysis by size fraction, but since this sample appeared to have RNA present when 
quantified by Nanodrop, it was sent for analysis.  The raw data was then normalized to the 
20 house keeping control genes included in the NanoString chip, and fold change and 
significance were determined. Genes with a greater than 2-fold change in gene expression in 
either direction, along with a p-value of greater than 0.05 were considered significant. 
Unadjusted p-values were used as corrections for multiple tests are not recommended by 
NanoString as the assumption of independence between genes does not hold true when 
analysing a pre-selected panel of functionally related genes.  
Comparison of Tim4hi KC in control (olive oil) and CCl4-treated mice revealed very high 
similarity with only 17 genes significantly differentially expressed (fig. 6.14A). In Tim4hi KC 
post injury only a handful of genes were upregulated including Mmp12, Itgax and Anxa1, 
while Nr4a2, an orphan nuclear receptor was strongly enriched in the control KC group (fig. 
6.14A). In contrast, many more and much larger differences in gene expression were 
apparent between Tim4hi KC and Tim4lo recruited mf after injury. In particular Tim4lo 
recruited mf showed very high expression of CX3CR1, CCR2, CCR1, Lat2 and Emp1 compared 
to Tim4hi KC whilst Tim4hi KC expressed very high levels of the scavenger receptor Marco 
compared to the recruited Tim4lo population (fig. 6.14B). Comparison of the top 50 
differentially regulated genes between Tim4hi KC and Tim4lo recruited mf after injury 
revealed a clear gene signature between Tim4hi KC and Tim4lo recruited mf  post injury whilst 
Tim4hi KC post injury closely aligned with the Tim4hi control KC group (fig. 6.14C).  
 
6.2.8 F4/80hiCD11bloTim4lo recruited mf are recruited independently of CCR2 
As high levels of Ccr2 expression were identified in the recruited Tim4- macrophage 
population by the NanoString gene analysis, and given the availability of Ccr2-/- mice in the 
lab, I took advantage of these animals to try to knock down recruitment of these cells 
following injury, in the hope of learning more about their role in injury and resolution. Ccr2-
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/- or C57BL/6 control mice were given a single acute dose of CCl4 or olive oil, and assessed 24 
hours or 6 days later to look at both the acute damage and repair phases (fig. 6.15A). 
Comparison of serum ALT levels showed no significant difference between C57BL/6 and Ccr2-
/- mice (fig. 6.15B). As expected, compared with the large number of Ly6Chi monocytes 
recruited to the livers of C57BL/6 mice at 24 hours, more than 4-fold fewer were observed in 
the liver of Ccr2-/- mice (fig. 6.15C), confirming that there was not a significant recruitment of 
monocytes to the liver via a CCR2-independent mechanism in the context of the injury model. 
In contrast, the disappearance and reappearance of F4/80hiCD11blo cells at 24hr and 6 days 
respectively was equivalent between genotypes (fig. 6.15D), and no difference in the levels 
of proliferation of these cells was detected at either time point between C57BL/6 and Ccr2-/- 
mice (fig. 6.15E). Most surprisingly, it appeared that the Tim4lo macrophages still emerged in 
the liver of Ccr2-/- mice by day 6 post-injury, at an equivalent frequency to that seen in control 
mice (fig. 6.15F). This prevented further use of the Ccr2-/- mice to investigate the function of 
the F4/80hiCD11bloTim4lo recruited mf since they were still present, however it suggested, 
albeit not conclusively, that these recruited macrophages may not arise from classical Ly6Chi, 
CCR2-dependent monocytes.  
 
6.3 Long-term maintenance of KC following acute and chronic CCl4-driven 
liver damage  
6.3.1 Recruited F4/80hiCD11bloTim4lo mf do not persist long-term in the liver 
following acute injury  
Although in the lung alveolar macrophages repopulate through local proliferation following 
influenza infection (Yona et al. 2013), it has been shown in the liver that when KC are 
experimentally depleted, monocytes can replace them, converting into self-renewing KC 
which closely phenocopy the embryonic KC population (Scott et al. 2016). Thus, although 
F4/80hiCD11bloTim4lo recruited mf were spatially distinct from endogenous 
F4/80hiCD11bloTim4hi KC at day 6 following injury, I hypothesised that these newly recruited 
macrophages would become permanently engrafted into the KC population following total 
resolution of injury. I again used the partial chimera system to identify recruited cells within 
the liver at 6 days following acute injury, but this time included an 8 week recovery group 
(fig. 6.16A). As seen previously, there was no difference in the total number of 
F4/80hCD11bloTim4hi KC 6 days following injury, but unexpectedly, there was a small 
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reduction after 8 weeks (fig. 6.16B). This experiment was only performed once as these are 
very long experiments, and I focussed on the long-term recovery from chronic injury detailed 
below. Thus I cannot be sure that there is a biologically significant reduction in KC number 8 
weeks after injury. Chimerism of Ly6Chi monocytes in the blood remained stable in both olive 
oil control and CCl4 treatment groups across the time course (fig. 6.16C).  As previously, there 
was a clear population of F4/80hiCD11blo cells of donor origin at the 6 day time-point, but 
there was no evidence that these cells survived long-term, and chimerism within the total 
F4/80hiCD11blo population was reduced back to basal levels 8 weeks after injury (fig. 6.16D).  
 
6.3.2 Recruited F4/80hiCD11bloTim4lo mf do not persist long-term in the liver 
following chronic CCl4 injury and endogenous KC numbers are permanently 
reduced  
My data supported the conclusion that the endogenous resident KC self-maintained 
independently of recruited mf following an acute injury. I next investigated whether the 
same was true following a chronic liver injury. For this purpose I again used CCl4 to induce 
injury. Similar to my observations following acute injury, it has been shown previously that a 
marked loss of KC is evident in the liver immediately following cessation of CCl4-mediated 
iterative injury followed by a period proliferation and reconstitution over the following 6 days 
(Ramachandran et al. 2012). Hence, tissue-protected bone marrow chimeras were given the 
same dose of CCl4 used in the acute model, but animals received two doses a week for 4 
weeks. Following the final injection, mice were left for either 6 days at which point the 
resulting fibrosis is largely resolved (Ramachandran et al. 2012), or 8 weeks to examine long 
term survival potential of any recruited macrophages (fig. 6.17A). In contrast to the acute 
injury model, the number of F4/80hiCD11blo cells identified by flow-cytometry was reduced 
at the 6 day time point compared to olive oil control, and the numbers did not return to 
normal even after 8 weeks of recovery (fig. 6.17B). The level of chimerism in the 
F4/80hiCD11blo population at 6 days after chronic injury was remarkably similar to that after 
only an acute injury, with approximately 15% of the total F4/80hiCD11blo population of bone 
marrow origin (fig. 6.17C). Despite the chronic nature of the injury, these donor macrophages 
were still unable to engraft permanently into the liver, and chimerism returned back to a 
level which was not significantly different to the olive oil control group at 8 weeks following 
injury (fig. 6.17C). Although it was not statistically significant, the chimerism at 8 weeks did 
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appear slightly elevated compared to olive oil control. However, when the total number of 
F4/80hiCD11bloTim4lo recruited mf was calculated there was a clear increase in number at 6 
days which returned to normal 8 weeks after chronic injury (fig. 6.17D). For completeness, 
the total number of F4/80hiCD11bloTim4hi KC was also calculated, and numbers were indeed 
reduced at day 6, and did not return to normal even by 8 weeks following injury (fig. 6.17E). 
 
6.3.3 Attempted use of csf1r-EGFP ‘MacGreen’ donor bone marrow chimeric mice 
to provide a positive marker for recruited macrophages on immunofluorescent 
liver sections 
To provide a positive marker for recruited mf on immunofluorescent sections, MacGreen 
donor bone marrow was used for the acute experiment in section 6.3.1 and for one of the 
repeat chronic experiments included in section 6.3.2. In particular this would have allowed 
me to visualise the location of any recruited mf at the 8 week time point had they been 
permanently engrafted. The use of a positive marker for the recruited mf would have been 
superior to the F4/80 and Tim4 dual staining protocol since Tim4 was upregulated within one 
month of arrival of donor macrophages into the liver following experimental depletion of the 
embryonic KC population (Scott et al. 2016), and would therefore no longer be a useful 
discriminator between embryonic and recruited KC at 8 weeks following injury. With both 
the acute and the chronic injury models, the same pattern of GFP fluorescence could be 
observed surrounding vessels at the 6 day time point following CCl4 treatment (fig. 6.18A & 
6.18B). However, a chimeric mouse which had received control C57BL/6 donor bone marrow 
followed by chronic CCl4 treatment showed the same pattern of green fluorescence (fig. 
6.18B), indicating autofluorescence rather than genuine detection of EGFP expression. Use 
of a staining protocol in which a tyramide amplification step was added to boost EGFP 
detection did not reveal any additional EGFP staining in these livers, despite the fact that this 
protocol produced clear EGFP staining in a naïve whole MacGreen liver (data not shown). 
The autofluorescence pattern detected in these experiments is highly reminiscent of the 
autofluorescence seen by another group following an 8 week CCl4 treatment (Rantakari et al. 
2016). The authors identified these autofluorescent bodies as ‘ceroid-laden macrophages’. 
Thus this protocol required further optimisation to be able to visualise the EGFP recruited 
cells but unfortunately there was not time for this within my doctoral studies. 
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6.3.4 Identification of recruited mf location following chronic liver injury using Tim4 
and F4/80 double immunofluorescence 
To visualise the spatial location of the F4/80hiCD11bloTim4lo recruited mf following chronic 
injury, I resorted back to the F4/80 and Tim4 double immunofluorescence protocol, where 
recruited mf could be identified as F4/80+ but Tim4- cells. A staining control sample revealed 
autofluorescence in the GFP channel even when the primary Tim4 antibody which is detected 
by the Fab-FITC secondary antibody was not added (fig. 6.19A, yellow arrows), confirming 
what was seen in with the MacGreen donor bone marrow chimeric images above. Thus with 
the fully stained sections, these autofluorescent cells could be identified by their location 
around vessels and because they were extremely bright in the GFP imaging channel (fig. 
6.19B, yellow arrows). However, there were also very clear single positive F4/80+Tim4- 
recruited mf (red), which had typical KC morphology and were scattered within the 
parenchyma (fig. 6.19B, white arrows), in high contrast to the clusters of recruited mf seen 
around vessels following acute injury. This indicated that following chronic injury, the 
F4/80hiCD11bloTim4lo recruited mf may be occupying the same niche as the 
F4/80hiCD11bloTim4hi KC of embryonic origin, yet despite this they did not permanently 
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Figure 6.1 CCl4 drives an acute necrotic liver injury. (A) Male C57Bl/6 mice were given a single dose 
of CCl4 and livers were assessed at 24 hours, 3 days and 6 days after injury. (B) Representative images 





















































































































































































Figure 6.2 Changes in myeloid cell populations over time following acute CCl4. (A) Representative 
flow plots of CD11b versus F4/80 at 24 hours, 3 days and 6 days after acute olive oil control or CCl4. 
Gated live, singlets, CD45+CD31-Lineage-. Gates show F4/80hiCD11blo KC and F4/80loCD11bhi mixed 
myeloid population. (B) Replicate data of total number of F4/80loCD11bhi cells per gram of liver. (C) 
Representative flow plots of Ly6C versus MHCII with gates for Ly6Chi monocytes, cDC2 and a recruited 
macrophage population that emerges at day 3 after injury, gated on live, CD45+CD31-Lineage-
F4/80loCD11bhi cells. (D) Proportion of the total CD45+ leukocyte population represented by Ly6Chi 
monocytes, (E) cDC2 and (F) recruited macrophages at each time point following CCl4 or olive oil 
control. (G) Overlays of Ly6Chi monocytes (green), cDC2 (orange), recruited macrophages (blue) Ly6Clo 
(black) and KC (red) and their expression of CD11b, Tim4 or FSC-A versus F4/80. n=6 per group pooled 
from two independent experiments. Graphs show mean ± SD. *p<0.05 **p<0.01 ***p<0.001 























































































Figure 6.3 Acute loss and recovery of KC following acute CCl4. (A) Frequency of total F4/80hiCD11blo 
KC population expressed as a % of the total CD45+CD31- leukocyte population and (B) total number of 
F4/80hiCD11blo KC per gram of liver at each time point following acute CCl4 or olive oil determined by 
flow cytometry. n=6 per group from 2 experiments, mean ± SD. (C) Representative confocal images of 
cryosectioned livers at each time point following CCl4 and a representative olive oil control stained 
with F4/80 (red) and DAPI (blue). White arrows indicate vessel-associated clusters and dotted region 
indicates area of loss of F4/80bright cells. (D) Quantification of total number of F4/80bright cells per field 
of view (FoV). 10 FoV counted per liver, each point represents the mean for each liver. Graph shows 
mean ± SD for each group. n=3 per group from one of the two experiments shown in A and B. **p<0.01 

























































Figure 6.4 Proliferation of KC following acute CCl4. (A) Representative flow plots showing BrdU+Ki67+ 
double positive cells on gated F4/80hiCD11blo KC and (D) replicate data at each time point after CCl4 
injury and a representative olive oil control. (B) Ki67 antibody isotype control sample and (C) a ‘no 
DNase’ sample as a negative control for BrdU incorporation. n=6 per group from 2 experiments, mean 






















































































Figure 6.5 Liver injury and myeloid cell numbers in protected BM chimeric mice. (A) CD45.1+ CD45.2+ 
host mice were irradiated with the upper body shielded by lead then reconstituted with bone marrow 
from CD45.2+ donor mice. Mice were left for 8 weeks before being given a single dose of CCl4 or olive 
oil control, and livers were assessed 24 hours, 3 and 6 days after injection. (B) serum ALT (left) and 
AST (right) levels. (C) Total number of F4/80loCD11bhi myeloid cells and (D) KC per gram of liver. n=3 
per group from a single experiment, mean ± SD. *p<0.05 ***p<0.001 ****p<0.0001 (multiple t tests 
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Figure 6.6 Changes in KC number in chimeric mice by immunofluorescence. (A) Representative 
confocal images of cryosectioned livers at each time point following CCl4 and an olive oil control 
stained with F4/80 (red) and DAPI (blue). (B) Quantification of total number of F4/80bright cells per field 
of view (FoV). 10 FoV counted per liver, each point represents the mean for each liver. Graph shows 
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Figure 6.7 Emergence of donor BM recruited cells in the KC population. (A) Representative plots of 
CD45.2 vs CD45.1 pre-gated on F4/80loCD11bhi myeloid cells or (C) F4/80hiCD11blo KC at each time 
point after CCl4 injury and a representative olive oil control. Gates show donor cells. (B) Chimerism in 
the F4/80loCD11bhi population or (D) F4/80hiCD11blo KC population normalized to Ly6Chi monocytes in 
blood. n=3 per group from one experiment, mean ± SD. **p<0.01 (multiple t tests with Holm-Sidak 
correction).  (E) Repeat data from subsequent experiments showing KC chimerism at the day 6 time 
point only. n=7 per group pooled from two independent experiments. ***p<0.001 (unpaired t test 
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Figure 6.8 Analysis of Tim4, Clec4f and CSF1R expression in recruited mf. (A) Representative flow 
plots of Tim4 and (D) Clec4f expression pre gated on F4/80hiCD11blo KC. Gates show proportions of 
Tim4+ and Tim4- KC at each time point and a representative olive oil control in non-chimeric C57BL/6 
WT mice. Representative of n=6 per group from 2 experiments. (B) Representative Tim4 expression in 
donor and host KC and respective FMO controls in livers of partial BM chimeric mice at day 6 following 
injury when donor KC are present. (C) % of donor and host KC that were Tim4hi at day 6. Representative 
of n=10 from 3 experiments. (E) Representative Clec4f expression in donor and host KC and respective 
FMO controls in livers of partial BM chimeric mice at day 6 following injury. Representative of n=6 
from 2 experiments. (F) Representative mApple expression by Tim4hi (KC) and Tim4lo (recruited mf) 
F4/80hiCD11blo cells in csf1r-mApple mice and mApple- littermate control at day 6 following injury. 










































Figure 6.9 Changes in numbers of Tim4hi KC and Tim4lo recruited mf following acute CCl4. (A) Total 
number of F4/80hiCD11bloTim4lo recruited mf and (B) F4/80hiCD11bloTim4lo KC per gram of liver 
following acute CCl4 or olive oil control. NB these are more detailed analysis of cell number from the 
same experiments shown in fig. 6.6 in light of the finding that a proportion of the presumed ‘KC’ was 
a recruited mf with a distinct phenotype from KC. n=6 per group from two experiments, mean ± SD. 
























































Figure 6.10 Tim4 as a marker of recent bone marrow origin. (A) Linear regression plot of % Tim4lo of 
F4/80hiCD11blo cells versus normalized chimerism of F4/80hiCD11blo cells in partial BM chimeras used 
as controls across multiple experiments (ie given PBS s.c. or olive oil i.p.) R2=0.08204, p=0.2801. n=19 
pooled from 6 experiments. (B) Linear regression plot as in A but for partial BM chimeras given 
‘treatment’ (ie CSF1-Fc s.c. or CCl4 i.p.). R2=0.8007, p<0.0001. n=23 from 6 experiments.  
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Figure 6.11 Development of F4/80 and Tim4 dual immunofluorescence staining protocol. (A) 
Schematic for primary and secondary antibodies used in pilot staining protocol and order of addition 
of antibodies. Cross reactivity can occur when the anti-Tim4 primary antibody is omitted between the 
fluorophore-conjugated secondary and the anti-F4/80 primary antibody (B) No Tim4 primary antibody 
staining control slide which indicates non-specific cross reactivity between the secondary antibody 
intended to detect Tim4 with the F4/80 primary antibody. (C) Schematic for revised protocol using Fab 
fragment secondary to saturate all possible binding sites on the primary antibody, to prevent cross 
reactivity. In this case note that the order of staining has been reversed from A, ie staining for Tim4 
was carried out before staining for F4/80. (D) No F4/80 primary antibody staining control indicating 
that the Fab fragment successfully prevented any binding of the secondary intended to detect F4/80 
with the Tim4 primary antibody. The staining and acquisition of images was performed by Aliz Owolabi 
and these images were presented within her undergraduate dissertation. However, the figure shown 







































Figure 6.12 Tim4 and F4/80 staining of acute CCl4 injured livers. Representative confocal images of 
livers stained with DAPI (blue), Tim4 (green) and F4/80 (red) in an olive oil and CCl4 treated mouse 6 
days post acute injury. Arrows indicate clusters of F4/80+Tim4- recruited mf. Images representative of 
n=9 per group (a mix of C57BL/6 and chimeric mice) from 3 independent experiments.  
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Gated DAPI-à singlets à CD45+CD31- à F4/80+CD11b-A
Sample RNA conc. 
(ng/μl)
Total RNA  
(ng)
RNA quality score
Tim4lo 1 3.883 46.596 9.9
Tim4lo 2 3.662 43.944 9.5
Tim4lo 3 6.708 80.496 9.6
Tim4lo 4 6.470 77.640 9.0
Tim4hi 1 5.928 71.136 7.2
Tim4hi 2 6.060 72.720 8.1
Tim4hi 3 5.648 67.776 8.3
Tim4hi 4 0.087 1.044 NA
Tim4hi control 1 6.815 81.780 9.1
Tim4hi control 2 6.630 79.560 8.8
Tim4hi control 3 5.388 64.656 8.8

























Figure 6.13 FACS sort and RNA extraction for NanoString gene comparison analysis. (A) 
Representative post-sort purity flow plots of F4/80hiCD11bloTim4lo recruited mf and Tim4hi KC after 
acute CCl4 injury and Tim4hi control KC after olive oil injection, and Tim4 FMO control sample. (B) 
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Figure 6.14 NanoString gene comparison analysis 6 days after acute CCl4. (A) Volcano plot of log2 fold 
change versus p-value for expression of all 754 genes in control Tim4hi KC and Tim4hi KC and (B) in 
Tim4hi KC and Tim4lo recruited mf after injury. (C) Heat map of 50 most differentially expressed genes 
with fold change >2 and p<0.05 determined by t tests between Tim4hi KC and Tim4lo recruited mf, and 
expression in Tim4hi control samples for comparison. n=4 per group from a single experiment. 
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Figure 6.15 Acute CCl4 injury in Ccr2-/- mice. (A) Age and sex-matched C57BL/6J Crl and Ccr2-/- mice 
were given olive oil or CCl4 and were analysed 24h and 6 days later. (B) Serum ALT. (C) Frequency of 
Ly6Chi monocytes and (D) bulk F4/80hiCD11blo as a proportion of CD45+ leukocytes. n=4-10 pooled 
from 3 independent experiments. (E) Percentage of bulk F4/80hiCD11blo which were BrdU+Ki67+ 
double positive. (F) Representative flow plots of Tim4 versus F4/80 in each group after CCl4 treatment 
at day 6 post injury and (G) replicate data of percentage of KC which were Tim4lo. n=3-6 pooled from 
2 of the 3 experiments, as in repeat 3 BrdU and Ki67 staining was performed but samples were spilled 
prior to acquisition, and in repeat 2 Tim4 staining was performed but frequency that were Tim4lo was 
extremely low across all groups at day 6 compared to all other experiments performed in this chapter 
and were therefore excluded from analysis. Graphs show mean ± SD. **p<0.01 ***p<0.001 

























































































Figure 6.16 Effect of acute CCl4 on long term maintenance of KC. (A) CD45.1+CD45.2+ host mice were 
irradiated with the upper body shielded by lead then reconstituted with EGFP+ bone marrow from 
MacGreen donor mice. Mice were left for 8 weeks before being given a single dose of CCl4 or olive oil 
control, and livers were assessed 6 days or 8 weeks later. (B) Total number of F4/80hiCD11blo cells per 
gram of liver. (C) Ly6Chi blood monocyte chimerism in all mice before and after olive oil and CCl4. (D) 
Chimerism in the F4/80hiCD11blo population normalized to chimerism in Ly6Chi blood monocytes. n=3 
per group from a single experiment, mean ± SD. **p<0.01 (multiple t test with Holm-Sidak correction), 
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Figure 6.17 Effect of chronic CCl4 on long term maintenance of KC. (A) CD45.1+CD45.2+ host mice 
were irradiated with the upper body shielded by lead then reconstituted with EGFP+ bone marrow 
from MacGreen or CD45.2+ donor mice. Mice were left for 8 weeks before being given CCl4 or olive oil 
control twice a week for 4 weeks, and livers were assessed 6 days or 8 weeks following the final dose. 
(B) Total number of F4/80hiCD11blo cells per gram of liver. (C) Chimerism in the F4/80hiCD11blo 
population normalized to chimerism in blood Ly6Chi monocytes. (D) Total number of F4/80hiCD11blo 
recruited mf calculated by normalising the number of donor cells in the F4/80hiCD11blo to the 
maximum chimerism in Ly6Chi monocytes in blood. (E) Total number of F4/80hiCD11blo host 
macrophages calculated by subtracting the number of recruited mf shown in D from the total number 
shown in A . n= 9-12 per group pooled from 3 independent experiments, mean± SD *p<0.05 **p<0.01 
***p<0.001 ****p<0.0001 (multiple t test with Holm-Sidak correction).  
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Figure 6.18 Unsuccessful imaging of GFP fluorescence in MacGreen donor BM chimeras. (A) 
Representative confocal images of liver stained with DAPI (blue), F4/80 (red) and endogenous EGFP 
fluorescence (green) in olive oil and CCl4 treated mice 6 days post acute and (B) chronic injury. 
Representative of n=3 per group. Also (B), fluorescence in the GFP imaging channel in a control mouse 
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Figure 6.19 Tim4 and F4/80 staining of chronic CCl4 injured livers. (A) No Tim4 primary antibody 
staining control slide. (B) Representative confocal images of liver stained with DAPI (blue), Tim4 
(green) and F4/80 (red) and a merged image 6 days post chronic CCl4-driven injury. Yellow arrows 
indicate autofluorescence in the GFP imaging channel and white arrows indicate genuine F4/80+ Tim4- 




In this chapter I have shown that a reduction in the number of KC in the liver following both 
acute and chronic injury does not lead to their replenishment by monocyte-derived 
macrophages. Proliferation, at least in the acute setting may account for their return to 
normal numbers, but following chronic injury, KC number was permanently reduced. I have 
identified a population of recruited cells present at 6 days after acute and chronic injury 
which acquired an F4/80hiCD11blo phenotype but did not express the KC markers Tim4 or 
Clec4f. These cells were short-lived in the liver, and did not convert into self-renewing KC. 
These recruited macrophages were spatially distinct from F4/80hiCD11bloTim4hi KC following 
acute injury, but this was less obvious following chronic injury. The recruited macrophages 
clustered around vessels during the repair phase following acute injury, and expressed genes 
associated with cell adhesion, cytokine, chemokine and growth factor signalling and ECM 
remodelling, suggestive of a role in tissue repair and resolution of injury.  
 
6.4.1 Reduction in KC number following acute injury 
Through a combination of flow cytometric and imaging techniques I was able to show that 
there was a ~50% reduction in total KC numbers by 24 hours after a single dose of CCl4. The 
loss of F4/80+ cells on immunofluorescent liver sections mirrors the loss seen previously 
following APAP-driven injury (Dambach et al. 2002). In their study, Dambach et al. argue that 
activated KC down-regulate F4/80 which may explain why they appeared to be reduced in 
number on liver sections (Dambach et al. 2002). However, in my study I also stained liver 
sections for Tim4 and although I did not quantify the loss of Tim4+ cells on sections, there 
also appeared to be loss of Tim4 staining in the necrotic areas. By flow cytometry, the total 
number of KC defined as F4/80hiCD11bloTim4hi was also reduced by around 50%, and in 
chimeras there was no ‘appearance’ of an F4/80lo macrophage population of largely host 
origin which would account for the embryonic KC population having simply down regulated 
F4/80. Thus it appears most likely that following CCl4-driven acute liver injury KC are lost from 
the liver, which is in agreement with data from other studies which demonstrated a loss in 
frequency of KC following APAP-driven acute liver injury (Holt et al. 2008; Zigmond et al. 
2014; Mossanen et al. 2016).  It is unclear where these ‘disappearing’ cells go. One possibility 
is that those are in the vicinity of the liver damage simply die in situ through necrosis as 
collateral damage. In support of this idea, staining of liver sections using PAS revealed areas 
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of necrosis surrounding blood vessels, and there was also loss of F4/80+ cells surrounding 
vessels at 24 hours post injury, which appeared to be the necrotic areas as there was a dense 
cloud of DAPI staining in these regions. Additional staining with propidium iodide would 
confirm definitively that loss of F4/80+ cells was in the necrotic area. Additionally, KC may die 
through apoptosis, and I cannot rule out the possibility that F4/80+ cells were not also lost in 
areas where there was no necrotic damage without more sophisticated analysis, for example 
using caspase 3 staining to assess apoptosis (Porter et al. 1998). Alternatively, loss of F4/80+ 
cells could be due to their migration out of the liver, rather than cell death. Indeed,  alveolar 
macrophages have been shown to migrate from the lung to the draining lymph node 
following bacterial infection (Kirby et al. 2009). Thus rather than being simply collateral 
damage, the ‘disappearance’ of KC through apoptosis or migration might serve to trigger the 
initial immune response, either through local release of immune factors in the liver or by 
carrying antigen to lymph nodes. 
It was evident that the KC population returned to steady state size by 6 days after an acute 
CCl4 injury. A small spike in proliferation of KC at day 3 that occurred before emergence of 
the F4/80hiCD11bloTim4lo recruited mf, suggests the remaining 50% of KC of embryonic 
lineage underwent self-renewal to restore the population. However, the level of proliferation 
detected in KC at day 3 following injury appeared relatively minor. It is possible that I missed 
the peak of elevated proliferation with the chosen time points. It is also notable that the level 
of KC proliferation also fluctuated in the olive oil control mice across the time course, despite 
the fact that all mice were given BrdU on the same day, and livers were harvested, stained 
and run through the flow cytometer on the same end point day. Low endotoxin olive oil was 
used for injections, but there may have been some low level of inflammation induced by the 
olive oil or the intra peritoneal injection itself, and a completely naïve group of mice would 
have been a useful additional control for these experiments. Unfortunately constraints on 
the number of livers that it was possible to process for flow cytometry in a single day whilst 
ensuring high quality data meant this was not possible. Overall, I would still conclude that it 
is likely that elevated proliferation of KC contributes to their return to normal population size 
as this is in keeping with findings that KC underwent elevated proliferation following APAP-
driven acute liver injury (Zigmond et al. 2014), and following KC loss using a diphtheria toxin 
depletion model (Scott et al. 2016).  
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6.4.2 Emergence of F4/80hiCD11bloTim4lo recruited mf following acute liver injury 
In addition to evidence of elevated local proliferation, chimeras revealed that 10-30% of the 
F4/80hiCD11blo population was of recruited, bone marrow origin at day 6. There was a high 
level of variance within the CCl4 treatment group which may be a reflection of level of injury 
achieved in each individual mouse, despite the fact that CCl4 was weight dosed and mice 
were age and sex matched. However, in each separate experiment there was an increase in 
chimerism in the CCl4 treated group compared to the olive oil control group. Unlike host KC, 
the donor F4/80hiCD11blo mf were not positive for either Tim4, or the KC-specific marker 
Clec4f, although overall, detection of Clec4f was admittedly poor. One possibility was that 
that 6 days was insufficient time for expression of these KC markers to occur in these cells. 
In a recent study, monocytes were shown to be recruited to the liver and replenish the KC 
population following depletion via diphtheria toxin, and in this scenario, there was a delay of 
at least one month in the expression of Tim4 by the recruited cells (Scott et al. 2016). 
However, there was no such delay in expression of Clec4f, which is not in keeping with our 
finding that at 6 days the donor cells did not express this marker. Furthermore, when a group 
of mice were left for 8 weeks to recover from acute injury, the donor population was no 
longer apparent within the F4/80hiCD11blo cells, showing that it was not simply a matter of 
allowing the recruited cells observed at day 6 more time to differentiate and acquire full KC 
phenotype. Thus the monocyte-derived recruited mf present at day 6 did not appear to be 
macrophages in the process of maturing into self-renewing KC. This suggested that the 
monocytes being recruited into the inflammatory environment of the injured liver were 
following an alternative pathway of differentiation to that observed in more steady state 
conditions by Scott et al., and indicated that the recruited mf served a specific purpose 
within the injury or repair process. Although the presence of recruited macrophages which 
are phenotypically distinct from resident KC has been demonstrated previously following 
acute or chronic liver injury (Ramachandran et al. 2012; Zigmond et al. 2014; Dal-Secco et al. 
2015), these have been assumed to be very transient and were not observed in the liver by 
7 or 5 days following injury respectively (Ramachandran et al. 2012; Zigmond et al. 2014). 
Since the recruited mf identified in my study - using the definitive fate mapping system of 
chimeric mice - express the classic F4/80hiCD11blo profile typically used to define KC, they 
would have been missed in these previous studies or assumed to be bona fide KC.  
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6.4.3 Spatial location of recruited mf following acute injury  
As discussed in chapter 5, an additional population of macrophages has recently been 
described in the liver. Termed ‘capsular macrophages’, these cells have been identified as 
CX3CR1+ cells which are more rapidly turned over from CCR2+ monocytes than resident KC 
(Sierro et al. 2017). Thus, using flow cytometry data alone, I could not rule out the possibility 
that the F4/80hiCD11bloTim4lo recruited mf were not capsular macrophages, which had 
increased in number through additional recruitment of monocytes or through local 
proliferation, since capsular macrophages are replenished from bone marrow even in steady 
state and would therefore be of donor origin prior to injury (Sierro et al. 2017). The most 
robust way to identify the recruited mf in liver sections would have been with a positive 
marker to uniquely distinguish them from embryonic KC. To provide this, I used MacGreen 
donor bone marrow in some chimera experiments for both acute and chronic liver damage 
experiments. Unfortunately I was unable to successfully detect true EGFP signal, and instead 
saw very autofluorescent cells in the GFP imaging channel, the pattern of which was akin to 
the autofluorescent ‘ceroid-laden macrophages’ described elsewhere (Rantakari et al. 2016). 
This autofluorescence was present in BL/6 donor bone marrow staining control mice, and 
adjusting of acquisition settings on the confocal microscope was unable to remove the 
autofluorescent signal from detection. Trial staining of sections with a tyramide step to 
enhance EGFP signal did not reveal any additional EGFP staining compared to naïve EGFP 
fluorescence, though further optimisation of the protocol may have been necessary to detect 
EGFP. Although using a lack of marker to identify the recruited mf is arguably less robust, 
staining of liver sections for Tim4 and F4/80, allowed the clear identification of F4/80+Tim4- 
recruited mf at day 6 following injury. This revealed a peri-vascular location of at least a 
significant number of these recruited cells, arguing that they are intra-hepatic macrophages 
and not capsular macrophages. However, new markers may be required in future to 
adequately distinguish capsular macrophages from intrahepatic bone marrow-derived 
macrophages recruited during injury.   
The F4/80+Tim4- mf were seen in clusters surrounding blood vessels after acute injury which 
was in stark contrast to the sinusoidal location of F4/80+Tim4+ KC revealed through 
immunofluorescence. The presence of macrophages in a ring-like structure around the area 
of injury is not a novel finding (Mori et al. 2009; Dal-Secco et al. 2015; Triantafyllou et al. 
2018). Thus it is likely in the acute CCl4 model the F4/80+Tim4- mf  are clustered around the 
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central vein, which would indicate that they may play a role in repair and remodelling of the 
necrotic damage that occurs in this area. PanCK staining could be used to identify the portal 
tract since it stains hepatic progenitor cells found in this region (Lu et al. 2015), and thus its 
absence would reveal central veins, and would be a useful stain to add to future analysis. 
 
6.4.4 NanoString gene expression analysis 
To further elucidate possible roles for the F4/80hiCD11bloTim4lo mf I used Tim4 as a 
discriminator to allow me to FACS sort the embryonic F4/80hiCD11bloTim4hi KC and 
F4/80hiCD11bloTim4lo recruited mf. I was then able to use NanoString technology to compare 
gene expression between the two populations. F4/80hiCD11bloTim4hi KC in olive oil control 
mice and following CCl4-driven acute liver injury closely aligned, suggesting that the role of 
KC in injury is not differ dramatically from their role in steady state. Admittedly, only 732 
genes were studied, and assessment of the whole genome using RNAseq may reveal more 
differences. However, KC were also shown to be highly similar pre and post APAP-driven 
acute liver injury (Zigmond et al. 2014). There were many differences between the Tim4hi KC 
population and the Tim4lo recruited mf population following injury. Of note, KC expressed 
higher levels of scavenger receptors including MARCO, which is important for clearance of 
bacteria in the liver (van der Laan et al. 1999). However, most of the significant differences 
were genes enriched in the Tim4lo mf population. They expressed high levels of the 
chemokine receptors Cx3cr1, Ccr2 and Ccr1, in line with being migratory cells recently 
derived from blood monocytes. Co-expression of CCR2 and CX3CR1 was shown on wound 
associated macrophages in a sterile sponge wound model (Crane et al. 2014), and in a liver 
burn injury model (Dal-Secco et al. 2015). This suggested that the Tim4lo recruited mf were 
indeed associated with the wound site, as the Tim4 and F4/80 immunofluorescence imaging 
had indicated. The Tim4lo recruited mf present at day 6 following CCl4 were closely aligned 
to the CX3CR1+ recruited mf present at day 3 following APAP overdose which the authors 
described as having a ‘prorestorative genetic signature’ (Zigmond et al. 2014). In the study 
by Zigmond et al., the recruited cells expressed high levels of metallomatrix proteinases, a 
group of zinc-dependent enzymes with the ability to degrade extra cellular matrix (Nagase et 
al. 2006). Likewise, the Tim4lo recruited mf in my study expressed high levels of MMP8 which 
preferentially degrades type 1 collagen (Siller-Lopez et al. 2004). In a rat model of CCl4-
induced liver fibrosis, its over-expression was shown to reduce fibrosis, and the authors 
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suggest that it is critical for degradation of ECM in the necrotic area to allow efficient tissue 
remodelling and hepatocyte expansion (Siller-Lopez et al. 2004). The Tim4lo recruited mf also 
expressed Osm and OSMR-/- mice displayed impaired liver regeneration following high dose 
acute CCl4, in part through reduced hepatocyte proliferation (Nakamura et al. 2004). OSM 
was found to act down stream of IL-6 signalling (Nakamura et al. 2004), and Il6 was highly 
enriched in Tim4hi KC in my study, indicating that KC may contribute to activating the tissue 
repair phenotype of the Tim4lo mf. The Tim4lo mf were also enriched for Anxa1 and Havcr2 
which encodes TIM3, both of which reduced production of ROS and dampened inflammation 
in a mouse model of non-alcoholic steatohepatitis, a chronic liver disease (Du et al. 2018; 
Locatelli et al. 2014). Thus the Tim4lo mf appear to have  a pro-restorative phenotype and 
likely contribute to tissue repair in the area of necrosis. Liver regeneration is associated with 
proliferation of hepatocytes, and peak hepatocyte proliferation was seen at only 36 hours 
after partial hepatectomy (Goh et al. 2013). Thus it is perhaps unexpected that the Tim4lo 
mf, which arrived between day 3 and day 6 expressed genes associated with hepatocyte 
proliferation such as Osm. However, they may have been recruited to the tissue earlier than 
day 3, and the transient macrophage population identified at day 3 likely represent the 
intermediate phenotype between Ly6Chi monocytes recruited to the liver and the Tim4lo mf. 
Indeed, there is experimental evidence to suggest that pro-wound healing mf which 
promote tissue formation through secretion of growth factors later differentiate into pro-
resolving mf which help to remodel ECM (Crane et al. 2014; Hesketh et al. 2017). Thus the 
phenotype of the recruited mf likely changes throughout the course of the injury and repair 
phases in response to local signals. Inclusion of the Ly6Chi monocytes at an early time point, 
along with the transient macrophages at day 3 into the Nanostring analysis may have 
revealed their developmental relationship, and could explain expression of genes associated 
with the earlier wound healing phase.   
 
6.4.5 Ccr2-/- experiment 
The emergence of monocyte-derived macrophages in this study provoked the question of 
whether they were derived from classical Ly6ChiCCR2+ monocytes, non-classical Ly6CloCCR2- 
or possibly an intermediate phenotype. During liver injury classical, inflammatory monocytes 
are recruited to the liver and express high levels of pro-inflammatory cytokines including 
TNF-α and IL-6 (Triantafyllou et al., 2018). In APAP-induced acute liver injury this recruitment 
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was shown to be CCR2-dependent, upon which they were found to contribute to resolution 
of injury (Holt et al., 2009). Similarly, in chronic CCl4-induced liver injury, classical monocytes 
were found to downregulate Ly6C and become pro-restorative (Ramachandran et al., 2012). 
This phenotypic switch of inflammatory monocytes to an anti-inflammatory, pro-restorative 
phenotype was elegantly demonstrated by directly visualising their conversion from 
CCR2+CX3CR1+ cells labelled with RFP to CCR2-CX3CR1+ GFP+ cells, along with intermediate 
orange and yellow cells which were dual positive for both CCR2 and CX3CR1 (Dal Secco et al., 
2015). IL-10, IL-4 and clearance of necrotic material all contributed to triggering this 
phenotypic switch. The CX3CL1-CX3CR1 axis appears to be crucial for this phenotypic switch, 
as recruited monocytes in CX3CR1-/- mice do not effectively convert and remain 
inappropriately pro-inflammatory resulting in prolonged liver inflammation (Karlmark et al., 
2009). Thus, rather than sequential recruitment of inflammatory- followed by reparatory- 
monocytes from blood, differentiation of classical monocytes in situ appears to be necessary 
for the process of injury followed by repair. A similar differentiation process appears to be 
necessary in humans. CD14+CD16- classical monocytes have been demonstrated to switch 
towards the intermediate CD14+CD16+ phenotype in response to TGF-β and IL-10 (Liaskon et 
al., 2012). These intermediate cells were pro-inflammatory and may contribute to ongoing 
hepatic fibrosis in humans with chronic liver injury (Liaskon et al., 2012). Interestingly, 
CX3CR1 is downregulated in patients with cirrhosis, compared to healthy volunteers, 
indicating that for resolution of liver disease the phenotypic switch to a CX3CR1+ non-
classical, pro-restorative monocyte may be dis-regulated (Karlmark et al., 2009).  
Given the high levels of expression of Ccr2 on the F4/80hiCD11bloTim4lo recruited mf 
compared to the F4/80hiCD11bloTim4hi KC, and the dependence of monocyte-derived 
macrophages on Ccr2 for recruitment following acetaminophen overdose (Zigmond et al. 
2014), Ccr2-/- mice were used to try to prevent their recruitment to the liver following injury, 
to give insight into their function. Ccr2-/- mice showed no difference in injury compared to 
WT controls as serum ALT levels were equivalent. The extent of loss of F4/80hiCD11blo cells 
was also equivalent between Ccr2-/- and WT, and most surprisingly, the F4/80hiCD11bloTim4lo 
population was recruited to the liver in the same abundance as in WT control mice. It is 
therefore possible that despite the high levels of Ccr2 expression in the NanoString data, 
Ly6Chi monocytes are not the precursor of the F4/80hiCD11bloTim4lo recruited mf population. 
An alternative precursor might be Ly6Clo monocytes, and this hypothesis would be in keeping 
with previously published data in which latex bead-labelled Ly6Clo monocytes in circulation 
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were later found in the F4/80hiCD11blo KC population 7 days into the resolution phase 
following chronic CCl4-induced injury (Ramachandran et al. 2012). It has been shown that 
deletion of a specific enhancer region in the Nr4a1 gene, which is specific and critical to Ly6Clo 
monocyte survival (Hanna et al. 2011), can be used to deplete Ly6Clo monocytes whilst 
leaving the rest of the mononuclear phagocyte system intact (Thomas et al. 2016). Delivery 
of CCl4 to these mice would allow me to test whether Ly6Clo monocytes are the precursor to 
the F4/80hiTim4lo population that arises in our model. However, given the high degree of Ccr2 
expression in F4/80hiCD11bloTim4lo recruited mf, the fact that Ccr2 is a gene which is 
switched off in Ly6Clo monocytes (Yamasaki et al. 2012), and the fact that monocytes were 
only reduced 4-fold in the blood of the Ccr2-/- mice used in this experiment, it seems more 
likely that some recruited Ly6Chi monocytes remain able to enter the injured liver in Ccr2-/- 
mice and become F4/80hiCD11bloTim4lo cells. Perhaps the small number of monocytes which 
do make it into the liver are able to proliferate to increase numbers, and a time point 
between 24 hours and 6 days would have been required to determine this. If Ly6Chi 
monocytes are indeed the precursor of F4/80hiCD11bloTim4lo recruited mf, their transient 
depletion at day 6 when the liver has regenerated could be possible using anti-CCR2 
strategies to further explore their function. Such experiments would have the added benefit 
of allowing initial recruitment of monocytes to occur unimpaired, thereby revealing what 
functions may be specific to the  mature population of F4/80hiCD11bloTim4lo recruited mf. 
 
6.4.6 Long-term fate of KC following acute or chronic injury 
Whether resident macrophages rely on monocyte replenishment is highly tissue specific, 
leading to much interest into the factors that determine whether monocytes can convert to 
long-lived resident macrophages, or whether resident macrophages survive independently 
of monocytes through proliferation or longevity. Thus in this chapter I ultimately set out to 
determine whether KC, which are relatively autonomous from monocytes in the steady state 
required monocyte replenishment in the context of liver injury. However, the 
F4/80hiCD11bloTim4lo recruited mf did not permanently contribute to the KC population, 
following either acute or chronic injury, which is consistent with another study published 
towards the end of this study in which monocyte-derived macrophages recruited to the liver 
were tracked using robust fate mapping approaches following non-alcoholic fatty liver 
disease (NAFLD), and found to be only short lived (Devisscher et al. 2017). Ablation of the KC 
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population by irradiation or by Clec4f-specific deletion using diphtheria toxin has provided 
proof of principle that when there is an experimentally empty niche space in the liver, 
monocyte-derived cells can differentiate into KC, permanently engraft in the liver, and go on 
to proliferate in the steady state, with no further requirement for monocyte recruitment  
(Klein et al. 2007; Scott et al. 2016; Beattie et al. 2016). These studies are in keeping with the 
idea that an empty niche is required for monocyte conversion to KC (Guilliams and Scott 
2017). Accordingly, Devisscher et al. did not observe a loss of KC during NASH, and did not 
see monocyte contribution to KC (Devisscher et al. 2017). In contrast, my data suggest that 
despite a 50% loss in KC following injury, the KC niche remains highly regulated and protected 
from monocytes in the context of CCl4-driven liver injury and repair. It is possible that the 
recruited macrophages may not have sufficient access to survival factors such as CSF1, 
although experiments detailed in chapter 5 argue against CSF1 availability being the sole 
limiting factor in monocyte to KC conversion. Alternatively, one hypothesis is that the 
recruited macrophages do not receive the correct local, possibly even physical, signals to 
become KC. In the acute model, the fact that F4/80hiCD11bloTim4lo recruited mf are spatially 
distinct from F4/80hiCD11bloTim4hi KC seems to support this hypothesis. In a sterile wound 
model, pro-inflammatory Ly6Chi monocytes were shown to be recruited to the wound site 
where they became Ly6Clo macrophages and matured into pro-restorative macrophages 
(Crane et al. 2014). This switch to a wound healing macrophage was driven by IL-10 and IL-4 
within the local environment in a small, sterile burn wound to the liver, and the macrophages 
were found to encircle and then enter the wound upon maturation (Dal-Secco et al. 2015).  
Thus monocytes recruited to the liver in the context of tissue injury and repair following 
acute CCl4-driven damage may be diverted down a pathway towards a pro-restorative 
phenotype due to the local signals they receive, and are physically diverted from the KC 
niche. In the mean-time, it would appear that the remaining KC are able to proliferate to 
restore numbers. Once tissue repair is complete and KC numbers have been restored, the 
recruited macrophages may die out simply because the KC niche space has been filled.  
In the chronic model, it is less clear that there is any spatial distinction between recruited mf 
and KC. However, following chronic CCl4 delivery, the total number of KC did not fully recover, 
even 8 weeks after cessation of injury. Perhaps the niche space vacated by KC becomes 
somehow uninhabitable long-term following injury, such that monocytes cannot 
permanently engraft into self-renewing KC, and nor can remaining KC self-renew and the 
total population size is diminished. It would be important to leave mice for a much longer 
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recovery time than 8 weeks to confirm that KC population is permanently reduced in size, 
however. Long-term loss of KC may have serious clinical relevance since it would be expected 
to impact on the homeostatic function of the liver, and may have wide-spread implications 
in terms of inappropriate immune responses since KC are thought to maintain peripheral 
tolerance (Heymann et al. 2015).  
 
6.4.7 Concluding remarks 
My data indicate that in both acute and chronic injury settings, the embryonic origin of liver 
KC is highly ‘protected’ and monocyte-derived macrophages which are recruited to the liver 
following injury do not convert into long-lived KC, and are instead diverted to mature into 
short-lived macrophages which in the acute setting may be involved in tissue repair. KC were 
transiently reduced in number following acute injury and appeared permanently (over 8 
weeks) depleted following chronic injury. Thus although KC appeared to have vacated their 
niche, the fact that monocytes were unable to replenish them in the context of injury and 
repair raises further questions about whether injury renders the niche unavailable, and/or 
drives monocytes down an alternative path of differentiation from which they are unable to 
later convert into long-lived KC. 
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Chapter 7:  Final discussion 
 
7.1 Summary 
This thesis had two major aims: to investigate the role of CSF1 in KC maintenance and 
conversion of monocyte to KC, and to determine whether the KC population is replenished 
by monocytes following acute and/or chronic liver injury, and if so, what effect this may have 
on subsequent KC function.  
Before exploring these aims, in chapter 3 I established the most suitable protocol for the 
isolation and identification of KC from digested livers for flow cytometry, as this was to be 
the major mode of analysis in this project. A more comprehensive breakdown of myeloid cell 
populations using Csf1r transgene expression and additional cell surface markers in 
combination with reliance on CCR2 was used to identify KC, monocytes and DCs in the liver. 
A second population of liver macrophages, in addition to subcapsular macrophages identified 
by another group (Sierro et al. 2017), could not be identified.   
Chapters 4 and 5 addressed the first major aim. In chapter 4, KC were found to uptake the 
most circulating labelled CSF1-FcAF647 on a per cell basis, in keeping with their role in CSF1 
clearance (Bartocci et al. 1987). Monocytes in the blood and liver were also able to capture 
CSF1-FcAF647, but not as efficiently as KC. In chapter 5, exogenous administration of CSF1-Fc 
to chimeric mice identified the recruitment from bone marrow of a population of 
F4/80hiCD11blo macrophages, in addition to proliferation of both host resident KC and the 
donor recruited macrophages. However, monocyte-derived macrophages failed to express 
the KC marker Tim4, and persisted only transiently. Overall I found that CSF1 availability may 
be a limiting factor in the recruitment and conversion of monocytes to KC in the liver, but 
that autonomy of KC from monocytes is highly maintained in the steady state, suggesting 
that factors in addition to CSF1 availability may be responsible for maintaining the autonomy 
of the KC population. 
Chapter 6 addressed the second major aim. A KC ‘disappearance reaction’ was noted 
following both acute and chronic CCl4-driven liver injury, along with recruitment of 
monocyte-derived macrophages which acquired an F4/80hiCD11blo phenotype. Despite this, 
KC were not replenished by these recruited macrophages following either acute or chronic 
injury. Following acute injury the recruited macrophages did not express the KC markers 
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Clec4f or Tim4, and comparison of gene expression revealed the recruited macrophages to 
have a genotype consistent with a role in wound repair. Following chronic injury the recruited 
macrophages were not found in obvious clusters, as seen in acute injury, but were seemingly 
integrated alongside KC. KC were permanently reduced in number (for over 8 weeks) 
suggestive of possible damage to a component of their niche.  
 
7.2 Caveats with the chimera system and use of inbred mice 
This study relied heavily on the tissue-protected chimera system to fate map bone marrow-
derived cells, a method used extensively to determine the rate of monocyte contribution to 
tissue macrophages in a variety of settings and tissues (Jenkins et al. 2011; Bain et al. 2016; 
Scott et al. 2016; Devisscher et al. 2017). In our hands this protocol results in partial 
chimerism of around 20-30% in circulating Ly6Chi monocytes, but crucially protects tissue 
macrophages in organs shielded by the lead from the potentially toxic effects of total body 
irradiation, such as enhanced rate of turnover (Murphy et al. 2008). A downside of this 
technique is that we cannot determine the origin of the KC prior to irradiation, however, 
there is data to suggest they are largely of embryonic origin, with some contribution from 
BM-derived cells that engraft post birth (Perdiguero et al. 2014; Scott et al. 2016). However, 
the exact nature of origin of the KC population at the point of irradiation does not impact the 
conclusions of this study on how the population is maintained over the course of CSF1-Fc or 
CCl4 treatment.  
A more serious possible caveat of using BM chimeras is that there is potential for there to be 
a competitive effect between cells of host and donor lineage. An inherent advantage of 
CD45.2+ HSCs over CD45.1+ HSCs has been demonstrated in mixed competitive chimeras, 
including in terms of their myeloid differentiation potential (Mercier et al. 2016). However, I 
used heterozygous host mice which expressed both CD45.1 and CD45.2 alleles, to attenuate 
any competitive advantage of transplanted CD45.2+ homozygous bone marrow cells. 
Additionally, if CD45.2+ cells do exhibit a competitive advantage over CD45.1+ cells, this might 
be expected to over predict the contribution of monocytes to the KC pool, since donor cells 
were exclusively CD45.2+ in my study. Since monocytes did not contribute long-term to KC in 




The routine extrapolation of findings using C57BL/6 mice as a model for macrophage origins 
has been challenged recently (Hume et al. 2019), in particular citing a study in which C57BL/6 
and Balb/c mice displayed differing responses to filarial nematode infection in terms of 
resident macrophage proliferation versus monocyte recruitment (Campbell et al. 2018). 
However, the level of KC chimerism I observed in PBS-treated Balb/c chimeras was just over 
2% (taken from the above-mentioned Campbell study), which was the level also seen in PBS-
treated control C57BL/6 chimeras (from my study in chapter 5) (data not shown). Whilst 
reassuring, I cannot say definitively that my observations that KC remain autonomous of 
monocytes following liver injury would hold true in other mouse strains, or indeed other 
species. However, the wealth of data fate-mapping steady state origins of macrophages in 
the C57BL/6 mouse is backed up by results from human transplant cases, as detailed in the 
introduction (chapter 1), giving further confidence that my results may be relevant to human 
health.  
 
7.3 Maintenance and origin of KC in steady state 
As introduced in chapter 1, resident macrophages vary in reliance on self-renewal versus 
replenishment from monocytes, in a tissue-specific manner. Additional factors including age, 
sex (Bain et al. 2016) and inflammation also critically effect this balance. The microglia of the 
brain are highly autonomous of infiltrating monocytes, and an inability of circulating 
monocytes to cross the blood brain barrier in the steady state may play a role in this (Ajami 
et al. 2007; Mildner et al. 2011). Resident macrophages in the intestine are continually 
replaced by monocyte-derived macrophages which appears to be driven by the presence of 
microbiota (Bain et al. 2014). KC in the liver are located in the sinusoids through which 
monocytes are continually circulating and although KC are unlikely to be exposed to live 
commensals in healthy animals, they are continually exposed to gut bacterial products 
(Balmer et al. 2014). Thus it is perhaps surprising that KC do not appear to have any major 
contribution of adult monocytes in homeostatic conditions, apart from a possible window of 
recruitment during the immediate post-natal phase (Bain et al. 2014; Gomez Perdiguero et 
al. 2014; Hoeffel et al. 2015; Scott et al. 2016). Even as mice age there does not appear to be 
increased monocyte incorporation, reflected by only a small but insignificant increase in 
chimerism in tissue-protected chimeras over a 24 week period (Bain et al. 2016) and the 
results of my own study revealing equivalent population sizes in year-old Ccr2-/- and WT mice. 
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Notably, total body irradiation of mice leads to replenishment of KC through a combination 
of proliferation of surviving KC and recruitment of monocytes (Klein et al. 2007; Beattie et al. 
2016). Partial depletion of KC in a Clec4f-DTR mouse also resulted in both proliferation of 
surviving resident KC and recruitment of monocyte-derived macrophages which matured 
into long-lived self-renewing KC, after which there was no further input of monocytes (Scott 
et al. 2016). Together these studies, along with my own, have shown that whilst monocytes 
are capable in principle of becoming KC and recapitulating their genotype and phenotype, in 
steady state conditions, they do not.   
 
7.4 Contribution of cellular origin versus local environmental factors on 
macrophage function 
7.4.1 Importance of origin on macrophage function 
I found that KC were not replenished by monocytes following CSF1-Fc treatment, or acute 
and chronic CCl4 liver injury, which is supported by the findings of another study which 
observed only a transient increase in chimerism in the KC population following MCD-induced 
NAFLD in mice (Devisscher et al. 2017). However, monocyte-derived KC do arise following 
Listeria monocytogenes infection (Blériot et al. 2015), indicating that the mode of KC 
replenishment is specific to the infection or injury model. Beattie et al. demonstrated that 
whilst monocyte-derived and embryonic KC were comparable in their ability to clear old red 
blood cells, respond to LPS and to Leishmania infection, there were some differences in 
scavenging ability and phagocytosis of bacterial products (Beattie et al. 2016). Furthermore, 
mice with a population of monocyte-derived KC recruited following chlodronate liposome 
(CLP) depletion of the endogenous KC displayed enhanced injury to APAP overdose, and 
delayed return of liver function (David et al. 2016). The monocyte-derived KC displayed 
reduced phagocytic ability demonstrated by poor internalisation of E. coli (David et al. 2016). 
Thus there appears to be a functional consequence of replacing embryonic KC with 
monocyte-derived KC, which may explain why it is favourable for KC to be replenished 
through self-renewal, as has been observed in all tested scenarios apart from the Listeria 
infection model. To test this idea, KC could be knocked down during the recovery phase 
following acute CCl4, at the time when the monocyte-derived macrophages are being 
recruited to the liver, between 3 and 6 days post injury, for example using the Clec4f-DTR 
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mouse (Scott et al. 2016). Differences in function, for example phagocytosis between 
monocyte-derived KC and embryonic KC could then be tested. 
 
7.4.2 Importance of environment on macrophage function 
The differences in phagocytic ability observed in the study by David and colleagues were 
absent 60 days following CLP treatment (David et al. 2016), however, suggesting that time-
of-residence in the tissue, and thus local environmental factors are ultimately more 
important in conveying function than cellular origin. In support of this, yolk sac macrophages, 
foetal liver monocytes and bone marrow monocytes were all shown to be capable of giving 
rise to alveolar macrophages when transferred to AM-deficient Csf2r-/- mice, acquiring near 
identical gene expression patterns and preventing pulmonary alveolar proteinosis (PAP) that 
normally occurs in Csf2r-/- mice (van de Laar et al. 2016). Transferred peritoneal macrophages 
in the lung acquire 70% of AM genes (Lavin et al. 2014), indicating that even a highly 
differentiated tissue macrophage can largely alter its gene expression in response to changes 
in local environment. However, whilst AMs from a WT mouse transferred to a mouse with 
no AM were also able to prevent PAP, transferred peritoneal macrophages, KC, or colonic 
macrophages into the lung were unable to prevent PAP (van de Laar et al. 2016). One possible 
interpretation for this is that the tissue environment in which the macrophage first 
differentiated may have imprinted long-term or irreversible effects on its genome. Indeed, 
differences in epigenetic programming have been observed in macrophages differentiated 
from monocytes in differing conditions (Saeed et al. 2014). This resulted in ‘long-lasting’ (up 
to 5 days) effects in terms of their subsequent response – either tolerogenic or trained 
immunity leading to a decreased or increased pro-inflammatory response respectively 
(Saeed et al. 2014). Immune training and tolerance can also be induced in resident 
macrophages, as has been demonstrated in microglia. Wendeln and colleagues gave either 
1 or 4 injection(s) of LPS to mice intra-peritoneally, resulting in immune training or immune 
tolerance respectively in microglia. Immune training led to reduced IL-10 production and 
increased neuropathology in a mouse model of Alzheimer’s disease or in focal brain 
ischaemia, whilst immune tolerance resulted in decreased production of IL-1b, IL-6 and IL-12 
and alleviated brain injury (Wendeln et al. 2018). Given that KC self-renew under non-
homeostatic conditions following acute CCl4-driven liver injury, it may be important to 
examine whether there are epigenetic changes driven by the inflammatory or indeed repair-
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associated environmental factors, and whether these confer long-lasting effects on their 
function, particularly in response to subsequent liver injury, but also in terms of their 
homeostatic functions. Although origin may have some effect on tissue macrophage 
function, environment appears to be the major contributing factor, and it is therefore 
important to understand what constitutes the macrophage niche, as discussed below.  
 
7.5 A model for the KC niche 
In a recent review, Guilliams and Scott hypothesize that tissue macrophage populations are 
regulated by a theoretical niche, which likely comprises biochemical and/or signalling 
molecules, along with physical factors such as the presence of specific structural cells 
(Guilliams and Scott 2017). They propose that there is limited niche space available in every 
tissue which defines the size of the resident macrophage population, and whether they are 
replenished through self-renewal or monocyte recruitment. Here I propose that two of the 
niche factors for KC are the availability of CSF1 and a requirement for physical contact with 
a specific cell type, likely liver sinusoidal endothelial cells (LSECs). A summary of how niche 
availability following CSF1-Fc and acute and chronic CCl4 affects KC maintenance is shown 
below (fig. 7.1). 
 
7.5.1 CSF1 and CSF1-producing cells as a niche factor 
CSF1 availability has been proposed previously as a way in which tissue macrophage numbers 
are regulated and restored following apoptosis in steady state or the macrophage 
disappearance reaction following inflammation (Jenkins and Hume 2014). Elevated levels of 
CSF1 alone were sufficient to cause recruitment and maturation of monocyte-derived 
macrophages in the liver. Despite this, monocyte-derived macrophages were lost 
preferentially over resident KC upon withdrawal of exogenous CSF1 (see fig. 7A). If the 
monocyte-derived KC had full access to all factors controlling the KC niche, then loss of host 
and donor KC would be expected to be stochastic. It is possible that the monocyte-derived 
KC are not as efficient at capturing CSF1 as the resident KC, and the CSF1-FcAF647 assay 
developed in chapter 4 could be used to determine this. Staining of livers using the Tim4 and 
F4/80 immunofluorescence protocol developed in chapter 6 would determine where the 























































Figure 7.1 Graphical summary of findings in chapters 5 and 6. (A) Monocyte-derived macrophages 
are recruited to the liver during CSF1-Fc treatment, and both donor and host macrophages proliferate 
at an enhanced rate. Upon CSF1-Fc withdrawal, donor macrophages are selectively lost over host 
macrophages. (B) 50% of KC are lost with acute CCl4, but monocyte-derived macrophages are diverted 
to the area of injury instead of replenishing the lost KC, which proliferate to restore normal numbers. 
(C) KC are lost with chronic CCl4 and do not return to normal numbers after 8 weeks of recovery. 
Monocyte-derived macrophages are recruited and may or may not come into contact with the KC 
niche supporting cells, but they do not replenish the KC population long-term, nor do monocytes 
recruited to the tissue once homeostasis is restored, indicating damage to the niche.    
 
 alongside the Tim4hi KC this would further support the idea that there are spatially defined 
niche cells which are required to support long-lived KC. It was recently shown that 
macrophages and fibroblasts form a stable two-cell circuit in vitro, with macrophages 
producing the fibroblast growth factor PDGFb whilst fibroblasts produce CSF1 (Zhou et al. 
2018). Proliferation of fibroblasts was related to the amount of space available, whilst 
macrophage proliferation was largely independent of space, indicating that fibroblasts and 
not macrophages were at ‘carrying capacity’ (Zhou et al. 2018). In other words, the size of 
the macrophage population appears to be limited by the maximum size of the fibroblast 
population in this two cell circuit. Thus in vivo, KC population size may be limited by 
population size of another cell type with which it forms a stable circuit. There are no 
fibroblasts in the liver, but there are hepatic stellate cells which become myofibroblasts when 
activated, and produce CSF1 (Baum and Duffy 2011) making them a possible niche cell 
candidate. Cell contacts were shown to be critical for the stability of the two cell circuit in 
vitro, thus perhaps when the CSF1-Fc is removed in my model, embryonic KC may still be 
attached to the CSF1-producing cell, conveying a survival advantage over the recently 
recruited KC.  
 
7.5.2 LSECs as a possible niche factor 
Macrophages are extremely sensitive to physical factors in their microenvironment, for 
example rigidity, interstitial flow and substrate softness (Jain et al. 2019), further suggesting 
there could be a specific cell type which constitutes the KC niche. Whilst physical contacts 
between macrophages and fibroblasts were shown to be critical for establishment of a stable 
circuit, LSECs have also been proposed to be a likely candidate ‘niche cell’ for supporting KC 
(Guilliams and Scott 2017). KC have been shown to put their filopodia through the 
fenestrations of LSECs (Lough et al. 1987), which may be to anchor themselves and prevent 
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them being carried away by the blood flow through the sinusoid. The central zone of the liver 
is largely devoid of KC and there is good evidence that endothelial cells also change in 
different regions of the liver, and it has been shown in rats that the endothelial cells of the 
central zone are not fenestrated (Burkel and Low 1966). Furthermore, KC numbers were 
reduced in cirrhotic livers in rats during CCl4-driven injury specifically in the regions of 
capillarisation (Lough et al. 1987). Additionally, we have identified that the ‘endothelial 
contamination’ discovered in the KC gate following a conventional CD45+Lineage-
F4/80hiCD11blo gating strategy included some LSECs which were in tight association with KC 
or KC membranes (Lynch et al. 2018). These associations were not separated even with 
enzymatic digestion, mechanic and manual shaking and the presence of EDTA which 
diminishes cell-cell contacts through chelation of Ca2+ (Le et al. 1999). Thus these associations 
identified by flow cytometry may actually represent a functionally significant conjugate, as 
was demonstrated between T follicular helper cells and B cells (Reinhardt et al. 2009). The 
isolation of CD31+ LSECs which are still in association with F4/80hiCD11blo KC in our study 
(Lynch et al. 2018) provides a tool to further examine these cells, and compare differences 
between these LSECs and the rest of the LSEC population to determine whether there are 
specific transcriptional or morphological differences which confer ability to support a KC.  
Following chronic injury, flow cytometry indicated that KC did not recover in number even 8 
weeks after the final dose of CCl4. This finding needs to be further backed up with imaging, 
but it appears that neither incumbent KC nor monocyte-derived macrophages were able to 
replenish the population, indicating that a component of the niche had been damaged. This 
may be due to loss of KC-supporting LSECs through capillarization. Very recently, it was 
shown that defenestration does not occur in the chronic condition NAFLD that results from 
high fat diet over 20 weeks (Kus et al. 2019), and this could explain why KC were not reduced 
in number in the Devisscher study of NAFLD, discussed in chapter 6 (Devisscher et al. 2017). 
Proving that fenestrated LSECs are absolutely required for maintaining KC will be difficult, 
but one way to do this might be by using 2D and 3D co-culture systems. For example, contact 
with endothelial cells has already been shown to be able to support differentiation of F4/80+ 
cells from a mixed haematopoietic cell population using a 2D co-culture system (He et al. 
2012). Using macrophages and neurones derived from induced pluripotent stem cells, it has 
been shown that the soluble components in neuron-conditioned media were sufficient for 
induced macrophage survival, but that direct contact with neurons was required for their full 
differentiation into microglia-like macrophages (Takata et al. 2017). Thus this technique 
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could be adapted to show that full development of KC requires contacts with fenestrated 
endothelium. If treatments which cause defenestration, for example, knock down of Cav-1 
(Luo et al. 2018), also result in loss of KC, or disruption of their morphology or phenotype this 
would further support a role of fenestrated LSEC in maintaining KC. A drug called Plumbagin 
has recently been shown to ameliorate capillarization of LSECs in vitro (Li et al. 2017), and it 
would be interesting to know whether treatment with Plumbagin or similar drugs could 
reverse or prevent defenestration in vivo, and if this would also lead to recovery of normal 
KC numbers in chronic CCl4 injury. Thus the next major next step will be proving the exact 
identity of the KC niche cell, as this may be critical for manipulating KC and monocyte-derived 
macrophage fate, function and number during liver injury and repair.  
 
7.6 Why does injury lead to a macrophage disappearance reaction?  
The loss of macrophages following injury or infection is not unique to the liver: alveolar 
macrophages are reduced in number following influenza A infection, F4/80hi peritoneal 
macrophages are lost following zymosan-induced inflammation and Langerhans cells are lost 
following exposure to UV light (Merad et al. 2002; Davies et al. 2011; Lauder et al. 2011). The 
loss of KC following liver injury observed in my study following both acute and chronic CCl4-
driven injury may serve to activate the subsequent immune response. Indeed, chlodronate 
liposome depletion of KC resulted in enhanced recruitment of Ly6Chi monocytes and more 
rapid clearance of hepatitis B virus in mice (Wu et al. 2019). But how does the loss of KC result 
in enhanced recruitment of monocytes? Activated macrophages are known to increase in 
size, but resident macrophages may be prevented from fully spreading due to the fact that 
they are tightly packed by surrounding cells. Confinement of macrophages resulted in a 
reduced pro-inflammatory response to LPS in vitro, including reduced expression of IL-6, IL-
1b and iNOS (Jain and Vogel 2018), and Hume et al. theorize that loss of a proportion of the 
resident macrophage population allows the remaining cells to spread fully, resulting in an 
inflammatory immune response. (Hume et al. 2019). This doesn’t appear to be the case in 
the CCl4 model as immunofluorescence imaging indicates that KC were lost in the area of 
injury. However, more sophisticated analysis of images would be required to confirm that 
there is not also a reduction in density of KC in the healthy parenchyma. With CCl4, KC may 
be lost through apoptosis or more likely necrosis or necroptosis, which in itself results in 
release of DAMPs and immune cell activation (Sachet et al. 2017). Given the high 
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consumption of CSF1 by KC demonstrated in chapter 4 (Hawley et al. 2018), it is also possible 
that loss of KC may be required to ‘free up’ CSF1 availability to allow sufficient recruitment 
of monocytes to the injured liver. Certainly recruitment of inflammatory macrophages to the 
peritoneal cavity is CSF1-dependent in a variety of inflammation models, as neutralisation of 
CSF1 using an anti-CSF1 antibody resulted in reduced numbers of recruited macrophages 
(Louis et al. 2015). CSF1 expression in the liver increased 4-fold 24 hours following APAP-
induced acute liver injury, and delivery of rCSF1 in this model resulted in increased numbers 
of monocyte-derived macrophages (Zigmond et al. 2014). Thus loss of KC may result in 
monocyte recruitment through a combination of expression or release of inflammatory 
cytokines and DAMPs, and by allowing CSF1 levels which are sufficient to result in enhanced 
monocyte recruitment. Death of KC may also serve an additional purpose which could be to 
aid tissue regeneration – necroptosis of microglia has been shown to be critical for 
remyelination following injury to the CNS, as the death of the proinflammatory microglia 
allows repopulation to a pro-regenerative phenotype (Lloyd et al. 2019). The authors 
demonstrated the role of necroptosis through its inhibition using necrostatin-1, and a similar 
approach could be employed following CCl4 injury to reveal whether KC death plays a similar 
role in this model.  
 
7.7 Role of monocyte subsets in liver injury 
The emergence of monocyte-derived macrophages in this study provoked the question of 
whether they were derived from classical Ly6ChiCCR2+ monocytes, non-classical Ly6CloCCR2- 
or possibly an intermediate phenotype. During liver injury classical, inflammatory monocytes 
are recruited to the liver and express high levels of pro-inflammatory cytokines including 
TNF-α and IL-6 (Triantafyllou et al., 2018). In APAP-induced acute liver injury this recruitment 
was shown to be CCR2-dependent, upon which they were found to contribute to resolution 
of injury (Holt et al., 2009). Similarly, in chronic CCl4-induced liver injury, classical monocytes 
were found to downregulate Ly6C and become pro-restorative (Ramachandran et al., 2012). 
This phenotypic switch of inflammatory monocytes to an anti-inflammatory, pro-restorative 
phenotype was elegantly demonstrated by directly visualising their conversion from 
CCR2+CX3CR1+ cells labelled with RFP to CCR2-CX3CR1+ GFP+ cells, along with intermediate 
orange and yellow cells which were dual positive for both CCR2 and CX3CR1 (Dal Secco et al., 
2015). IL-10, IL-4 and clearance of necrotic material all contributed to triggering this 
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phenotypic switch. The CX3CL1-CX3CR1 axis appears to be crucial for this phenotypic switch, 
as recruited monocytes in CX3CR1-/- mice do not effectively convert and remain 
inappropriately pro-inflammatory resulting in prolonged liver inflammation (Karlmark et al., 
2009). Thus, rather than sequential recruitment of inflammatory- followed by reparatory- 
monocytes from blood, differentiation of classical monocytes in situ appears to be necessary 
for the process of injury followed by repair. A similar differentiation process appears to be 
necessary in humans. CD14+CD16- classical monocytes have been demonstrated to switch 
towards the intermediate CD14+CD16+ phenotype in response to TGF-β and IL-10 (Liaskou et 
al., 2012). These intermediate cells were pro-inflammatory and may contribute to ongoing 
hepatic fibrosis in humans with chronic liver injury (Liaskou et al., 2013). Interestingly, 
CX3CR1 is downregulated in patients with cirrhosis, compared to healthy volunteers, 
indicating that for resolution of liver disease the phenotypic switch to a CX3CR1+ non-
classical, pro-restorative monocyte may be dis-regulated (Karlmark et al., 2009). Thus, 
Ly6ChiCCR2+ classical monocytes remain the most likely candidate for the precursor of the 
recruited macrophages identified in this study.  
 
7.8 Concluding remarks 
Overall I believe that this body of work contributes significantly to our understanding of how 
KC are maintained in both homeostasis and liver injury, and provides answers to questions 
which were pertinent in the field when I embarked on this research. The clear outstanding 
questions are whether manipulation of niche factors provides a promising way to affect 
macrophage population size and function and prevent the pathological consequences that 
accompany loss or change KC function during chronic liver injury (Balmer et al. 2014; 
Heymann et al. 2015), and what are the specific niche factors that govern resident 
macrophages in other tissues? My finding that KC persist via self-renewal through the course 
of acute and chronic injury also raises the question of whether inflammation imprints long 
term effects on KC function, akin to so called ‘trained immunity’ that occurs in monocytes 
and other tissue macrophages with activation, and if so, what these effects may be? This 
question maybe particularly pertinent to pathological processes that occur with intermittent 
liver injury, for example with binge drinking. If we can begin to answer these questions, this 
could help with understanding how KC can be targeted in human health, particularly with 
regard to improving homeostatic liver function in the setting of chronic liver diseases.  
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Abstract
Multicolor flow cytometry and cell sorting are powerful immunologic tools for the study of hep-
atic m!, yet there is no consensus on the optimal method to prepare liver homogenates for these
analyses. Using a combination of m! and endothelial cell reporter mice, flow cytometry, and con-
focal imaging, we have shown that conventional flow-cytometric strategies for identification of
Kupffer cells (KCs) leads to inclusion of a significant proportion of CD31hi endothelial cells. These
cells were present regardless of the method used to prepare cells for flow cytometry and rep-
resented endothelium tightly adhered to remnants of KC membrane. Antibodies to endothelial
markers, such as CD31, were vital for their exclusion. This result brings into focus recently pub-
lished microarray datasets that identify high expression of endothelial cell-associated genes by
KCs compared with other tissue-resident m!. Our studies also revealed significant and specific
loss of KCs among leukocytes with commonly used isolation methods that led to enrichment of
proliferating and monocyte-derived m!. Hence, we present an optimal method to generate high
yields of liver myeloid cells without bias for cell type or contamination with endothelial cells.
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1 INTRODUCTION
Liver Kupffer cells (KCs) are one of the largest populations of res-
ident m! in the body. KCs are located in the sinusoids of the liver
where they scavenge and phagocytose apoptotic cells and damaged
erythrocytes,1 contribute to maintenance of immunologic tolerance
by priming Foxp3+ T-regulatory cells,2 and capture gut commensal
bacteria that enter the circulation.3 Under homeostatic conditions,
KCs proliferate in situ and persist with relatively little input from
conventional hematopoiesis in adult mice.4–6 However, during liver
inflammation, stress, or injury, Ly6Chi monocytes are recruited to the
liver and subsequently mature into monocyte-derived hepatic m!.
Both KCs andmonocyte-derivedm! have been attributed prorestora-
tive or proinflammatory roles in models of acute and chronic liver
damage.7–9 To better understand the function of KCs and monocyte
Abbreviations: Cdh5, Cadherin 5; CLEC4F, C-type lectin domain family 4member F; KCs, Kupffer cells; LSEC, liver sinusoidal endothelial cells
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derived m!, it is important not only to accurately identify these cells
but also to ensure a comprehensive portrait of the in vivo population
is generated.
Multiparameter flow cytometry is a powerful tool for evaluating
changes in number, frequency, and phenotype of diverse monocyte
and m! populations and is the basis by which these cells are purified
for subsequent functional and genomic analyses. Many protocols have
been used to isolate leukocytes from the liver, but there is no consen-
sus on which method is most valid, particularly for KCs. Furthermore,
although the definition of KCs by flow cytometry is widely accepted
as F4/80hiCD11blo cells, the reliability of this approach has not
been fully investigated. For example, several microarray and RNA-seq
datasets identified Cdh5, a gene typically associated with endothelial
cells,10 as differentially expressed by KCs comparedwith other tissue-
resident m!.11–13
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Here, we demonstrate that the population of KCs conventionally
defined by their F4/80hiCD11blo phenotype contains a significant pro-
portion of contaminatingCD45+CD31hi endothelial cells, and that this
contaminationwas present regardless of themethod used for isolating
leukocytes from the liver. Inclusion of endothelial markers rather than
additional surface markers of m! was critical for excluding these cells
fromanalysis. Furthermore, quantity and quality of isolatedKCs varied
significantly dependent on the purificationmethod used.We therefore
present a comprehensive protocol for faithfully isolating leukocytes




Wild-type (WT) C57BL/6OlaHsd CD45.2+, congenic C57BL/6
CD45.1+CD45.2+, C57BL/6OlaHsd Csf1r-mApple+ mice,14
and Cdh5-Cre-ERT2 mice15 crossed with the mTmG
(Rosa26Sortm4(ACTB-tdTomato, EGFP)Lou/J) line,16 were bred and main-
tained in specific pathogen-free facilities at the University of Edin-
burgh, UK. Mice were sex and age matched, 6–12 weeks for WT
studies and 11–12 weeks for Cdh5 mice. Bone marrow chimeric
mice were generated as previously described.17 Briefly, C57BL/6
CD45.1+CD45.2+ mice were anesthetized and hind legs irradiated
with 950 rad while remaining tissues were protected by lead. Mice
were reconstituted the next day with 2–5 × 106 donor bone marrow
cells from congenic CD45.2+ animals and rested for 8 weeks prior
to analysis. All experiments were approved by the University of
Edinburgh Animal Welfare and Ethical Review Body under license
granted by the UKHomeOffice.
2.2 Tamoxifen administration
To induce Cre expression in Cdh5-Cre-ERT2:mTmG mice, sterile fil-
tered tamoxifen (Sigma, Irvine, UK; 100 mg/kg) dissolved in corn oil
(Sigma; 20 mg/ml) was administered i.p. for 5 consecutive days and
mice left for 2 weeks.
2.3 CSF1-Fc and BrdU administration
An Fc conjugate of porcine CSF1 (CSF1-Fc) was prepared as
described.18 Analysis of KC and endothelial cell proliferation in
response to administration of CSF1-Fc was performed on cells from a
larger unpublished study aimed at assessing the effect of chronic CSF1
delivery on KCs origin in tissue-protected bone marrow chimeric mice
made as described previously.17 Tissue protected chimeric mice were
given 1 "g/g CSF1-Fc delivered in PBS s.c. or PBS control on day 1, 3,
17, 19, 33, and 35 before analysis on day 37. Mice were pulsed with
1mg BrdU s.c. 2 h before necropsy.
2.4 Isolation of leukocytes from liver
Following perfusion of PBS through the inferior vena cava, livers were
placed into RPMI, finely chopped using a razor blade and digested in
5 ml of enzyme mix (RPMI with 0.625 mg/ml collagenase D, 30 U/ml
DNase [Roche, Burgess Hill, UK], 0.85 mg/ml collagenase V [Sigma],
and 1 mg/ml dispase [Invitrogen, Paisley, UK] for 25 min at 37◦C, in
an orbital shaker with additional manual shaking every 5 min. Digests
were poured through a 100 "m strainer and then prepared according
to the protocols below. Unless otherwise stated, all wash buffers were
kept at 4◦C. At the end of all protocols, cell pellets were resuspended,
passed through a 40 "m strainer, and live cells counted using a Casey
TT counter (Roche).
2.5 300 g centrifugation
Cells were washed in 50ml, then 30ml RPMI, and centrifuged at 300 g
for 5 min, maximum break and accelerator. RBC lysis buffer (Sigma;
2 ml) was added for 2 min, followed by 2 ml FACS buffer (PBS supple-
mented with 0.5% BSA and 2 mM EDTA). Cells were pelleted (300 g,
5 min) and the supernatant discarded.
2.6 33%PercollTM gradient
Cells were washed twice in 50 ml liver wash buffer (PBS/2% FCS) by
centrifugation at 443 g for 6min, maximum break and accelerator. The
pellet was resuspended in a room-temperature 33% Percoll gradient
(25 ml per sample) and spun at 693 g for 12 min, with minimum break
and accelerator. The cell pelletwaswashed in 30ml liverwashbuffer at
300 g for 5min. RBC lysis buffer (5ml) was added for 5min, then 30ml
liver wash buffer and cells spun at 300 g for 5min.
2.7 50 g centrifugation
Cells were washed in 15ml RPMI containing 10% FCS and centrifuged
at 50 g for 10min withminimum break. The supernatant was collected
and spun at 340 g for 10 min, minimum break. The pellet was lysed for
5 min in 2 ml RBC lysis buffer on ice, topped up with RPMI + 10% FCS
and spun at 340 g for 10min, minimum break.
2.8 Collection of discarded fractions
For the 300 g spin and Percoll gradient methods, the supernatant or
both the hepatocyte layer, and the supernatant between the hepato-
cyte layer and the leukocyte pellet, respectively, was collected into a
fresh tube and centrifuged at 400 g for 5 min. The resultant pellets
were counted and stained. For the 50 g slow-spin method, the pellet
generated following the 50 g spin was counted and stained.
2.9 Isolation of leukocytes from lung
Perfused lungs were collected into RPMI, homogenized using scissors
and digested in 2 ml of the enzyme mix detailed above, for 45 min at
37◦C. Digests were filtered through a 100 "m strainer, washed with
FACS buffer and RBC lysed in 3 ml RBC lysis buffer (Sigma) for 3 min.
Afterwashing, cellswerepassed througha40"mstrainer andcounted.
2.10 Flow cytometry
2 × 106 liver cells, or 20 "l of whole blood was incubated with Zombie
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then with 0.025 !g anti-CD16/32 (2.4G2; Biolegend) in 10% normal
mouse serum (Life Technologies, Paisley, UK). Cells were then incu-
batedwith antibodies (Supplemental Table 1). Cells werewashed, spun
at 300 g for 5 min and, where necessary, incubated with fluorescently
labeled streptavidin. 7-AAD solution (Biolegend) was added to sam-
ples 10 min before acquisition when comparing isolation protocols.
DAPI was used as a viability marker for FACS. Liver cells were gated
as shown, whereas alveolar and interstitial m" were identified as
CD45+CD11c+SiglecF+ and CD45+CD11c+SiglecF−MHCII+CD64+
cells, respectively.
For BrdU and Ki67 staining, cells were fixed and permeabilized
overnight in FoxP3/Transcription Factor Staining Buffer (eBioscience).
Cells were washed in PermWash (eBioscience) and stained with anti-
Ki67 and anti-BrdU antibodies.
Cellswere acquiredona LSRFortessa (BDBiosciences,Wokingham,
UK) or FACSAriaII (BD) at the QMRI Flow Cytometry and Cell Sorting
Facility, University of Edinburgh, and data analyzed in FlowJo software
(Tree Star, Ashland, Oregon). Fluorescence-minus-one controls were
used to set gates.
2.11 Immunofluorescence
The median lobe from perfused liver of Cdh5-Cre-ERT2:mTmG mice
was fixed in 4% methanol-free PFA (Thermo Scientific, Paisley, UK) at
4◦C for 2–3 h then washed in PBS and resuspended in 15% sucrose
gradient for 1 h at room temperature followed by 30% sucrose at 4◦C
overnight. Tissue was then flash frozen in optimal cutting temperature
(OCT) embedding matrix (Fisher Scientific, Loughborough, UK) and
stored at−80◦C. Seven-micrometer sectionswere cut using a cryostat.
Following blocking with 20% normal goat serum, sections were
stained with rat anti-mouse F4/80 (Abcam, Cambridge, UK; CI:A3-
1) then AlexaFluor-594 goat anti-Rat IgG secondary (Abcam). Total
number of F4/80+ KCs were enumerated per liver slice and GFP and
F4/80 coexpression assessed. Immunofluorescent analysis of single
cells was performed on FACS-purified cells. Ten microliters of sorted
cells was plated on a perfusion open and closed chamber for analy-
sis at 20× magnification and images acquired using a Leica confocal
SP5microscope.
2.12 Statistical analysis
Datawere analyzed in Prism 6 or 7 (GraphPad), with statistics detailed
in relevant figure legends. *P < 0.05, **P < 0.01, ***P < 0.001,
****P< 0.0001.
3 RESULTS
3.1 F4/80hiCD11blo KCs identified by flow
cytometry contain a subset of Cdh5hiCD31hi cells
KCs have been traditionally defined by their F4/80hiCD11blo
phenotype, which distinguishes them from F4/80loCD11b+ bone-
marrow-derived myeloid cells.19 Global transcriptomic analyses have
demonstrated that, like all tissue m", KCs have a unique transcrip-
tional signature,11–13 withCLEC4FandTim4emerging asmarkers that
aid their discrimination from other hepatic monocytes and m".12,20
However, these same analyses also identified Cdh5 (which encodes
cadherin-5), a gene strongly associated with endothelial cells,10 as
part of the KC-specific signature.11–13 Interrogation of the publically
available ImmGen resource (www.immgen.org) revealed a similarly
high enrichment of Cdh5 transcripts in KCs compared with other
tissuem" (data not shown). To establish whether KCs expressed Cdh5,
we used a transgenic mouse strain that expresses tamoxifen-inducible
Cre recombinase under the control of the Cdh5 promoter (Cdh5-Cre-
ERT2)15 crossed tomTmG reportermice.16 While all cells inCdh5-Cre-
ERT2:mTmGmice express tdTomato, tamoxifen administration results
in Cre recombinase activity, excision of the tdTomato cassette, and an
irreversible switch to EGFP expression in Cdh5 expressing cells and
their progeny. Flow cytometric analysis of whole liver isolates gated
on live, CD45+ lineage− leukocytes (Fig. 1A) revealed a clear bimodal
expression of GFP in F4/80hiCD11blo KCs, suggesting higher expres-
sion of Cdh5 by a fraction of these cells (Fig. 1B). Bimodal expression
of the endothelial marker CD31 was also evident (Fig. 1B), and simul-
taneous analysis of GFP and CD31 revealed a bright double positive
population (Fig. 1C) that accounted for ∼10% of the F4/80hiCD11blo
population (Fig. 1D). In comparison, less than 0.52% of lung interstitial
m" and 0.53% of alveolar m" were CD31hiGFPhi suggesting this phe-
nomenonwas not common to all m" populations (Fig. 1D). Back-gating
of the CD31hiGFPhi andCD31loGFPlo populations revealed they could
not be discriminated based on size, granularity, and expression of other
leukocyte markers such as CD45, Ly6C, and MHCII (data not shown).
However, whereas tdTomato expression was significantly diminished
in the CD31hiGFPhi fraction of KCs (Fig. 1E), the CD31lo GFPlo cells
retained identical levels to untreated control mice, indicating that
Cre-mediated excision of the tdTomato cassette had not occurred
(Fig. 1F). A similar minor increase in GFP fluorescence without loss of
tdTomato expression was also observed in B cells, T cells, neutrophils,
and monocytes following tamoxifen treatment (data not shown).
Hence, although F4/80hiCD11blo-defined KCs contain a subset of
CD31hi Cre-expressing cells, it seems likely that the low GFP fluores-
cence of CD31lo KC from tamoxifen-treated mice does not represent
meaningful expression of Cdh5-driven Cre.
3.2 Endothelial cells contaminate the traditional
F4/80hi CD11blo KC gate
We further investigated the identity of the CD31hiGFP+ fraction of
F4/80hiCD11blo cells. Analysis of all CD31hi cells within the liver
preparations revealedbindingofCD45andF4/80antibodies tobe spe-
cific when compared with their respective isotype controls (Fig. 2A).
Unlike CD31lo KCs, the CD31hi F4/80hiCD11blo cells also expressed
high levels of ICAM-2 and Lyve-1 (Fig. 2B), consistent with a lym-
phatic or liver sinusoidal endothelial phenotype. However, tissue sec-
tions from Cdh5-Cre-ERT2:mTmG mice suggested little true colocal-
ization of F4/80 with GFP (Figs. 2C and 2D). Indeed, FACS sorting fol-
lowed by confocal microscopy revealed some CD45+F4/80hiCD31hi
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F IGURE 1 (A) Identification of F4/80hiCD11blo KCs in murine liver. Lineage = CD3, CD19, Ly6G, and Siglec F. (B) Representative GFP and
CD31 expression by F4/80hiCD11blo liver cells from Cdh5-Cre-ERT2;mTmG mice. Proportion of GFP+ and CD31hi cells shown (mean, n = 7, 3
experiments). (C) Representative GFP and CD31 expression by F4/80hiCD11blo liver cells from Cdh5-Cre-ERT2;mTmG mice ± tamoxifen. (D)
The frequency of CD31hiGFP+ cells amongst KCs, lung interstitial and alveolar m!. Liver (n = 7, 3 experiments) and lung (n = 4, 2 experiments).
(E and F) Geometric mean fluorescence intensity (GeoMFI) of dTomato expression by CD31loGFP− KCs (E) and CD31hiGFP+ cells (F) (n= 3/group,
representative of 3 experiments)
whereas the majority of CD31hi cells exhibited punctate colocalized
surface staining of CD45 and F4/80 indicative of endothelial cells to
which surface membrane from KC was tightly adhered (Fig. 2E). Con-
sistent with this, staining for other KC-specific surface markers, such
as Tim4 or CLEC4f,12 could not differentiate the CD31hi and CD31lo
populations despite a very marginal difference in expression intensity
(Fig. 2F). In contrast, expression of a Csf1r-driven mApple transgene, a
cytoplasmic marker of myeloid cells,14 distinguished mApplehiCD31lo
KCs from mApple−CD31hi contaminants (Fig. 2G). Furthermore,
CD31hiF4/80hiCD11blo cells did not proliferate in response to the
m! mitogen CSF1 (Fig. 2H).18,21 Thus, it would seem most likely that
CD45+F4/80hiCD31hi cells identified by flow cytometry represent
endothelial cells with remnants of KC membranes that are largely
devoid of the intracellular components of these cells. Hence, although
transgenic or intranuclear markers of KCs can aid their discrimina-
tion, surface staining forCD31would seem themost technically simple
method for excluding these cells during flow cytometry or FACS.
Of note, unbiased analysis of all CD31hi cells expressing the
hematopoietic marker CD45 revealed them to comprise both
F4/80hiCD11blo cells as described above but also other hematopoietic
cells (Fig. 2I). Rather than bona fide CD45+ endothelial cells, FACS
and imaging of CD45+F4/80−CD31hi cells revealed a population of
endothelial cells that appeared to envelop small CD45+ cells (Fig. 2J).
Although these could be simple doublets, they may also represent
transmigrating hematopoietic cells described in human liver sinusoidal
endothelial cells (LSECs) in vitro.22 Either way, we find no evidence
that CD45+CD31hi cells represent single cells with both hematopoi-
etic and endothelial characteristics akin to those described in
rat liver.23
3.3 Endothelial cell contamination is present
irrespective of liver digestion protocol
Multiple methods for generating single cell preparations of murine
liver leukocytes have been published and while most protocols involve
enzymatic digestion, the separation of leukocytes from hepatocyte
debris is more inconsistent. Hence, to exclude the possibility that the
observed endothelial cell contamination was an artifact specific to
our protocol for isolation of leukocytes from the liver, we compared
the frequency of CD31hi cells in the KCs population retrieved using
3 methods representative of commonly published protocols. In brief,
all methods used the same enzymatic digestion step but employed
either two 300 g centrifugation steps (as used for Figs. 1 and 2),17 an
initial 50 g prespin to first pellet and discard hepatocytes,24,25 or a
33% Percoll gradient to remove the majority of hepatic debris.26,27
The relative frequency of all CD31hi endothelial cells recovered as
a proportion of all live cells was equivalent between the 300 g and
the Percoll gradient methods, though reduced with the 50 g prespin
method, suggesting a proportion of endothelial cells are removed by
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F IGURE 2 (A) Representative expression of CD45 and F4/80 by
total CD31hi liver cells (n = 6, 2 experiments). (B) Representative
histograms (n = 6, 2 experiments) and delta MFI (n = 3/group, rep-
resentative of 3 experiments) of ICAM-2 and LYVE-1 expression by
F4/80hiCD31hi cells and F4/80hiCD31lo KCs. Significance determined
by t-test. (C) Confocal image of liver from Cdh5-Cre-ERT2;mTmGmice
(dTomato = nonrecombined cells; GFP = recombined cells) stained
with F4/80 (blue). Scale bar, 20 !m. (D) Proportion of F4/80+Cdh5+
cells from (C) (10 FoV at 40× magnification of 4 livers). (E) Repre-
sentative maximal projections of confocal z-stacks of FACS-purified
(continued on the next column)
cells within the F4/80hiCD11blo KC gate using all 3 protocols (Figs. 3B
and 3C), and most pronounced with the 50 g method. Notably,
KC-specific Cdh5 expression was observed in microarray datasets
generated with11,13 or without12 Percoll gradient purification and
low-speed centrifugation. Hence, although it remains possible that KC
express Cdh5 at higher levels than other resident tissuem", it is highly
likely that contaminating endothelial cells contributed significantly to
the high expression of this gene by KCs. The exclusion of CD31hi cells
(Fig. 3D) is therefore a critical step for the faithful identification of KCs
inmouse liver irrespective of isolation protocol.
3.4 Isolationmethod can lead to selective
loss of KCs
After removal of CD31hi endothelial cells, we observed clear differ-
ences in the relative abundance of KCs amongst live CD45+ cells
between isolation methods, with much lower frequencies using both
the Percoll and 50 g prespin methods, whereas the frequency of
F4/80loCD11bhi cells was more consistent (Fig. 4A). To determine
whether the difference in relative abundance in KCs between meth-
ods was due to selective loss of these cells with the Percoll gradient
and 50 g prespin methods or enrichment with the 300 g method, we
analyzed the hepatocyte pellet from the 50 g prespin, the supernatant
from the first 300 g spin, and the hepatocyte layer from the Percoll gra-
dient alongside the normal isolates. KCswere clearly identifiable in the
discards from all protocols but at an elevated frequency in the Percoll
and 50 g spin methods (Fig. 4B). Comparison of the frequency of KCs
of total CD45+CD31− cells within the isolate compared directly with
the frequency of KCs in the discard for each sample showed that KCs
were significantly enriched in the discard of both the Percoll and 50 g
spin methods, but not in the 300 g spin method (Figs. 4C–4E). Thus,
KCswere selectively lost using both thePercoll and the 50 g spinmeth-
ods,whereas the ratio of all leukocytes includingKCswasnot altered in
the discard versus the isolate with the 300 g spin method. The Percoll
method also yielded far fewer CD45+ cells compared with the 300 g
method (Fig. 4F), that together with the lower abundance of KCs, cor-
responded to over a 7-fold reduction in yield of KCs using this method
(Fig. 4G). It was not possible to obtain accurate cell counts from the
50 g method due to large amount of debris seemingly retained with
this method, nor were many KCs present in the pellet extracted from
the discarded Percoll (Fig. 4G), suggesting most remained within the
F4/80hiCD31hi. CD31 (green), F4/80 (blue), CD45 (red), and merge
(purple). White arrows indicate areas of punctate surface F4/80
and CD45 staining by CD31+ cells (n = 5 from 2 separate experi-
ments). Scale bar, 10 !m. (F) Representative Tim4, Clec4f, and CD31
expression by F4/80hiCD11blo cells. (G) Representative mApple and
CD31 expression by F4/80hiCD11blo cells from Csf1r-mApple trans-
genic mice or their negative littermate controls (n = 9, 3 exper-
iments). (H) Proportion of BrdU+Ki67+ cells amongst CD31hi and
CD31lo F4/80hiCD11blo cells after administration of CSF1-Fc or PBS
(n = 4, 1 experiment). Significance determined by 1-way ANOVA.
(I) Overlay of all CD45+CD31hi cells (red) onto CD45+CD31lo cells.
(J) Representative maximal projections of confocal z-stacks of FACS
sorted CD45+F4/80−CD31hi cells, demonstrating a CD45+ cell (red)
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F IGURE 3 (A)The frequencyofCD31hi cells of all live, single cells. (B andC)Representative flowplots (B) and replicatedata (C) of theproportion
of CD31hi cells amongst F4/80hiCD11blo cells obtainedwith different protocols (300 g, Percoll, 50 g) (n= 4–8/group, 2 experiments). (D) Improved
gating strategy incorporating CD31 to identify endothelial contaminants from the F4/80hiCD11blo KCs population. Significance determined by
1-way ANOVA
F IGURE 4 (A and B) Representative flow plots of all isolated (A) and discarded (B) live CD45+CD31lo cells showing proportions of
F4/80hiCD11blo and F4/80loCD11bhi populations from livers prepared for flow cytometry by 1 of 3 different protocols. (C–E) The relative
frequency of F4/80hiCD11blo KCs, F4/80lo cells granulocytes, B cells and T cells as a proportion of all CD45+CD31lo leukocytes in the cell iso-
late linked to the frequency in the discard for the various protocols (n = 4–8/group, 2 experiments). Significance determined by multiple t-test
(Holm-Sidak correction). (F andG) Number of CD45+ cells or CD45+F4/80hiCD31lo KCs isolated by either 300 g or Percoll method (n= 8/group, 2
experiments). Significance determined by t-test and 1-way ANOVA respectively. (H) Nonhost chimerism amongst KCs and F4/80lo cells from liver
of WT > WT tissue-protected BM chimeric mice isolated by 300 g or Percoll protocol (n = 8/group, 2 experiments). (I) Proportion of Ki67+ KCs
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Percoll. Importantly, the loss of a large fraction of KCs using the Per-
coll method also led to different interpretation of important aspects
of KCs biology. Specifically, KCs turnover in CD45.1/CD45.2 congenic
BM chimeras was exaggerated in Percoll preparations compared with
the 300 g method, as was the frequency of KCs positive for the cell
cyclemarker, Ki67 (Figs. 4H–4I). Hence, the choice of isolationmethod
also significantly affected readouts of KCs origin and function. Two
300 g centrifugation steps would appear to give the most accurate,
unbiased assessment of the frequency of KCs within liver leukocytes,
the greatest yield of leukocytes, and hence the most representative
portrayal of the characteristics of KCs in vivo.
For simplicity, only 1 slow prespin (50 g) and 1 density gradient
(33% Percoll) method were compared in our study. However, we
acknowledge that there is considerable variation reported in number
and speed of centrifugations, as well as gradient concentrations
used in protocols to isolate liver leukocytes.11,13,28,29 Nevertheless,
our data suggest that careful optimization of these methods will be
required for studies where KCs are themajor cell of interest.
4 SUMMARY
It is imperative that populations isolated for flow cytometric,
gene comparison, and functional analyses are representative
of those in vivo. We have demonstrated that the established
CD45+F4/80hiCD11blo gating strategy used to identify KCs in
liver preparations also contains a population of endothelial cells. These
cells could not be excluded using antibodies to KCs surface antigens
and because endothelial cells were also found to form aggregates
with other CD45+ cell types, we propose the simplest method to
exclude them from analysis is by inclusion of antibodies to CD31 or
other endothelial markers. We suggest that this strategy be adopted
universally (Fig. 3D), particularly as endothelial contamination was
apparent using all commonly used methods for the preparation of
hepatic leukocytes for flow cytometric analysis. Cell conjugates iden-
tified by flow cytometry can reveal functionally important in vivo cell
interactions30 and hence, endothelial cells to which KC membrane is
tightly bound may well represent those LSECs intimately interacting
with KCs at the point of necropsy. Since KCs remain largely static in
the steady state31 further investigation of this subset of LSECs may
identify factors controlling the turnover and function of KCs.32
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